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1001-91 The P-selectin Gene Polymorphism val168met: A Novel 
Risk Marker for the Occurrence of Primary Ventricular 
Fibrillation During Acute Myocardial Infarction
Elif Elmas, Peter Bugert, Tatjana Popp, Siegfried Lang, Christel Weiss, Christian 
Wolpert, Martina Brueckmann, Martin Borggrefe, Thorsten Kaelsch, University Hospital 
Mannheim, Medical Faculty Mannheim, University of Heidelberg, Germany, Mannheim, 
Germany, Institute of Transfusion Medicine and Immunology, Mannheim, Germany
Background: Ventricular fibrillation (VF) in the context of myocardial infarction (MI) is the 
leading cause of sudden cardiac death (SCD). Family history of SCD is described as risk 
factor for primary VF during acute MI. Genetic factors may be associated with primary VF. 
Therefore, the aim was to examine polymorphisms in various candidate genes of patients 
with and without VF in the setting of MI and among healthy controls.
Methods: 240 patients with a history of MI and 475 healthy controls were studied. 73 
patients (30%) had primary VF during acute MI. By using PCR techniques with sequence-
specific primers (PCR-SSP) we genotyped 5 single nucleotide polymorphisms (SNPs) 
in P-Selectin (PSEL) (V168M, S290N, N592D, V599L, T715P), 2 SNPs in P-selectin 
glycoprotein ligand-1 (PSGL-1) (M62I, S273F), 1 SNP in SCN5A (H558R), and 5 SNPs in 
CD40L (A-3459G, A122C, A123C, T148C, intr4_T13C). In addition, length polymorphisms 
in PSGL-1 (36bp-tandem repeat) and CD40L (CA-repeat) were genotyped by PCR-
methods. Results were evaluated by two-sided t-tests, chi square tests and logistic 
regression analysis.
Results: Overall, the PSEL variant 168M was found in 27 of 240 patients (11.25%) 
which was very similar to the frequency among healthy controls (approx. 12%). Among 
patients with a history of VF however, the PSEL 168M allele showed a significantly higher 
prevalence (14/73 patients; 19%) as compared to patients without VF (13/167 patients; 
8%)(p=0.01). This association remained significant in a logistic regression analysis after 
adjustment for age and gender (p=0.01; Odds ratio 2.8; confidence interval 1.2-6.3). 
There was no significant associations found between the remaining polymorphisms and 
the occurrence of VF or MI.
Conclusions: This is the first description of an association of the PSEL gene variant 168M 
with primary VF during acute MI. This variant may be a candidate polymorphism for 
evaluating the susceptibility for VF in the setting of acute MI.
10:00 a.m.
1001-92 Molecular basis of the inhibition of cardiac IK1 current 
by protein kinase C: role of PKC beta and Kir2.x 
channel subunit heterogeneity
Claudia Kiesecker, Daniel Scherer, Edgar Zitron, Eberhard P. Scholz, Martin Kulzer, 
Ramona Bloehs, Dierk Thomas, Alexander Bauer, Christoph A. Karle, University 
Hospital Heidelberg, Heidelberg, Germany
Background: The cardiac IK1 current is essential to maintain the resting membrane 
potential of cardiomyocytes. On the molecular level, IK1 is mediated by three channel 
subunits: Kir2.1, Kir2.2 and Kir2.3. The PKC system has been shown to play a major role 
in the regulation of IK1. However, the underlying molecular mechanisms have not been 
elucidated yet. Therefore, we studied the regulation of the different subunits by PKC and 
the role of different PKC isoenzymes.
Methods: Kir2 channels were expressed in Xenopus oocytes and experiments were 
performed using two-microelectrode voltage clamp. Native IK1 was measured with the 
whole-cell patch clamp technique in isolated rat ventricular cardiomyocytes.
Results: Activation of PKC with PMA (1µM) which activates conventional and novel 
isoforms of PKC induced inhibitory effects in all homomeric Kir2 channels. In Kir2.1, 
inhibition was only weak. In Kir2.2 and Kir2.3 channels the inhibitory effect was very 
pronounced. Heteromeric channels exhibited differing sensitivity: In Kir2.1/Kir2.2 and 
Kir2.1/Kir2.3 heteromers the inhibitory effect was markedly attenuated, whereas it was 
very pronounced in Kir2.2/Kir2.3.
Thymeleatoxin (100nM), a small molecule activator of cPKC isoenzymes, induced a 
strong inhibition of Kir2.2, thereby reproducing the effect of PMA, pointing to a prominent 
role of cPKC for this regulation. The small molecule antagonist PKC-β-inhibitor (1µM) 
significantly attenuated the effect of thymeleatoxin in Kir2.2. In contrast, thymeleatoxin did 
not reproduce the PMA effect in Kir2.3 and only induced a mild inhibition. In rat ventricular 
cardiomyocytes, thymeleatoxin (100nM) caused a strong inhibition of IK1 currents. This 
inhibition could be suppressed completely by co-application of PKC-beta-inhibitor (1µM).
Conclusion: Kir2 channels are inhibited by the PKC system. Kir2.2 subunits play a major 
role in this regulation, whereas Kir2.3 channels contribute to a lesser extent. Mainly 
cPKC isoenzymes are involved in the regulation of Kir2.2. Native IK1 current seems to be 
regulated mainly by the PKC-β isoenzyme. This regulation may contribute to functional 
IK1 downregulation and arrhythmogenesis under adrenergic stimulation.
10:00 a.m.
1001-93 Impact Energy Does Not Alter Narrow Time Window of 
Vulnerability in Ventricular Fibrillation (Commotio Cordis)
ALAWI A. ALSHEIKH-ALI, CHRISTOPHER MADIAS, BARRY J. MARON, JONATHAN 
WEINSTOCK, N. A. MARK ESTES, III, MARK S. LINK, TUFTS-NEW ENGLAND 
MEDICAL CENTER, BOSTON, MA
BACKGROUND: In an experimental model of sudden death with chest wall impact 
(commotio cordis), both energy and timing of the impact to a narrow window on the 
upslope of the T-wave are critical determinants of ventricular fibrillation (VF) induction. 
Whether changes in the energy of the impact alter the critical window of vulnerability to 
VF is unknown. The present study sought to determine the effect of impact energy on the 
timing limits of vulnerability to VF in an animal model of commotio cordis.
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1001-89 Effects of Verapamil Suggest that Calcium Current is 
Important in Maintaining Ventricular Fibrillation Lasting 
More Than 3 to 4 Minutes
Qi Jin, Raymond E. Ideker, Jian Huang, Shanghai Rui Jin Hospital, Shanghai Jiao Tong 
University School of Medicine, Shanghai, People’s Republic of China, University of 
Alabama at Birmingham, Birmingham, AL
Background: While it is known that both the Na+ and Ca++ currents are active during 
the first seconds of ventricular fibrillation (VF), it is not known if both channels remain 
active during the long duration VF of cardiac arrest. The increased membrane potential 
caused by the global ischemia of VF would be expected to inactivate Na+ channels as 
VF progressed, so that Ca++ channels should become more important in long duration 
VF maintenance. We used verapamil, an L-type Ca++ channel blocker, to test this 
hypothesis.
Methods: Six open-chest pigs received intravenous verapamil (0.136 mg/kg). Another six 
pigs received intravenous 0.9% sodium chloride as controls. Recordings from a 21x24 
unipolar electrode plaque (2 mm spacing) sutured to the lateral posterior epicardium were 
analyzed throughout the first 10 min of VF to calculate wavefront propagation velocity 
and activation rate.
Results: After 200 s, wavefronts propagated significantly more slowly and the activation 
rate was significantly slower in pigs treated with verapamil than in control pigs (Figures).
Conclusion: Verapamil significantly slowed activation and wavefront propagation after 200 
s of VF suggesting that, while Na+ channels are active during the early stages of VF, their 
activity decreases after 200 s of VF, Ca++ channels remain active after this time and are 
important in the maintenance of long duration VF.
10:00 a.m.
1001-90 The Effects of Chiral Isolates of Methadone on HERG 
Current
Congrong Lin, Vasant Ranade, Xiaogang Ke, Janos Molnar, John C. Somberg, Rush 
University, Chicago, IL
Methadone (M) is a synthetic opioid that has been used as an analgesic and in the 
treatment of narcotic addiction. Drug induced QT prolongation has been noted, and 
Torsade de Pointes ventricular tachycardia and death have been reported with M. M 
proarrhythmic toxicity is related to the inhibition of cardiac IKr channel and prolongation of 
the action potential. M is a racemate mixture of dl-methadone. We hypothesized that the 
two isomers of M may have different effects on the cardiac IKr channel, and separation 
of these isomers may produce an effective drug with less QT effect. The effect of M and 
its two isomers on IKr were evaluated by using an oocyte system with heterogeneously 
expressed human-ether-a-go-go-related gene (HERG). Two electrode voltage clamp 
technique was employed and the experiments were performed at room temperature. d- 
and l- methadone were obtained by a HPLC chiral separation using a cyclobond column. 
Racemic M was separated into two distinct chromatographic peaks each with different 
retention times and optical rotations -141 and +143 degree respectively, with both 
isolates showing the same mass/charge ratio (m/z) of 310, identical to that of racemic 
M. At concentrations of 0.01, 0.03, 0.1, 0.3, 1, and 3 mM, dl-methadone produced a 
dose dependent inhibition of HERG by 17±5, 23±4, 40±4, 57±3, 69±3, and 80±1%. The 
IC50 of dl-methadone was 0.21±0.02 mM. Both d- and l-M inhibited HERG current. The 
HERG inhibitory effect of l-M is less than that of d-M. At 0.1, 0.3 and 1mM, d-M reduced 
HERG current by 50±4, 76±5, 87±5%, and l-M reduced HERG current by 26±4, 53±3, 
77±3% respectively. There was a significant difference in the percentage current inhibition 
between d-and l-M, p<0.01 at 0.1 and 0.3 mM. The IC50 of d- and l-M was 0.10±0.01 
and 0.27±0.01 mM respectively. Our results show that M can be chirally separated with 
l-M causing significantly less HERG block at lower concentrations. l-M is 50 times more 
potent analgesic than d-M and l-M may thus be a safer agent with less QT effect at 
therapeutic doses.
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METHODS: Anesthetized juvenile swine (8 to 25 kg) were placed prone in a sling to 
receive chest wall strikes with varying impact velocities and at different time intervals 
during ventricular repolarization. Vulnerability to VF (defined as % impacts resulting in VF) 
was assessed across the following impact velocities (< 30, 30, 40, and > 40 MPH).
RESULTS: In 260 animals with 1062 impacts, VF was induced 221 times. Across all 
categories of impact velocity, VF induction was critically dependent on timing of the impact 
to the same narrow 30 ms window on the upslope of the T-wave (FIGURE).
CONCLUSION: In an animal model of commotio cordis, the narrow time window of 
vulnerability to VF during ventricular repolarization is constant across varying impact 
velocities and is independent of impact energy. These data may in part explain the 
relatively uncommon occurrence of sudden death due to chest blow on the athletic field. 
10:00 a.m.
1001-94  Placebo-Controlled Double-Blind Dose-Ranging 
Study of the Efficacy and Safety of Celivarone for the 
Prevention of Ventricular Arrhythmia-Triggered ICD 
Interventions
Peter R. Kowey, Etienne M. Eliot, Alessandro Capucci, Stuart J. Connolly, Harry Crijns, 
Stefan H. Hohnloser, Piotr Kulakowski, Denis Roy, David Radzik, Main Line Health Heart 
Center Lankenau, Wynnewood, PA, Sanofi-Aventis R&D, Paris, France
Background: Celivarone (C) is a new long-acting benzofuran derivative without iodine with 
an electrophysiological profile similar to amiodarone.
Methods: In this study patients (pts) with an implantable cardioverter defibrillator (ICD) 
for life-threatening ventricular arrhythmia and left ventricular ejection fraction of 40% 
or less were randomized at centers in Europe and the US to receive C orally: 100mg 
(C100, n=52), 300mg (C300, n=48) or placebo (P, n=53) once daily for 6 months.The 
primary endpoint was the occurrence of all ventricular tachycardia (VT) or fibrillation (VF) 
episodes documented by ICD interrogation requiring therapy.
Results:Mean age was 64.2 yrs, 91% were males mainly with coronary artery disease. A 
46% reduction in the number of sustained VT or VF episodes was observed in the C300 
group compared to P over 180 days (p-value= 0.172). Although the difference did not 
reach statistical significance, the event curves suggest a dose-response.
 
There were no torsades de pointes, and the proportion of treated pts with adverse events 
requiring treatment discontinuation was similar: 13.2%, 11.8% and 10.6% in the P, C100 
and C300 groups respectively.
Conclusions: These results suggest that C could be effective for the prevention of 
ventricualr arrhythmia triggered interventions in ICD pts and warrant investigation in a 
larger cohort. Tolerability was good across doses with no evidence of proarrhythmia or 
organ toxicity.
10:00 a.m.
1001-94A Left Ventricular Structural Remodeling Increases 
Cardiac Electrical Stability in Exercised Rat
Horesh Dor-Haim, Shimon Rosenheck, Chaim Lotan, Moshe Swissa, Hadassah Hebrew 
University, Jerusalem, Israel, Kaplan Medical Center, Rehovot, Israel
Background: Aerobic training reduces the occurrence of sudden cardiac death, despite 
the induction of LVH. We looked into the electrophysiological changes following aerobic 
training that might explain reduction in ventricular arrhythmias. 
Methods: Thirty adult rats were studied for 8 weeks. Seven of them were trained for 4 
weeks in a moderate treadmill exercise program (MTP), seven trained for 8 weeks in 
an intensive treadmill exercise program (ITP) and sixteen served as sedentary control 
(SCN). EPS study was performed on the isolated Langendorff perfusion system.
Results: Isolated trained hearts showed up to 3-fold improvement in their tolerance to the 
induction of ventricular fibrillation (VF) in a dose response manner. More intensive training 
protocol caused a higher ventricular fibrillation threshold (VFT), shorter VFT duration and 
lower VFT probability. Training also significantly decreased VF window of susceptibility. 
Significant concentric LVH was found in ITP and MTP animals. VFT strongly correlated 
to heart weight in ITP (r = 0.94, P<0.01). Additional significant correlations were found 
between VFT and high training intensity (r = 0.8, p<0.0001), rats fitness level (r = 0.51, 
p<0.05) and low body weight (r = 0.49, p<0.05). Exercise did not decrease ventricular 
tachycardia (VT) probability.
Conclusion: This study is the first to show a positive relationship between LVH and 
electrical stability. A multiple regression analysis has shown an independent effect of 
training on VFT. This effect was mediated through decreased body weight, increased 
aerobic fitness and increased hypertrophy. Therefore, exercise-induced cardiac structural 
remodeling, may positively effect the enhancement of electrophysiological remodeling. 
The specific mechanism may be related to an enhanced cardiac conductance and action 
potential spatiotemporal organization.
10:00 a.m.
1001-97 The Effects of Chronic Nicotine Administration on 
Atrial Fibrosis and Atrial Vulnerability to Fibrillation in 
Normal and Hypertensive Rats: Implication for Atrial 
Fibrillation in Smokers
Mizuho Miyauchi, Yasushi Miyauchi, Reiko Okazaki, Yu-ki Iwasaki, Yoshinori Kobayashi, 
Takao Katoh, Kyoichi Mizuno, Nippon Medical School, Tokyo, Japan
Background:Smoking is associated with an increased risk of atrial tachyarrhythmias. 
We hypothesized nicotine develops proarrhythmic effects through inducing increase of 
fibrosis in atria.
Methods:Twenty-six normal rats (WKY) and 15 hypertensive rats (SHR, 12-18W) were 
anesthetized and implanted an osmotic pump filled with nicotine at several concentrations 
(0, 1, 5, 10, 20 and 40mg/kg/day) subcutaneously. After four weeks of continuous 
administration of nicotine, the heart and lung were removed and vulnerability to atrial 
fibrillation was tested under Langendorff perfusion. The tissue was stained with Masson-
Trichrome to quantify the amount of atrial fibrosis.
Results:Plasma levels of nicotine were 0.065±0.045µg/ml that were equivalent to those 
in habitual smokers in rats with 5mg/kg/day dose nicotine. In normal rats, %fibrosis 
in atria was 5.9±0.6% in 0 mg (control) group, and modestly increased in 5mg group 
(11.1±0.8%, p=0.08), while it was significantly increased to 21.0±3.0 % in 10mg group 
(p<0.01). In 20mg and 40mg groups, atrial fibrosis was markedly increased to 25.3±4.2% 
and 31.0±1.5%, respectively. In SHR, fibrosis was significantly increased in 5mg group 
compared to control SHR (10.8±3.7% Versus 16.6±2.5%, p=0.02) and markedly increased 
to 25.59±7.8% in 10mg group. In normal rats, repetitive atrial response with short duration 
(<1sec) or atrial tachycardia could be induced in rats treated with very high dose (>10mg/
kg/day) nicotine. On the other hand, in SHR treated with nicotine at levels of habitual 
smokers (5mg/kg/day), sustained AF could be induced and continued for more than 30 
sec, while AF of short duration or atrial tachycardia were induced in control SHR. 
Conclusions:Chronic nicotine exposure at level of habitual smokers induced significant 
atrial fibrosis and vulnerability to atrial fibrillation in SHR, whereas the effects were 
modest in normal rats. That may explain the increased incidence of atrial fibrillation in 
habitual smokers with hypertension.
10:00 a.m.
1001-98 Deficiency of Inositol 1,4,5-Triphosphate Receptor Type 
1 in the Murine Heart Causes HV Prolongation Without 
Alteration in Cardiac Structure or Function
Amardeep Saluja, Andrew M. Bellinger, Shinichi Okuda, Daniel O. Cervantes, James 
Coromilas, Andrew R. Marks, Columbia University, New York, NY
Background: The type 1 inositol 1,4,5-triphosphate receptor (IP3R1) is a sarcoplasmic 
reticulum calcium release channel. In the heart, it has been localized primarily to 
His-Purkinje tissue, however its function is unclear. We studied the functional and 
electrophysiological (EP) phenotype of two different mouse models; a cardiac-specific 
knockout (KO) with absence of IP3R1 expression and a hypomorph (HM) with attenuated 
expression.
Methods: HM mice with ~75% globally attenuated IP3R1 expression were generated 
by partially disrupting the IP3R1 promoter with loxP motifs. Crossbreeding with tissue-
specific Cre-expressing mice produced cardiac-specific KOs.
Cardiac structure and function was assessed by histology, echocardiography, surface 
EKG, and Holter monitoring. EP studies were performed on 11 WT, 20 HM, and 15 KO 
mice by two blinded operators. Mice were intubated after injection with with 0.5 mg/Kg 
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intraperitoneal (IP) pentobarbital and an octopolar catheter was introduced into the right 
ventricle via the external jugular vein. Baseline intervals, refractory periods, sinus node 
recovery time and Wenchebach cycle lengths were measured. In a subset of 3 WT, 3 HM, 
and 4 KO mice, EP studies were performed before and after 30mcg/g IP procainamide.
Results: All mice had normal cardiac histology, contractile function by echocardiography, 
sinus rates, and surface EKG intervals and morphology. There were no differences in 
AH time between WT, HM, and KO mice (29.1 ± 5.7, 27.5 ± 7.8, 27.1 ± 7.5; p=NS all 
comparisons). HV time increased significantly with progressive deficiency of IP3R1 (5.2 ± 
1.0, 6.3 ± 1.3, 7.4 ± 1.2, p<.05 all comparisons). No differences in sinus nodal, atrial, AV 
nodal, or ventricular parameters were found. Despite similar degrees of QRS prolongation 
(2.0 ± 1.0, 3.0 ± 2.7, 2.8 ± 1.5, p>.05 all comparisons), procainamide induced greater HV 
prolongation in KO (2.5 ± 0.6) vs WT mice (0.3 ± 0.6; p=.01), while prolongation in the HM 
was intermediate (2.0 ± 2.7; p=NS vs HM and KO).
Conclusion: Progressive deficiency of IP3R1 results in a progressive increase in the HV 
interval without changes in cardiac structure or function, indicating a novel functional role 
for IP3R1 in His-Purkinje conduction.
10:00 a.m.
1001-99 The Natural Compound Acacetin Prolongs Atrial 
Refractory Period and Prevents Experimental Atrial 
Fibrillation in Anesthetized Dogs
Gui-Rong Li, Man-Wen Jin, Qiang Tang, Guo-Wei Qin, Hong-Bing Wang, Xiao-Hua 
Zhang, Hung-Fat Tse, Chu-Pak Lau, The University of Hong Kong, Pokfulam, Hong Kong
Background: We have recently demonstrated that the natural compound acacetin from 
the traditional Chinese medicine Xuelainhua preferentially blocks the ultra-rapid delayed 
rectifier potassium channel current (IKur), prolongs action potential duration in human atrial 
myocytes, and also inhibits acetylcholine-activated potassium channel current (IKACh) in 
guinea pig atrial myocytes. The agent has no long QT risk potential. The present study 
was designed to investigate whether this compound would have anti-atrial fibrillation (AF) 
effect. Methods: Atrial effective refractory period (ERP) was measured by introducing 
pacing and mono-phasic action potential recording electrodes to right and left atria, 
respectively, and AF was generated by extra stimuli of right atrium with stimulation of two 
sides of vagal nerves in anesthetized dogs. Results: Acacetin at 5 mg/kg significantly 
prolonged ERP in both right and left atria at post 1-4 h duodenal administration 
without QTc prolongation. However, sotalol at 5 mg/kg prolonged both atrial ERP and 
QTc interval at 1-4 h post duodenal administration. Interestingly, acacetin significantly 
prevented AF at 2.5 mg/kg (50%, n = 6, P<0.01 vs vehicle, 0%, n = 4), 5 mg/kg (71.4 %, 
n = 7, P<0.01 vs vehicle) and 10 mg/kg (71.4%, n = 7, P<0.01 vs vehicle) at 1.5-2.5 h 
post administration. Sotalol at 5 mg/kg also significantly prevented AF at 1.5-2.5 h post 
administration (60%, n = 5, P<0.01 vs vehicle). Conclusions: Acacetin prolongs atrial 
ERP without prolonging QTc interval, and effectively prevents AF in anesthetized dogs 
after duodenal administration. These results suggest that the natural compound acacetin 
from traditional Chinese medicine is likely an orally effective promising atrial-selective 
anti-atrial fibrillation agent.
10:00 a.m.
1001-100 Saftey of Magnetic Resonance Imaging in Patients 
with Cardiac Pacemakers: A prospective study in 115 
patients at 1.5 Tesla
Alexander Becker, Olaf Muehling, Martin Hinterseer, Dominik Morhard, Christopher 
Reithmann, Ludwig-Maximilians-University, Munich, Germany
Background: Cardiac pacemakers are still regarded as a contraindication to magnetic 
resonance imaging (MRI). In the following study we wanted to evaluate the feasibility and 
safety of cranial MRI in patients with cardiac pacemakers.
Methods: We examined 115 patients (age 67.3 ± 7.3 years, 73 men, 42 women, 42 single 
and 73 dual chamber systems) with cardiac pacemakers and an urgent indication for 
cranial MRI. 43 patients were pacemaker-dependent. Prior to the scan all pacemakers 
were programmed to an asynchronous mode. The scans were performed with an 1.5 
Tesla system (Magnetom Vision, Siemens Medical Systems, Germany). Thereby specific 
absorption rate was limited to 1.5 W/ kg bodyweight and total scan time was limited to 
30 minutes. During the scan patients were monitored with ecg and puls oximetry. We 
performed follow up examinations to determine pacing capture threshold, sensing 
threshold, and lead impedance immediately after the scan, two weeks, and two months 
after the scan.
Results: MR scans could be performed safely in all patients. All patients tolerated 
the asynchronous stimulation. We did not register any ventricular or supraventicular 
arrhythmias induced by the MR scan. Programmed parameters and battery voltage 
remained unchanged. No pacemaker dysfunction was registred. We could not observe a 
significant change of pacing capture threshold (0.12 ± 0.8 ms resp.0.9 ± 0.7 V) immediately 
after the scan (0.11 ± 0.9 ms resp.0.9 ± 0.8 V) or in the 2 month follow up (0.12 ± 0.9 ms 
resp. 1.0 ± 0.8 V, p = 0.46). There was no siginificant change in sensing threshold (2.2 ± 
0.9 mV vs.2.1 ± 0.8 mV atrial lead and 8.2 ± 3.9 mV vs. 8.4 ± 4.0 mV ventricular lead, p = 
0.39) and lead impedance (571 ± 238 Ω vs. 584 ± 241 Ω, p = 0.57)
Conclusions: Cranial MRT with a 1.5 Tesla systems could be performed safely in patients 
with cardiac pacemakers under cardiological monitoring and follow up. Especially an 
increase in pacing capture threshold could not be observed.
10:00 a.m.
1001-101 INO-8875, a Highly-Selective A1 Adenosine Receptor 
Agonist: Evaluation of Chronotropic, Dromotropic and 
Hemodynamic Effects in Rats
Yoram Etzion, Aryeh Shalev, Michal Mor, Arie Moran, Amos Katz, Soroka University 
Medical Center, Beer-Sheva, Israel, Ben-Gurion University, Beer-Sheva, Israel
BACKGROUND: Although adenosine is the most potent known pharmacologic inhibitor 
of AV nodal conduction, its therapeutic utility is limited to the acute treatment of SVT 
owing to its extremely short physiological half-life and hemodynamic side-effect profile. 
The purpose of the present study was to compare the cardiovascular profiles of two novel 
adenosine 1 (A1) receptor agonists intended for slowing of AV nodal conduction. CV-
510 has demonstrated negative dromotropic clinical effect with minimal chronotropic and 
hemodynamic activity. INO-8875 (Ki < 1 nM; A1/A2a receptor binding affinity > 10,000) 
has recently entered human studies. 
METHODS AND RESULTS: Mechanically-ventilated rats were instrumented with bipolar 
mini-hook electrodes inserted via a minimal lateral thoracotomy. Pacing and recording 
hooks were placed on the high and low RA, respectively, whereas a third pair recorded 
from the RV. INO-8875 (1-50 µg/Kg) and CVT-510 (20 and 50 µg/Kg) injected IV over 
20 min induced dose-dependent slowing of AV nodal conduction and heart rate that 
were linearly related, although INO-8875 activity was significantly more pronounced on 
AV nodal conduction (regression slopes of INO-8875/CV-510 = 0.42/0.27, p< 0.05). At 
the highest doses, INO-8875 and CVT-510 increased the RR interval to 165±12 % and 
180±4 % of control, respectively (n=5, p<0.01 for both), and prolonged the minimal 1:1 
AV conduction cycle to 131±78 % of control (n=5, p<0.05) and 119±5 % (n=4, P<0.05), 
respectively. INO-8875 exhibited a greater duration of action, lasting up to 2.5 hours post-
dosing, whereas the effects of CV-510 dissipated over 1 hour (p<0.01). Under constant 
atrial pacing (150 ms cycle length) INO-8875 (50 µg/Kg) did not reduce the carotid arterial 
blood pressure (n=4). 
CONCLUSIONS: In rats, INO-8875 exhibits increased dromotropic activity and greater 
duration of action compared to CV-510. INO-8875 does not reduce the arterial blood 
pressure up to the maximal tested dose of the present study (50 µg/Kg). Based upon the 
above data, INO-8875 may have future role in acute and sub-acute clinical situations that 
need AV conduction slowing such as AF or A flutter/tachycadia
10:00 a.m.
1001-102 Novel Basis of Interstitial Remodeling in Left Ventricular 
Hypertrophy and Sudden Cardiac Death
Balaji Tamarappoo, Benjamin T. John, Stacey Clegg, Karen Gunson, Sumeet S. Chugh, 
Oregon Health and Science University, Portland, OR
Background: We have previously reported enhancement of myocardial interstitial 
remodeling in patients with isolated left ventricular hypertrophy and sudden cardiac 
death (LVH SCD). Some animal models of dilated cardiomyopathy and increased SCD 
risk display altered myocardial collagen composition, but this has not been evaluated in 
human LVH SCD.
Methods: Twelve consecutive patients with LVH SCD in the absence of hypertrophic 
cardiomyopathy, coronary artery disease or any other significant cardiac structural 
abnormality were ascertained in the Oregon Sudden Unexpected Death Study, an 
ongoing prospective, population-based study in a community of 700,000 residents. 
Comparisons were conducted with 18 geographic and age-matched patients with LVH 
and unnatural death such as gunshot wound or suicide (LVH control); as well as 6 
patients with structurally normal heart and unnatural death (Normal control). Myocardial 
tissue sections and homogenates were prepared from LV free wall obtained at the time 
of autopsy. Collagen volume fraction (CVF) was measured by picrosirius red staining 
and a polarized digital light microscopy system. Collagen types I and III extracted from 
tissue homogenates were separated by polyacrylamide gel electrophoresis. The staining 
intensity of one representative peptide fragment corresponding to collagen I or collagen 
III was quantified by densitometry.
Results: Heart weight normalized to body weight was higher (6.9±2.1) in LVH SCD when 
compared to LVH controls (4.9±1.4; p=0.03) and Normal controls (4.1±0.5; p=0.02). CVF 
was also highest in LVH SCD (3.1±0.4) vs. LVH controls (2.3±0.4; p=0.02) and Normal 
controls (1.5±0.3; p=0.009). The relative amount of collagen III was significantly higher 
in LVH SCD (33±4%) when compared to LVH control (20.8±4%; p=0.001) and Normal 
control (13.4±3%; p=0.002).
Conclusions: In addition to increased myocardial mass and collagen volume fraction, fatal 
arrhythmogenesis in human LVH is associated with a relative abundance of collagen 
type III.
10:00 a.m.
1001-103 Transmural Propagation of Wavefronts During Long 
Duration Ventricular Fibrillation
Paul B. Tabereaux, Derek J. Dosdall, Raymond E. Ideker, Jian Huang, University of 
Alabama at Birmingham, Birmingham, AL
Introduction: Recently foci were recorded from Purkinje fibers on the endocardium 
during long duration ventricular fibrillation (LDVF) in dogs. If these foci represent 
endocardial breakthrough of intramural wavefronts, VF wavefronts should propagate 
transmurally towards the endocardium. If foci represent abnormal automaticity and/
or afterdepolarizations, VF wavefronts should propagate transmurally towards the 
epicardium.
Methods and Results: Using two 528 channel mapping systems, we mapped VF for 10 
min with a transmural unipolar electrode array in 6 open-chest dogs. The array consisted 
of two crisscrossing rows of plunge consisting of 21 horizontal needles by 24 vertical 
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needles spaced 2mm apart. Plunge needles held 12 electrodes 2 mm apart. By grouping 
active samples that were adjacent in space and time, individual wavefronts were isolated. 
The velocity of the centroid of each wavefront was calculated in M/s and the transmural 
component of the velocity vector was determined throughout VF. After 3 min of VF, the 
wavefronts moved from endo to epicardium with a mean conduction velocity (CV) vector 
in this direction (Table: + numbers depict endo to epicardial movement and - numbers 
from epi to endocardial).
Conclusion: During LDVF in dogs, wavefronts are directed from the endocardium to the 
epicardial surface. This finding is consistent with recent data that spontaneous activations 
arising from Purkinje play an active role in maintaining LDVF by mechanisms in addition 
to reentry. 
Minutes VF 1 2 3 4 5 6 7 8 9 10
Mean CV vector 0.02 -0.03 -0.04 0.18* 0.23* 0.45* 0.52* 0.32* 0.35* 0.09*
* p < 0.05 compared to 0.
10:00 a.m.
1001-104 Induction of Remodeling Gene Expression During 
Ectopic Activity in Isolated Rat Left Atrial Appendages
Paul E. Wolkowicz, Hernan E. Grenett, Jian Huang, Edlue Tabengwa, Ferdinand 
Urthaler, David D. Ku, University of Alabama at Birmingham, Birmingham, AL
Background: Clinical atrial tachyarrhythmias alter atrial gene expression to transform 
atrial electrical properties and induce fibrosis, both of which increase risk for fibrillation. 
Identifying models of atrial arrhythmias that provoke such molecular changes acutely 
in intact, isolated muscle would allow the investigation of the initial molecular events 
underlying atrial remodeling. We have reported a new, pharmacological model to induce 
sporadic or tachycardic ectopy in isolated rat left atrial appendage (LAA) ( doi:10.1016/
j.ejphar.2007.08.004 ). Here we determine whether remodeling gene expression is 
induced during this ectopic activity.
Methods: Isolated rat LAA (n= 4 per) were paced at 3Hz, superfused in Krebs-
Henseliet (KH) buffer at 30°C and then were (i) exposed to the calcium leak inducer 2-
aminoethoxydiphenyl borate (20µM; 2APB) for 40min to provoke sporadic ectopic activity 
or (ii) were maintained in normal KH for 40min. LAA mechanical and electrical activity 
was recorded with force transducers and glass microelectrodes, respectively. Total LAA 
mRNA was extracted with TriZol and analyzed using reverse transcriptase-polymerase 
chain amplification with appropriate primers.
Results: LAA superfused with KH and 2APB exhibit ectopic electrical and mechanical 
events at a rate of 46±6 events/min in the absence of pacing while untreated LAA are 
quiescent. 3Hz-Paced LAA experiencing this calcium-leak induced ectopy show significant 
increases in (i) their c-fos/GAPDH mRNA ratio (0.9 vs. 0.25), (ii) their connective tissue 
growth factor/GAPDH mRNA ratio (1.6 vs. 0.3) and (iii) their transforming growth factor 
β/GAPDH mRNA ratio (0.55 vs. 0.15) compared to untreated LAA. In contrast the Kv4.2/
GAPDH mRNA ratio increases only slightly (0.8 vs. 0.55; 2APB vs. untreated).
Conclusions: The expression of key remodeling genes increases in isolated, normal rat 
LAA during acute, calcium leak-induced sporadic ectopic activity. This suggests that atrial 
calcium leaks which provoke ectopy may also alter LAA gene expression to enhance 
fibrosis. Such novel leak may act both to trigger arrhythmias and create an electrical 
substrate that favors more severe rhythm disturbances.
10:00 a.m.
1001-105 Ranolazine Suppresses Ectopic Activity in Isolated Rat 
Left Atrial Appendage
Paul E. Wolkowicz, Jian Huang, Hernan E. Grenett, Edlue Tabengwa, Ferdinand 
Urthaler, David D. Ku, University of Alabama at Birmingham, Birmingham, AL
Background: Myocardial sodium (Na) and calcium (Ca) overload predispose to triggered 
cardiac rhythm disturbances. Ranolazine inhibits the late sodium current (IC50~10µM), 
thereby decreasing myocardial Na & Ca overload, and clinical data suggest it as a 
promising pharmaceutical intervention against arrhythmias. We have reported that a 
novel sarcoplasmic reticulum calcium leak triggers ectopy and tachycardia in isolated 
rat left atrial appendage (LAA) ( doi:10.1016/j.ejphar.2007.08.004 ). Here we determine 
whether ranolazine selectively suppresses this ectopic LAA electro-mechanical activity.
Methods: Paced rat LAA (n= 7-9 per) were superfused at 30°Cin Krebs-Henseliet buffer. 
LAA were (i) exposed to 0 or 20µM of the calcium leak inducer, 2-aminoethoxydiphenyl 
borate (2APB), (ii) were pre-treated with 0 to 80µM ranolazine then with 2APB, or (iii) were 
treated with 2APB for 10min and then with ranolazine. LAA mechanical and electrical 
activity was recorded using force transducers and glass microelectrodes, respectively, in 
the presence and absence of pacing stimulus.
Results: Normal rat LAA superfused with 2APB produce ectopic, spontaneous action 
potentials and mechanical events in a 1:1 stoichiometry at a rate of 46±6 spontaneous 
ectopic events/min. These events occur in the absence of external pacing. As expected, 
untreated LAA require a pacing stimulus to generate action potentials and subsequent 
mechanical events. Ranolazine prevents and reverses this ectopic LAA electrical and 
mechanical activity with an EC50 of 8.6µM. Ranolazine (80µM) does not affect LAA 
time-to-peak tension or 50/90% relaxation times and decreases LAA mechanical force 
little (0.1Hz: 1.54±0.14 vs. 1.57±0.17 and 1Hz 1.23±0.12 vs. 1.07±0.13g; untreated vs. 
ranolazine, respectively).
Conclusions: A novel calcium leak provokes spontaneous ectopic events in isolated, 
normal rat LAA which exhibit many characteristics of triggered activity. Ranolazine 
prevents and reverses this ectopic activity selectively, suggesting this experimental model 
may aid investigations of the role of the late Na current and Na overload in triggered atrial 
arrhythmias.
10:00 a.m.
1001-106 Cryoablation of Extrinsic Cardiac Sympathovagal 
Nerves Prevents Paroxysmal Atrial Tachyarrhythmias in 
Remodeled Canine Atria
Alex Y. Tan, Shengmei Zhou, Masahiro Ogawa, Juan Song, Mattheew Chu, Hongmei 
Li, Michael C. Fishbein, Shien-Fong Lin, Lan S. Chen, Peng-Sheng Chen, Cedars-Sinai 
Medical Center, Los Angeles, CA, Krannert Institute of Cardiology, Indianapolis, IN
Background: Simultaneous sympathovagal discharge is associated with spontaneous 
onset of atrial tachyarrhythmias in ambulatory dogs. We sought to determine if 
sympathovagal denervation is effective in preventing the atrial tachyarrhythmia.
Methods: We used implanted radiotransmitters to continuously record stellate ganglion 
(SG) nerve activity (SGNA) and vagal nerve activity (VNA) in 13 ambulatory dogs. Group 
1 dogs (n=7) had cryoablation of both SG and cardiac branch of vagal nerve. Group 2 
dogs did not. All dogs then underwent chronic intermittent atrial pacing.
Results: On post-operative day 1 (POD1), but not POD10, group 1 dogs had decreased 
levels of SGNA, VNA and mean RR. The standard deviation (SD) of RR (SDRR) was 
persistently lower in Group 1 than Group 2 (p≤0.05). Group 1 and 2 dogs developed 
sustained AF after 7±4 and 3±1 weeks respectively (p=0.01). Compared to group 2 
dogs, group 1 dogs had less episodes of premature atrial contractions (2±1 vs 4 ± 1 
episodes/d, p<0.01), no episodes of paroxysmal atrial fibrillation (vs. 4 ± 2 episodes/d 
in 3/7 group 2 dogs, p<0.01) and no episodes of paroxysmal atrial tachycardia (vs. 10 
± 3 episodes/d, p<0.01). In both groups, there was a significant increase in transcardiac 
nerve growth factor, norepinephrine after chronic pacing and increased sympathetic but 
not parasympathetic nerve densities.
Conclusions: Sympathovagal activation is a trigger for paroxysmal atrial arrhythmias 
in ambulatory dogs. Cryoablation of extracardiac autonomic nerves, without left atrial 
ablation, can effectively prevent paroxysmal atrial tachyarrhythmias even in the presence 
of a remodeled atrial substrate.
10:00 a.m.
1001-107 Role of Sterol Regulatory Element Binding Protein 
(SREBP) in the Regulation of the Parasympathetic 
Response and Inducible Ventricular Arrhythmia
Christopher Madias, Ho-Jin Park, Yali Zhang, Serban P. Georgescu, Richard D. Patten, 
Mark J. Aronovitz, Hitoshi Shimano, Richard H. Karas, Mark S. Link, Jonas B. Galper, 
Tufts-New England Medical Center, Boston, MA, University of Tsukuba, Tsukuba, Japan
Background. Preserved parasympathetic tone is protective against sudden death after 
myocardial infarction (MI). In cultured atrial myocytes, sterol regulatory element binding protein 
1 (SREBP1), regulates expression of the G-protein coupled inward rectifying K+ channel 
(GIRK1), which mediates the parasympathetic response of the heart. Here, we determined 
whether expression of GIRK1 was decreased in atria of SREBP1 KO mice and whether 
SREBP1 KO mice have an increased susceptibility to post-MI ventricular tachycardia (VT).
Methods. GIRK1 expression was determined by Western blot analysis. In vivo programmed 
ventricular stimulation with sensed single, double, and triple extrastimuli was performed 2 
wks post ligation of the left anterior descending artery in 9 SREBP1 KO and 7 WT mice. 
Induction of six or more repetitive ventricular beats was considered a positive test. MI size 
was determined by echocardiography or by planimetry of scar.
Results. In atrial extracts of SREBP1 KO mice GIRK1 was decreased by 48 ± 7% 
(N=5, p<0.03) as compared to WT. Post-MI, SREBP1 KO mice showed no difference in 
infarct size or fractional shortening as compared to WT (see Table). With programmed 
stimulation, SREBP1 KO mice were more likely to be induced to VT than WT mice (89% 
SREBP1 KO vs. 43% WT, p < 0.05).
Conclusions. As compared to WT mice, SREBP1 KO mice demonstrate decreased 
expression of GIRK1 and an increased incidence of inducible arrhythmias post-MI. These 
data suggest a novel role of SREBP1 in the development of arrhythmia.
10:00 a.m.
1001-108 Chemical Ablation of Subendocardium and Purkinje 
Fibers in Dogs Causes Early Termination and Activation 
Rate Slowing of Long Duration Ventricular Fibrillation
Derek J. Dosdall, Paul B. Tabereaux, Jong J. Kim, Gregory P. Walcott, Jack M. Rogers, 
Cheryl R. Killingsworth, Jian Huang, William M. Smith, Raymond E. Ideker, University of 
Alabama at Birmingham, Birmingham, AL
Background: Endocardial mapping has suggested that Purkinje fibers may play a role in 
the maintenance of long duration ventricular fibrillation (LDVF). To determine the influence 
of Purkinje fibers on LDVF, we chemically ablated the Purkinje fiber system and mapped 
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endocardial activation during LDVF.
Methods: Dog hearts were isolated and perfused through the left main coronary artery. 
The left ventricular endocardium was exposed and treated with Lugol’s solution (n=6) or 
saline as a control (n=6). The anterior papillary muscle endocardium was mapped with 
a 504 electrode (21x24) plaque with electrodes spaced at 1 mm. VF was induced, and 
perfusion was terminated.
Results: LDVF spontaneously terminated sooner in Lugol’s ablated hearts than control 
hearts (4.9 ± 1.5 min vs. 9.2 ± 3.2 min, p=0.01). Average activation rate over the plaque 
was determined during a 5 s episode every min while LDVF persisted. While activation 
rates were similar during the first 3 min of LDVF for Lugol’s ablated and control hearts, 
they were significantly slower in ablated hearts during minutes 4-5.
Conclusions: Chemical ablation of the Purkinje fiber system does not significantly slow 
endocardial VF activation rate in early VF, but does cause activation rate slowing in LDVF 
lasting more than 3 min and early spontaneous termination of LDVF. These results suggest 
that the subendocardium and Purkinje fibers play an increasingly important role in LDVF 
maintenance as the duration of unperfused LDVF increases and global ischemia develops.
10:00 a.m.
1001-109 Concordance of Sites With Latest Activation and 
Epicardial Left Ventricular Lead Fixation is a Strong 
Predictor of Response to Robotically Implanted 
Cardiac Resynchronization Therapy
Ajay S. Shah, Rawa Sarji, Olga Kuteyeva, Sripal Bangalore, Ganesh Kamath, Shruthi 
Pranesh, Eftekhari Hossein, Donna Macmillan-Marotti, Sandhya Balaram, Jonathan S. 
Steinberg, Farooq A. Chaudhry, St. Luke’s-Roosevelt Hospital Center, New York, NY
Background and Objective
Robotically implanted CRT is a rescue therapy for pts with failed endovascular implants 
with advantage to place left ventricular (LV) lead over the latest dyssynchronous 
myocardial region. The value of concordance of dyssynchrony and LV lead fixation site in 
improving response to CRT in these pts. is not defined.
Methods: 30 pts (67±12yrs; 53%male; LVEF 18±6 % ) with end-stage heart failure , LVEF 
≤35%, QRS >120ms and LBBB were included. LV dyssynchrony (DYS) was defined as 
> 65ms opposing LV wall delay in peak systolic contraction by Tissue Synchronization 
Imaging. CON was defined if site of most delayed contraction and robotic LV lead fixation 
were same. Responders were defined by improvement in LVEF of ≥15 % from baseline 
during follow-up of 8 ± 3 mos.
Results: 22 pts (73%) had dyssynchrony. 17 pts (56%) had CON, of whom 15 (88%) were 
responders, compared to discordance in 13 (44%), of whom 6. (46%; p= 0.001) were 
responders.Uni and multivariate analysis showed that concordance is a strong predictor 
of response to CRT {OR=36; p=0.003}. In pts. with no concordance the LVEF changed 
from 16±4 to 22±16 (p = 0.2) compared to pts with concordance in whom the LVEF 
changed from 19±6 vs. 31±12 (p <0.0001).
Conclusion: Concordance results in improved outcome after robotically-assisted CRT. 
Direct epicardial LV lead placement is an effective alternative to transvenous placement, 
and may offer superior opportunity to achieve concordance, a hypothesis that should be 
tested in clinical trials.
10:00 a.m.
1001-110 Chronotropic incompetence (CI) in chronic heart failure 
- Time to pace ?
Emma Arrezi, Ulrich P. Jorde, Columbia University, New York, NY
CI, defined as the inability to reach 80% of maximally predicted age-adjusted heart rate 
(HR) occurs in approximately 70% of CHF patients with peak VO2 (pVO2) < 14 and 
contributes to exercise intolerance. Safety concerns prohibit restoring maximal exercise 
heart rate in CHF, but the possible benefits of rate responsive pacing (RRP) at low levels 
of exercise are less well studied. We propose that maintenance of stroke volume (SV) 
during heart rate increases might be an appropiate early safety measure.
Methods and Results: 99 male and 36 female subjects underwent the Modified Naughton 
protocol and were stratified according to pVO2 (ml/kg/min) [< 14.00 = Group A (n=54), 
14.01 -17.99 = Group B (n=50), > 18.00 = Group C (n=31)]. Beta blocker use was 74, 
72, and 69% respectively (p=NS). HR and oxygen pulse (O2 pulse = VO2/HR, an indirect 
measure of SV) were recorded throughout exercise at 1 minute intervals. O2 pulse 
increased throughout the first 5 min in all subjects. HR=100 was reached within 2.5 min in 
group B and C, but not until 4 min in group A (= VO2 < 14).
Discussion: In the early phase of exercise at least to HR of 100 bpm, O2 pulse increases 
in subjects with CHF including those with most advanced disease. However, and despite a 
strictly standardized work load, time to reach HR 100 is significantly prolonged in subjects 
with most advanced disease. RRP to reach HR 100 early (if necessary in conjunction 
with CRT to avoid dyssynchrony) may improve functional capacity of subjects with CHF 
through early cardiac output (HR xSV) increase. 
10:00 a.m.
1001-111 Three Dimensional and Biatrial Mapping of Atrial 
Tachyarrhythmias in Coronary and Hypertensive Heart 
Disease: Identifying Mechanisms that Initiate and 
Maintain Persistent Atrial Fibrillation
Sanjeev Saksena, Nicholas Skadsberg, Electrophysiology Research Foundation, 
Warren, NJ
Background:Atrial tachyarrhythmias (ATs) are being identified in pts with persistent atrial 
fibrillation (AF) but their role and relationship to structural heart disease (SHD) remains 
unclear. Methods: Spontaneous atrial premature beats (APBs) & ATs were mapped with 
simultaneous biatrial catheter & 3-D non-contact mapping (NCM) in pts with refractory 
AF at AF onset and maintenance in pts without structural heart disease (AF-NSHD, 
Group 1) and compared to with AF pts with coronary artery disease (AF-CAD, Group 2), 
systemic hypertension (AF-HTN, Group 3) and when both CAD & HTN were present (AF-
CAD+HTN, Group 4). Results: 53 pts (Gp.1, n=19 pts; Gp.2, n=8 pts; Gp.3, n=15 pts and 
Gp.4, n = 11pts) were studied. Mean LA diameter, mean LV ejection fraction and mean 
P-wave duration in the 4 groups were comparable (p=ns). The origin of APBs was biatrial 
and also not significantly different (Gp.1 = 35% in LA, Gp.2 = 30% in LA, Gp.3 = 30% in 
LA, and Gp.4 = 28% in LA). However, the distribution of spontaneous ATs at AF onset 
was biatrial in Gps 1, 2 & 3 but predominated in the right atrium (RA) & septum in Gp 
4. Persistent AF was associated with a wider distribution of ATs, particularly in the RA & 
septum. (Figure, p<.05 ) Conclusions: 1. Biatrial distribution of triggers and ATs suggests 
either biatrial structural changes and/or autonomic mechanisms are present particularly 
in persistent AF and can be identified both at the AF onset & maintenance. 2. A shift to RA 
& septal ATs with the coexistence of CAD & HTN suggests an expanding RA substrate 
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10:00 a.m.
1001-112 Improvement of Left Atrial Function is Associated with 
Lower Incidence of Atrial Fibrillation and Mortality after 
Cardiac Resynchronization Therapy
Jeffrey WH Fung, Gabriel WK Yip, Fang Fang, Qing Zhang, Joseph YS Chan, Chun-
mei Li, Li-wen Wu, Gary CP Chan, Hamish CK Chan, Cheuk-man Yu, The Chinese 
University of Hong Kong, Shatin, Hong Kong
Background: Left atrial (LA) volume is a predictor of cardiovascular events in patients with 
heart failure (HF). Improvement of LA function and reverse remodeling was observed 
after cardiac resynchronization therapy (CRT). The current study aims to explore the 
clinical significance of improvement in (LA) function after CRT.
Methods: Echocardiographic studies were performed before and 3 months after CRT in 
97 patients (age: 63.8 ± 13.3, male = 72) with standard CRT indication but without history 
of atrial fibrillation (AF). LA active emptying fraction based on the change in volumes 
(LAV-EF) were calculated and significant improvement in LA function (LA responder) was 
defined as a relative increase of > 50% from baseline LAV-EF. The primary endpoints 
were newly developed AF detected by ECG or device and all-cause mortality.
Results: After 1200 ± 705 days of follow up, LA responders (n = 47, 48.5%) had significantly 
lower incidence of AF (12.8% Vs 40%; p=0.002) and mortality (17% Vs 44%; p=0.004) 
than LA non-responders. In the Cox proportional hazard analysis, LA responders was 
the only independent predictor of lower risk of new-onset AF (HR 0.22, 95% CI: 0.08-
0.61; p=0.003) while both LA responders (HR 0.22, 95% CI: 0.09-0.53; p<0.001) and LV 
reverse remodeling (>10% reduction in LV end-systolic volume at 3 months) (HR 0.96, 
95% CI: 0.93-0.99; p=0.03) were independent predictors of lower risk of death after CRT.
Conclusion: Improvement of LA function after CRT was associated with lower incidence 
of AF and mortality in AF naïve patients with severe HF.
10:00 a.m.
1001-113 Under-Referral of Women for Atrial Fibrillation Ablation: 
Can This Be Explained by Gender Differences in 
Outcome?
Andrea M. Russo, Erica Zado, Edward P. Gerstenfeld, Rupa Bala, Ralph J. Verdino, 
Fermin Garcia, David Lin, Sanjay Dixit, Joshua Cooper, David J. Callans, Mathew 
Hutchinson, Michael Riley, Francis E. Marchlinski, University of Pennsylvania, 
Philadelphia, PA
Background: Although women represent over one half of patients with atrial fibrillation 
(AF) in the United States, they are less often referred for AF ablation than men. It is 
currently unclear whether or not gender differences in outcome may contribute to this 
under-referral.
Methods: We compared baseline characteristics and outcome of 975 consecutive men 
and women who underwent AF ablation at our center.
Results: Women represented 23% of the cohort who underwent AF ablation. Mean follow-
up was 17.8 ± 14.1 months for women and 18.6 ± 15.3 months for men (p=NS). Compared 
with men, women were older, had a smaller left atrial size, higher LVEF, and were less 
likely to have persistent AF than men. (Table) Women were less likely to undergo repeat 
ablation (17% versus 28%, p < 0.01). At last follow-up, 88% of women and 92% of men 
had arrhythmia control on or off antiarrhythmic agents (p = 0.07). This trend toward a 
difference in outcome could be related to fewer repeat ablations performed in women. 
Following ablation, 19 women (9%) and 57 men (8%) were restarted on antiarrhythmic 
agents to obtain arrhythmia control after AF recurrence (p = NS).
Conclusions: Baseline characteristics differ between men and women undergoing AF 
ablation. In spite of these differences, good arrhythmia control was apparent in both 
groups. The results suggest that the tendency to limit ablative therapy in women, reflected 
by a comparison of overall AF incidence and percentage of women referred for ablation, 
is not justified based on clinical outcome.
Gender Differences in Baseline Characteristics
Women 
N=223
Men 
N=752 p value
Age (years) 57 ± 12 54 ± 10 <0.01
Persistent AF (%) 26% 38% <0.01
LA size (cm) 4.1 ± 0.7 4.5 ± 0.7 <0.01
LVEF (%) 60 ± 8 58 ± 10 <0.01
10:00 a.m.
1001-114 Association of Paroxysmal Atrial Tachyarrhytmias 
with Heart Failure Exacerbations: Assessment 
Using Implanted Pacemakers With Trans-Pulmonary 
Impedance Capability (OptiVol ®)
Rajat Jhanjee, Grant Templeton, John Nguyen, Cengiz Ermis, Laura Van Heel, Keith 
Lurie, Simon Milstein, David Benditt, University of Minnesota, Minneapolis, MN, Central 
Minnesota Heart Center, St. Cloud, MN
Background: Clinical experience suggests that susceptibility to atrial tachyarrhythmias 
(AT), particularly atrial fibrillation, is increased during worsening heart failure (HF), 
However, quantifying this association is challenging. Recently, certain pacemakers can 
assess HF status by estimating pulmonary fluid volume over time using a measure of 
trans-pulmonary electrical impedance change (OptiVol Index® [OI], Medtronic, Inc, 
Minneapolis MN). This study utilized OI values to evaluate AT versus HF relationship 
in patients implanted with an OI-capable cardiac pacemaker, left ventricular dysfunction 
and HF. Specifically, we assessed the frequency with which AT accompanies HF, and 
determined whether a specific OI value predicts increased AT susceptibility.
Methods: AT frequency was assessed for 3 subsets of OI values: <40 (Group 1), 40-70 
(Group 2) and >70 (Group 3). Chi-squared test was used to measure association between 
OI and AT frequency. AT duration was compared between groups using ANOVA.
Results: OI and AT events were examined in 45 patients (mean age ± SD = 66 ±10.5 
years; 69% male, ischemic cardiomyopathy 46%). Three patients with permanent AT, and 
2 with incomplete data, and one without HF history were excluded. Average left ventricular 
ejection fraction was 27 ±10%. OI and AT were evaluated at a total of 116 patient follow-
up visits, with a mean follow-up of 2.7±1.7 months. There were 65 visits in Group 1, 29 in 
Group 2 and 22 in Group 3. The corresponding frequencies of paroxysmal AT episodes 
in each of the 3 groups were: 21(32%), 13(45%), and 19(86%), X2=19.4, p<0.0001. 
Mean hours of AT duration (AT burden) was: 17.9, 1.76, and 287 for Groups 1, 2, and 
3 respectively. AT burden differed significantly between Groups 1 and 3 (p<0.0001), and 
Groups 2 and 3 (p=0.0002). Groups 1 and 2 were statistically indistinguishable (p=0.78).
Conclusion: In HF patients with cardiac pacemakers, increased OI value was associated 
with increased AT frequency. In particular, an OptiVol Index® >70 was accompanied by 
both significantly greater AT frequency and AT burden.
10:00 a.m.
1001-115 High Density Mapping of Atrial Fibrillation in Humans: 
Relationship Between High Frequency Activation and 
Electrogram Fractionation
Martin K. Stiles, Anthony G. Brooks, Pawel Kuklik, Bobby John, Glenn D. Young, 
Prashanthan Sanders, Cardiovascular Research Centre, Royal Adelaide Hospital and 
University of Adelaide, Adelaide, Australia
Background: Sites of complex fractionated atrial electrograms (CFAEs) and dominant 
frequency (DF) have been implicated in maintaining atrial fibrillation (AF), however their 
relationship is poorly understood.
Methods: Twenty patients (58±9y, 16 male) with AF were studied. High-density mapping 
(507±150 points/patient) was performed of both atria during AF prior to catheter ablation. 
CFAE characterization using NavX software provided a representation of electrogram 
complexity (CFE-mean). Offline spectral analysis defined DF as the frequency with 
greatest power.
Results: Median CFE-mean was 103ms (IQR 76-143ms) for the right and 98ms (72-
139ms) for left atria (p<0.001); 117ms (85-161ms) in paroxysmal and 92ms (70-127ms) 
in persistent AF (p<0.001). Median DF was 5.49Hz (4.91-6.15Hz) for the right and 5.57Hz 
(4.91-6.23Hz) for left atria (p=0.02); 5.27Hz (4.69-5.71Hz) in paroxysmal and 5.93Hz 
(5.35-6.67Hz) in persistent AF (p<0.001). Regional analysis revealed pulmonary veins, 
appendages and the left atrial roof as preferential areas with high DF in paroxysmal 
(p<0.05) but not persistent AF where regional differences were less apparent. Highest 
DF points were clustered together, such that the mean number of high DF clusters was 
5.2±1.7 per patient. The correlation between CFE-mean and DF was poor on a point-
by-point basis (r=-0.17), but was moderate at the atrial level (r=-0.50). Evaluation of 
the spatial relationship demonstrated CFAEs to be in close proximity to high DF sites; 
superimposed in 17%, within 10 mm in 63% and 10-20mm in 10%.
Conclusions: Greater fractionation (low CFE-mean) and higher DF are seen in persistent 
AF and in left atria. Preferential areas of high DF are observed in paroxysmal but not 
persistent AF. While there is little correlation between CFAEs and DF on a point-by-
point basis these factors demonstrate a relationship at the atrial level. With high-density 
mapping, 80% of clusters of high DF were observed to be at or adjacent to areas of 
CFAEs.
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1008-89 Atrial Fibrillation Progression in Patients With and 
Without Lone Atrial Fibrillation. A Five-Year Prospective 
Follow-Up Study
Vincenzo Santinelli, Andrea Radinovic, Francesco Manguso, Simone Sala, Gabriele 
Vicedomini, Patrizio Mazzone, Giuseppe Ciconte, Enrico Frigoli, Giuseppe Augello, 
Emma Gelera, Simone Gulletta, Massimo Saviano, Alessia Pappone, Gabriele Paglino, 
Carlo Pappone, San Raffaele Hospital, Milan, Italy
Background: There are no prospective data on progression of AF in patients with and 
without lone AF.
Methods: All consecutive patients with first-detected paroxysmal AF were analyzed. 
Primary end-point was the cumulative probability of progression to permanent AF within 
5 years and related risk factors.
Results: Among 402 screened patients, 106 (mean age, 57.5 years) were enrolled. 
Of them, 54 (mean age, 53.3 years) had lone AF and 52 (mean age, 62.0 years) had 
comorbidities. At the end of the 5-year follow-up, 50 patients (47%) had no episodes, 
31 (29%) had recurrent paroxysmal episodes, 9 (9%) had persistent episodes, and 16 
(15%) definitively progressed to the permanent AF. Patients with lone AF were less likely 
to progress to recurrent paroxysmal/persistent and permanent arrhythmia (p<0.001). Age 
was the common predictor for all clinical forms regardless of comorbidities presence. 
Comorbidities predicted progression to persistent (p=0.003) and permanent AF (p=0.028), 
but not to paroxysmal AF. Persistent AF (p=0.005), heart failure (p=0.006) and diabetes 
mellitus (p=0.007) predicted progression to permanent AF.
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Conclusions: Patients with lone AF are less likely to progress over 5-year follow-up. Age, 
comorbidities, and persistent AF are predictors of progression to permanent AF. Early 
identification of patients at risk to determine the optimal timing of catheter ablation before 
progression to permanent AF is desirable.
2:00 p.m.
1008-90 AV-FREEZE: Prospective Safety Assessment of Cryo-
Effects on the Human AV Node
Timm Dickfeld, Apostoles Voudouris, Anthony Johnson, Jagan Akella, Michael Nillas, 
Robert Peters, R.E. Hood, Stephen Shorofsky, University of Maryland, Baltimore
Background: Cryoenergy (CE) is assumed to be safer than RF energy due to its rapid 
reversibility. While this assumption is based on limited data, it has led to use of CE for 
ablations around the AV node and in pediatric patients. To address the issue of safety, this 
study was designed to test the reversibility of cryo-induced complete heart block (CHB).
Methods: In five patients (51.8 years) with a clinical indication for AV node ablation, 
CE was delivered to the AV node region using a 6mm tip cryocatheter (Cryocath) at a 
temperature of -80°C. If CHB was observed, cryoenergy was continued for an additional 
10s. The heart rhythm was monitored for 30 min to assess recovery of conduction. If 
the effect was temporary an additional 20s of CE was delivered after development of 
CHB. The primary endpoint was the creation of CHB persisting for >30min after only 10s 
of additional CE. The secondary endpoint was any documented damage to the native 
conduction system.
Results: Primary endpoint of CHB>30min was observed in two of five patients [40%]. Time 
interval from CE-onset to CHB was 10.5±0.7s [range 10-11s]. Time of cryoapplication 
after CHB was 11.0±0.7s. The secondary endpoint of any effect on the conduction system 
(CHB or RBBB) was observed in all five patients [100%]. Persisting CHB and RBBB of 
>30min was observed after additional 20s of CE in patient four and five, respectively.
Conclusions: CHB persisting >30min was observed in 40% of the patients with only 10s 
of additional cryoenergy after onset of CHB. There are significant effects of CE on the 
native conduction system, which last >30min in 80% of patients. These findings raise 
considerable concerns about the rapid reversibility of cryo-induced effects on the human 
conduction system
2:00 p.m.
1008-91 Clinical Characteristics of Patients With Very Late 
Recurrence of Atrial Fibrillation Post Ablation
Chi Keong Ching, Claude S. Elayi, Luigi Di Biase, Barrett Conor, Meulet John, Thomas 
Callahan, John Zakaib, Robert Schweikert, Walid Saliba, Oussama Wazni, Mauricio 
Arruda, Jennifer Cummings, Mohamed Kanj, Andrea Natale, Cleveland Clinic, 
Cleveland, OH
Background: Recurrence of atrial fibrillation (AF) usually occurred within 6 months post 
ablation. Very late recurrence (>12 months) is uncommon and these patients may have 
unique clinical characteristics. We aim to describe the clinical characteristics of patients 
with very late AF recurrence post ablation.
Methods: Consecutive patients who underwent AF ablation over a period of 2 years were 
included. We identified 13 of 1971 patients (0.7%) with very late recurrence; defined as 
more than 12 months post ablation. Demographic, clinical and electrophysiologic data 
were collected at time of procedure and on subsequent follow-up visits. All patients 
underwent circular mapping catheter pulmonary vein isolation (PVI) to achieve electrical 
isolation of all pulmonary vein (PV) antra, verified by entry block to the respective PV. In 
addition, superior vena cava was also electrically isolated.
Results: The mean age of patients was 56 ± 10 years old with a preponderance of male 
(69%). The mean time to AF recurrence post ablation was 16 ± 4 months (range 12 to 
23 months). The left atrial size was 42 ± 5 mm with a left atrial cavity area of 23 ± 5 
cm2. Of note, most of these patients (60%) were not on anti-arrhythmic drugs at time 
of AF recurrence. There was no difference between incidence of paroxysmal vs non-
paroxysmal AF. Ablation catheters used for the index ablation was non irrigated tip (77%) 
vs open irrigated tip (23%). PV reconnectivity was found in almost all patients (92%) in 
the following frequency: RIPV (92%), LSPV (61.5%), RSPV (54%), LIPV (39%). Non-PV 
triggers were identified in 39%, either localized to the right interatrial septum or within 
the coronary sinus.
Conclusions: Majority of patients with very late AF recurrence post ablation demonstrated 
PV reconnectivity in addition to a high prevalence of non-PV triggers which were not seen 
at the time of the initial ablation.
2:00 p.m.
1008-92 A Prognosis and Risk Factor Analysis in Paroxysmal, 
Persistent and Permanent Atrial Fibrillation
Laurent Fauchier, Bruno Rauzy, Laurent Gorin, Emilie Nonin, Bertrand Pierre, Caroline 
Grimard, Axel de Labriolle, Dominique Babuty, Bernard Charbonnier, Centre Hospitalier 
Universitaire Trousseau, Tours, France, Faculté de Médecine, Tours, France
Background: The presentation of atrial fibrillation (AF) has been categorized into 3 
general patterns: paroxysmal, persistent, and permanent AF. Whether AF pattern affects 
survival is poorly recognized.
Methods: Patients seen in the cardiology department in our institution (academic hospital, 
tertiary referral center) with AF between January 2000 and July 2007 were retrospectively 
identified and prospectively followed. The patients were identified by a search in the 
hospital discharge records which include information on type of AF, primary diagnoses 
and co-existing conditions, performed procedures, date of admission, discharge, and in-
hospital death.
Results: Among 6517 patients, those who died or were lost to follow-up within 30 days of 
their index event were excluded. In the remaining 4058 patients, (age 71±14 years; 2523 
men [62%]), 2167 had paroxysmal AF, 220 had persistent AF, and 1671 had permanent 
AF. During a follow-up of 946±767 days, 553 of them died. The mean annual mortality 
rate was 5.3 %. 
CHADS2 score was 1.53±1.08 in paroxysmal AF, 1.51±1.16 in persistent AF (p=NS vs 
paroxysmal AF) and 1.68±1.14 in permanent AF (p<0.0001 vs paroxysmal AF, p=0.03 vs 
persistent AF). Permanent AF was associated with higher mortality than paroxysmal AF 
(relative risk=1.45, 95% CI 1.30-1.62) and persistent AF (relative risk=2.8, 95% CI 2.16-
3.81). Persistent AF was associated with a better survival than paroxysmal AF, (relative 
risk=1.98, 95% CI 1.49-2.62) (all p<0.0001). The factors independently associated with 
increased mortality (Cox proportional hazards model) were concomitant heart failure 
(p<0.0001), older age (p<0.0001), history of stroke (p=0.002), male sex (p=0.007), 
diabetes (p=0.009) and AF pattern with paroxysmal or permanent AF (compared to 
persistent AF, p=0.003). 
Conclusions: Survival among patients with persistent AF was significantly better than 
that among patients with paroxysmal AF or permanent AF. The fact that paroxysmal and 
permanent AF were independently associated with increased mortality does not appear 
to be only related to concomitant cardiovascular risks. The decision and ability to maintain 
sinus rhythm may be associated with a better survival.
2:00 p.m.
1008-93 Risk Factors of the Progression From Paroxysmal or 
Persistent to Permanent Atrial Fibrillation
Laurent Fauchier, Bruno Rauzy, Emilie Nonin, Laurent Gorin, Bertrand Pierre, Caroline 
Grimard, Axel de Labriolle, Dominique Babuty, Bernard Charbonnier, Centre Hospitalier 
Universitaire Trousseau, Tours, France, Faculté de Médecine, Tours, France
Background: After its initial diagnosis, atrial fibrillation (AF) may progress from a 
paroxysmal or persistent pattern to permanent AF which may be associated with a 
worse prognosis. The rate of progression and risk factors for progression are not clearly 
recognized.
Methods: Patients seen in the cardiology department in our institution (academic hospital, 
tertiary referral center) with AF between January 2000 and July 2007 were retrospectively 
identified and prospectively followed. The initial population included 6517 patients 
identified by a search in the hospital discharge records which include information on type 
of AF, primary diagnoses and co-existing conditions. Observed survival was estimated 
using the Kaplan-Meier method.
Results: Among 4058 patients who survived or had a follow-up > 30 days of their index 
event (age 71±14 years; 2523 men [62%]), 2167 had paroxysmal AF, 220 had persistent 
AF, and 1671 had permanent AF. During a follow-up of 946±767 days, 553 of them died. 
Permanent AF was indeed associated with higher mortality compared to paroxysmal AF 
(relative risk=1.45, 95% CI 1.30-1.62) and persistent AF (relative risk=2.8, 95% CI 2.16-
3.81) (both p<0.0001).
Among 2167 patients with paroxysmal or persistent AF, 307 had progression to 
permanent AF (mean annual rate of 8.8 % with steady progression). The factors 
independently associated with progression to permanent AF (Cox proportional hazards 
model) were concomitant heart failure (p<0.0001), number of electrical cardioversion 
(p<0.0001), prosthetic heart valve (p=0.0001), older age (p=0.001) and history of dilated 
cardiomyopathy (p=0.05).
Conclusions: In paroxysmal or persistent AF, there is a slow but steady progression 
to permament AF which is associated with a worse prognosis. Older age, number of 
electrical cardioversion, cardiomyopathy and heart failure are independently associated 
with progression to permanent AF. Early optimization of the treatment of heart failure may 
help to maintain sinus rhythm and this may lead to a better survival.
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2:00 p.m.
1008-94 Long Term Efficacy When Using Multi-Array Catheters 
and Phased Radiofrequency Energy for Ablation of 
Chronic Atrial Fibrillation
Christoph Scharf, Lucas Boersma, Prapa Kanagaratnam, Wyn Davies, Nicholas Peters, 
Vince Paul, Edward Rowland, Simon Fynn, Andrew Grace, Clinic im Park, Zurich, 
Switzerland
Background: Widespread adaptation of radiofrequency catheter ablation (RFCA) of 
chronic atrial fibrillation (CAF) has been limited by long procedure times and low efficacy. 
This study was designed to evaluate the safety and efficacy of multi-array catheters 
combined with phased radiofrequency energy for RFCA of CAF.
Methods: Fifty-three patients with CAF underwent RFCA using a combination of three 
multi-array mapping and ablation catheters: A circumlinear 10-electrode catheter for 
antral pulmonary vein (PV) isolation, a 3-arm, 12 electrode catheter for septal ablation 
of complex fractionated atrial electrograms (CFAEs), and a 4-arm, 8 electrode catheter 
for CFAE ablation of the roof and other areas of the left atrium. Bipolar/unipolar phased 
radiofrequency was selectively delivered through all chosen electrodes at ratios of 1:1, 
2:1, and 4:1, depending on the desired lesion depth. Non-fluoroscopic navigation systems 
were not utilized during the procedures. Power was limited to 10 watts/electrode. Acute 
success was defined as complete isolation of all PVs and stable sinus rhythm at the end 
of the procedure. Chronic efficacy was assessed with a continuous 7-day Holter monitor 
at six months post procedure.
Results: Acute efficacy was documented in 50/53 patients (94.3%). Procedure times 
once a trans septal puncture was completed was 2 hours and 8 minutes. 21/53 (40%) 
of patients required two ablation procedures. 27 patients have completed a 7-day Holter 
monitor recording six months post ablation. 7 days of continuous sinus rhythm have been 
documented in 23/27 patients (79.4%). 2 patients demonstrated intermittent episodes 
of self terminating PAF totaling 3.3 and 11% of the total recording. Of the 23/27 (79.4%) 
chronic success patients 2 remained on an AAD. The only serious complication was a 
transient neurologic event in one patient.
Conclusions: Multi-array catheters in conjunction with phased radiofrequency energy may 
allow good safety and long term efficacy when ablating CAF.
2:00 p.m.
1008-94A Safety, Efficacy, and Follow-up of Circumferential 
Pulmonary Vein Ablation in Octogenarians
Vincenzo Santinelli, Andrea Radinovic, Simone Sala, Gabriele Vicedomini, Patrizio 
Mazzone, Simone Gulletta, Cristiano Ciaccio, Giuseppe Ciconte, Gabriele Paglino, 
Giuseppe Augello, Emma Gelera, Enrico Frigoli, Andreina Santagostino, Carlo Pappone, 
San Raffaele Hospital, Milan, Italy
Background. CPVA is an effective strategy for patients with atrial fibrillation (AF), but its 
safety and efficacy in the elderly have never been reported.
Methods. Between January 2005 and December 2006, all consecutive patients 
over the age of 80 referred for CPVA were enrolled. Complications and long-term 
outcome were prospectively assessed by daily transtelephonic monitoring (TTM) and 
echocardiography.
Results. The study population consisted of 172 patients (mean age, 83±2, male 55%) with 
paroxysmal AF (60 patients), persistent AF (50 patients), and permanent AF (62 patients). 
The average duration of AF prior to ablation was 7±5 years. Multiple comorbidities were 
present in 73% of patients (CAD in 38%, valvular heart disease in 46%, hypertension in 
77%, diabetes in 20%, heart failure 15%, respiratory disease 10%). Respiratory arrest 
during anesthesia occurred in 5 patients. Complications during the procedure occurred 
in 4 patients including femoral pseudoaneurysm, arterovenous fistula, or tamponade not 
requiring surgical intervention. Over a mean follow-up of 18±5 months, 43/172 patients 
with comorbidities (heart failure, diabetes and hypertension) had AF recurrences with 
an overall success rate of 75%; in particular, 54 patients (90%) with paroxysmal AF, 38 
(76%) with persistent AF and 37 pazienti (60%) with permanent AF were in sinus rhythm. 
AF recurrences, as documented by TTM, were silent in 23/43 patients (53%). A repeat 
procedure was done in 6/36 patients and the remaining patients were cured medically. 
Embolic events occurred in 6 patients (3.5%) despite optimal anticoagulation. In patients 
with permanent AF and sinus rhythm after ablation an inadequate atrial function persisted 
up to 1 year after procedure.
Conclusions. In octogenarians, CPVA is a safe and effective treatment particularly for 
paroxysmal and persistent AF. Greater attention is required during the procedure considering 
a higher number of procedure-related complications. Asymptomatic recurrences after 
ablation are frequent underestimating the true recurrence rate in such population supporting 
the need to continue anticoagulation even in the presence of sinus rhythm.
2:00 p.m.
1008-97 Visualizing Ablation Gaps in Vitro Using a Deflectable 
Fiber Optic Endocardial Visualization Catheter
Afraaz R. Irani, Bryant Lin, Christian Eversull, Paul J. Wang, Amin Al-Ahmad, Stanford 
University Medical School, Stanford, CA, Acumen Medical, Sunnyvale, CA
Background: The efficacy of pulmonary vein isolation for the treatment of atrial fibrillation 
(AF) may be limited by a clinician’s ability to make a continuous lesion with a catheter 
based system. Gaps often persist between ablation lesions leading to failed electrical 
isolation, leading to recurrence of AF or the genesis of atrial flutter.
Methods: Ninety-four radiofrequency lesions (RF) were delivered to ex-vivo porcine 
endocardium. Gaps between the lesions ranged between 0.1mm and 9.8mm. We utilize a 
deflectable fiberoptic endocardial visualization catheter using light in the visible spectrum 
to visualize the endocardial surface and lesions. Videos were taken of the lesions and 
shown to two blinded readers who were asked to identify the gaps ranging from less than 
0.1mm to 9.8mm.
Results: Ninety-four lesions were reviewed. The readers demonstrated a combined 
accuracy of 98.4% at identifying lesion gaps. Figure 1 shows a 0.4 mm gap between 
two ablation lesions. The left panel shows the video capture from the direct visualization 
catheter, and the right panel shows the gross specimen of the same sample.
Conclusion: Gaps between ablation lesions can be accurately identified down to less than 
1 mm distances in vitro using a direct visualization catheter. Further studies are warranted 
to confirm these finding in vivo. 
2:00 p.m.
1008-98 Comparison of Pulmonary Veins and Left Atrial 
Dimensions in Humans Using Gated Rotational Cardiac 
Fluoroscopy vs. Cardiac CT
Azar Mehdizadeh, Rebecca Fahrig, Paul J. Wang, Paul C. Zei, Henry H. Hsia, Teri 
Moore, Jarret Rosenberg, Amin Al-Ahmad, Stanford University, Stanford, CA, Siemens 
Medical AX Division, Forchheim, Germany
Background: Cardiac CT is useful in visualizing the anatomy of the left atrium (LA) and 
pulmonary veins (PV) for ablation of atrial fibrillation (AF). Recently, cardiac C-arm CT has 
been developed to allow acquisition of several bi-directional sweeps during synchronized 
acquisition of ECG for retrospective gating (AXIOM Artis dTA, DynaCT, Siemens Medical 
Solutions, Forchheim, Germany). To evaluate cardiac C-arm CT image quality, we 
compared LA and PVs dimensions using C-arm CT and clinical CT in an in-vivo human 
study.
Methods: Gated clinical CT images were obtained in 6 humans, then 0, 1 or 2 AF ablation 
procedures were carried out, and finally cardiac C-arm CT images were acquired. The LA 
and the 4 major PVs were measured in 3D volumes along 2 orthogonal axes at the largest 
cross sectional area and at the level of entry into the LA respectively.
Results: There was high intrareader reliability for both CT (.885, p<.001) and C-arm CT 
(.884, p<.001) and strong concordance correlation between them (.989, p<.001). Bland-
Altman Limits of Agreement were -.49 and +.37 mm. A Westlake test of equivalence 
found C-arm CT measurements equivalent within 20% to CT ones (p<.01), with mean 
differences of -0.167 mm (2 ablations) to 0.032 mm (no ablations).
Conclusions: 3D cardiac imaging, carried out in the EP lab using cardiac C-arm CT, is highly 
accurate and such images could be generated during an intervention, providing true images 
of patient anatomy during the intervention for guidance and procedural planning. 
2:00 p.m.
1008-99 Feasibility of ECG-Gated CT-Fluoroscopy Registration 
in Catheter-Based Atrial Fibrillation Ablation
M. Eyman Mortada, David Krum, Carol Gilbert, Rajinder Singh, Praveen Jammula, 
Elisabeth Soubelet, Barry Belanger, Regis Vaillant, Ananth Mohan, Masood Akhtar, 
Jasbir Sra, Aurora Sinai/Aurora St. Luke’s Med Ctrs, Univ Wisconsin School of Med and 
Public Health-MCC, Milwaukee, WI, GE Healthcare, Waukesha, WI
Background: CT-fluoroscopy integration has been used to navigate the ablation catheter 
in the complex anatomy of the left atrium (LA) during atrial fibrillation (AF) ablation. 
However, this modality still faces multiple obstacles, including registration error due to 
mismatch during the cardiac cycle. We report on the feasibility of using an ECG-gated 
technique to overcome this hurdle.
Methods: One-hundred-twenty consecutive patients with symptomatic AF refractory to 
medical therapy (60% paroxysmal, 40% persistent, age 58±9, 99 males) underwent 
catheter ablation. All patients received pre-procedural contrast-enhanced CT during 
inspiration. Three-dimensional segmentation was done at 75% of R-R interval for patients 
in normal sinus rhythm (NSR) or 45% of R-R interval for patients in AF. During the ablation 
procedure, the fluoroscopic images were gated to the ECG at the exact timing of the 
cardiac cycle where the CT image was taken using two different techniques: prospective 
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analysis in 87 patients (72.5%), retrospective analysis in 33 patients (27.5%). In both 
techniques, 60% of patients were in NSR and 40% were in AF at the time of registration. 
CT-fluoroscopy registration was performed automatically with manual correction as 
needed and used in navigation of the ablation catheter.
Results: LA volume was 129±35 cm3. The average segmentation time of the LA was 
30±10 minutes. Two independent investigators evaluated the quality of ECG gating. They 
found good quality in 86.6%. Retrospective analysis was found to be more accurate 
than prospective analysis (100% vs. 81.6%). The other factor affecting ECG gating 
accuracy was the patient’s rhythm during gating, AF was worse than NSR (74% vs. 94%). 
Regardless of the gating algorithm used, automatic registration gave perfect results or 
needed minimal manual correction 68% of the time. With manual adjustment (minimal or 
significant), satisfactory registration could be achieved 78% of the time.
Conclusions: Registration of CT images to ECG-gated fluoroscopic images during AF 
ablation is feasible. The retrospective gating technique works better than the prospective 
technique, especially in patients with AF at the time of registration.
2:00 p.m.
1008-100 Postoperative Atrial Fibrillation Management by 
Selective Epicardial Vagal Fat Pad Stimulation in Low 
Ejection Fraction Patients
Stefano Bianchi, Pietro Rossi, Alberto Della Scala, Ruggero De Paulis, Antonio Barretta, 
Herribert Pavaci, Fabio Miraldi, S. Giovanni Calibita Hospital, Roma, Italy
Background: Atrial fibrillation (AF) is the most common complication of cardiac surgery and 
particularly in patients with low left ventricular ejection fraction (LVEF). Pharmacological 
prophylaxis of AF is not satisfactory and high doses of atrio-ventricular (AV) selective 
drugs are usually necessary to reduce the mean ventricular rate (VR). Negative cardiac 
inotropic effects of these drugs are well known. The aim of this study is to verify if a 
high frequency stimulation of the right inferior vagal fat pad (RIVFP) allows control of VR 
without the use of drugs.
Methods: We enrolled 32 consecutive patients (mean age 62±9 years) candidate to 
on-pump coronary artery by-pass grafting, LVEF ≤ 45% and without history of AF. We 
performed an epicardial mapping of the RIVFP with a bipolar probe, using high frequency 
stimulation (amplitude: 3-10 V, duration: 200 µsec, frequency: 20-85 Hz) in order to obtain 
a temporary AV block. In this site, we implanted a temporary bipolar heart wire (Medtronic 
6495 StreamlineTM); furthermore backup atrial and ventricular pacing heart wires were 
inserted. In the postoperative period, we performed high frequency vagal stimulation in 
those patients who developed AF with rapid mean VR.
Results: The intra-operative (off-pump) mapping test, delivered in sinus rhythm, showed 
a functional complete AV block in 29 patients (91%), with three different patterns of atrial 
response: AF induction (41%), atrial tachycardia (31%) and isolated ectopic beats (28%).
Within three days from surgery, 14 patients (44%) developed post operative AF with a mean 
VR of 127±12 bpm. In all patients, RIVFP stimulation achieved at least a persistent 25% 
reduction of VR during spontaneous AF with a mean output voltage of 6.9±1.2 V (impulse 
duration 200 µsec, frequency 50 Hz). In all patients, complete AV block was obtained with a 
mean voltage of 8.1±2.9 V (impulse duration 200 µsec, frequency 50 Hz).
Conclusions: Epicardial RIVFP stimulation represents a safe, effective and feasible 
technique to decrease VR during post operative AF. This technique, overcoming the 
inotropic negative effects of drugs normally used in the clinical setting, could be applied 
in all surgical patients with or even without low LVEF.
2:00 p.m.
1008-101 Vernakalant Hydrochloride Injection for Recent-Onset 
Atrial Fibrillation: Summary From Two Randomized, 
Controlled Trials and One Open-Label Study
Humberto J. Vidaillet, Katherine M. Kavanagh, Therese Kitt, Bruce McNutt, Bo Yan, 
Garth Dickinson, Brian Mangal, Astellas Pharma US, Inc., Deerfield, IL, Cardiome 
Pharma Corp., Vancouver, BC, Canada
Background: Vernakalant hydrochloride injection (VNK) is a novel, relatively atrial-
selective, multiple ion channel blocker that prolongs the atrial refractory period and 
rapidly converts atrial fibrillation (AF) to sinus rhythm. The efficacy and safety of VNK 
in patients with recent-onset AF were evaluated in a pooled analysis from ACT I and III, 
2 randomized, placebo (PBO)- controlled trials (RCTs), and in ACT IV, an open-label 
study (OLS).
Methods: Patients aged ≥18 y with AF lasting >3 h to ≤7 d received VNK 3 mg/kg (or PBO in 
the RCTs) infused over 10 min. After 15 min, a second 10-min infusion of VNK 2 mg/kg (or 
PBO in the RCTs) was given if AF or atrial flutter was present. Efficacy assessments included 
the percentage of patients whose AF converted to sinus rhythm for at least 1 min within 90 
min of dosing (ie, responders) and the median time to conversion among responders. Safety 
evaluations included vital signs, Holter monitoring, heart rhythm monitoring (telemetry), 12-
lead ECG, clinical laboratory testing, physical examination, and adverse events.
Results: In the OLS (n=167), 50.9% of patients were responders with a median time to 
conversion of 14 min. These results were similar to those in the 2 RCTs (VNK, n=231; 
PBO, n=159), in which 51.1% of those given VNK were responders (vs 3.8% with PBO, 
P<.0001), with a 10-min median time to conversion. The incidence of serious adverse 
events with VNK was similar in the OLS and RCTs, 12.0% and 13.0%, respectively; the 
incidence with PBO was 12.6%. There were no cases of torsade de pointes with VNK in 
these patients with recent-onset AF (in the RCTs, 1 patient given PBO had torsade de 
pointes). Adverse events with VNK were similar in the OLS and RCTs. The most common 
adverse events with VNK in the OLS were dysgeusia (altered sense of taste), sneezing, 
paresthesia, and hypotension. The most common adverse events with VNK in the RCTs 
were dysgeusia, sneezing, paresthesia, dizziness, nausea, and headache.
Conclusions: In 2 randomized, controlled trials and 1 open-label study in patients with recent-
onset AF, VNK rapidly and effectively converted AF to sinus rhythm and was well tolerated.
2:00 p.m.
1008-102 Validation of Image Integration in a Swine Model: The 
Accuracy of Catheter Navigation After Integration of 
Three-Dimensional Computed Tomography Images With 
a Catheter Geometry
J. Jason West, Amit R. Patel, N. Craig Goodman, Eric Olson, Vamsee Rangavajhala, Jeff 
Schweitzer, John D. Ferguson, University of Virginia, Charlottesville, VA
Background: Electro-anatomical mapping systems should consistently provide accurate 
navigation of the catheter tip to within millimeters of specific ablation sites. This is a 
significant technological challenge. We have sought to validate the accuracy of a new 
system for catheter navigation using integration of three-dimensional (3D) CT images 
with a catheter geometry.
Methods: Using a lateral thoracotomy, two separate markers (3mm size) were sutured 
to the epicardial surface of each cardiac chamber in 7 swine. CT imaging produced a 
detailed 3D anatomy, which was then imported into the mapping system (Ensite NavX™, 
Fusion™ Registration Module, St Jude Medical). The 3D image was then registered with a 
detailed catheter geometry of the relevant chamber. This process utilized a novel dynamic 
registration algorithm. The epicardial markers, identified from the CT images, were then 
displayed on the 3D CT surface. Guided only by the 3D CT (without fluoroscopy), a single 
RF lesion was directed at each epicardial marker. At autopsy, a straight needle was 
passed from the epicardial marker to the nearest endocardial point. The distance from the 
needle to the center of the endocardial RF lesion was assessed.
Results: Complete data were obtained for 10 markers in each of the four cardiac 
chambers. The mean position error for the right atrium was 6.2±6.5mm, for the left atrium 
2.5±2.4mm, for the right ventricle 6.2±4.3mm, and for the left ventricle 4.7±3.4mm. The 
average distance (tissue thickness) from the epicardial marker to the nearest endocardial 
point was 3.6±1.1mm, 4.2±1.5mm, 6.7±2.1mm, 14.1±2.6mm for the RA, LA, RV and LV, 
respectively. There was no cardiac perforation or tamponade.
Conclusions: Integration of a catheter geometry and 3D CT images facilitates successful 
intracardiac navigation and endocardial ablation. Careful attention to all steps of image 
integration is necessary to minimize error.
2:00 p.m.
1008-103 Autoantibody Activation of Beta Adrenergic and M2 
Muscarinic Receptors in Hyperthyroid Patients With 
Atrial Fibrillation
Stavros Stavrakis, Reji Pappy, Eugene Patterson, Isabel DeAos, Madeleine W. 
Cunningham, David C. Kem, Xichun Yu, Univeristy of Oklahoma Health Sciences 
Center, Oklahoma City, OK
Background: Hyperthyroidism is an important factor in the etiology of atrial fibrillation (AF). 
Activation of the sympathetic and parasympathetic nervous system acts synergistically in 
the initiation of AF. We hypothesized that autoantibody activation of beta adrenergic (β-ΑR) 
and M2 muscarinic (M2-R) receptors would compound the effects of hyperthyroidism in 
the pathogenesis of atrial fibrillation.
Methods: We screened 24 patients with Graves’ disease, with or without AF, by ELISA 
for the presence of autoantibodies to β-ΑR (AAβΑR) and M2-R (AAM2). 11 patients 
had AF and 13 had normal sinus rhythm. To assess the functional properties of the 
autoantibodies, we studied the inotropic effects of purified IgG from these patients’ sera 
in an isolated perfused canine Purkinje fiber preparation. We measured the amplitude of 
stimulated contractions at 2 Hz during perfusion with buffer containing purified IgG from 
either control (n=7) or patients (n=24), with and without atropine (100nM).
Results: 20 of 24 (83%) patients were positive for either autoantibody group, whereas 
only 8 (33%) were positive for both. Each of the autoantibody-positive patients had 
ELISA titers of 1:1,600 to 12,800 with controls ranging from 1:400-1:800. IgG alone had a 
positive inotropic effect in 7 patients, had no effect in 13 and a negative inotropic effect in 
4 patients. IgG in the presence of atropine increased contractility to 124±8% of baseline 
(p<0.01) in 16 of 24, and had no effect in 8 patients. Activating autoantibodies (increase 
in contractility with IgG alone, or in the presence of atropine) were significantly more 
prevalent in patients with AF, compared to patients without AF (100% of patients with AF 
versus 46% of patients without AF, p=0.006 by Fischer’s exact test, OR=26.5).
Conclusions: Our data confirm the presence of AAβΑR and AAM2 in a significantly 
increased frequency in patients with Graves’ disease and concurrent AF. We conclude 
that activation of the β-ΑR and M2-R by AAβΑR and AAM2, respectively, enhances the 
arrhythmogenic activity of hyperthyroidism, and increases the substrate for generation of 
AF in this susceptible population.
2:00 p.m.
1008-104 Effect of Angiotensin Converting Enzyme Insertion/
Deletion Genotype on Collagen Type I Synthesis and 
Degradation in Patients With Atrial Fibrillation and 
Arterial Hypertension
Dimitrios Tziakas, George Chalikias, Dimitrios Stakos, Dimitrios Papazoglou, 
Nikolaos Papanas, Konstantinos Papatheodorou, Sofia Chatzikyriakou, Asimina 
Lantzouraki, Efstratios Maltezos, Harisios Boudoulas, Democritus University of Thrace, 
Alexandroupolis, Greece, Center for Clinical Research, Foundation of Biomedical 
Research, Athens, Greece
Background: Previous studies have shown that atrial fibrosis with collagen deposition 
is the underlying substrate in atrial fibrillation (AF) and that the activation of the renin-
angiotensin - aldosterone system promotes collagen deposition and myocardial fibrosis. 
The insertion (I) / deletion (D) polymorphism in the gene encoding angiotensin converting 
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enzyme (ACE) influences enzyme expression and concentration of angiotensin II.
The present study was undertaken to assess the impact of the ACE I/D polymorphisms 
on circulating markers of collagen type I synthesis and degradation and the effect of 
therapy with ACE inhibitors on these markers in hypertensive patients with AF.
Methods: ACE I/D genotypes were assessed in 158 hypertensive patients [71±9 years, 
72 male] with AF and 174 patients with arterial hypertension in sinus rhythm (SR) [71±9 
years, 88 male]. Serum concentrations of amino-terminal propeptide of pro-collagen type 
I (PINP) and of carboxy-terminal telopeptide of collagen type I (CITP), indexes of collagen 
type I synthesis and degradation respectively, were measured.
Results: Of the 332 study participants 74 (22.3%) were I/I, 158 (47.6%) I/D and 100 
(30.1%) D/D carriers. Genetic variation in ACE significantly influenced serum CITP levels 
in AF patients (p=0.011). CITP levels were lower in D allele carriers (DD and ID) compared 
to I/I. There was no difference in PINP levels between the different ACE genotype groups 
(p=0.302). Patients treated with ACE inhibitors had higher CITP levels compared to those 
not treated (p=0.036).
Conclusions: This study suggests that the presence of the D allele in hypertensive patients 
with AF is associated with attenuation of type I collagen degradation and that therapy with 
ACE inhibitors increases degradation of collagen type I. The data indicate a subgroup of 
patients with AF arterial and hypertension who may benefit more from therapy with ACE 
inhibitors, thus, providing a basis for pharmacogenetics.
2:00 p.m.
1008-105 Relative Endocardial Sparing in Lesions With an Open 
Irrigated Catheter: Relationship With Power Setting and 
Catheter Pressure
Luigi Di Biase, Walid I. Saliba, Conor Barrett, Robert A. Schweikert, Chi Keong Ching, 
Mauricio Arruda, J. David Burkhardt, Andrea Natale, Jennifer E. Cummings, Cleveland 
Clinic, Cleveland, OH
Introduction: Transmurality is key in lesion effectiveness. Catheters with open irrigation 
(OIC) have become the standard of care. However, the power titration protocols proposed 
with this catheter have differed. We assessed lesion characteristics with different power 
settings and catheter pressure.
Methods: An OIC ablation catheter was advanced via a transeptal puncture into the left 
atrium (LA) in 6 dogs. After creation of the RA and LA maps using the Ensite/NavX, 
lesions were placed in the atria at 6 distinct settings (Table 1) using two power levels, a 
constant duration (40 sec) and flow rate of either 17cc/min or 30cc/min. Necropsy was 
performed and lesions were examined.
Results: Lesions placed with a power setting less than 35 Watts were more likely to result 
in relative sparing of the endocardial surface than lesions at a power settings higher than 
35 Watts (77.8% vs 38.9%) regardless of pressure.
With a fixed pressure setting (20-30g) (group 4) the majority of lesions performed at 40-
45W power demonstrated transmurality (83.1%) while it was present only in 16.7% of the 
lesions placed at 30 watts.
Conclusions: These data indicate that lesions placed with open irrigated catheters at a 
fixed contact pressure and lower power setting (< 35W) were more likely have a relatively 
spared endocardial surface. This phenomenon nearly disappeared with higher power 
settings (>35 W). Our findings have important implications when performing ablation with 
any open irrigated catheter.
Table1: 
Group Power (W) Pressure (g) %Transmurality Endocardial sparing
Group 1 30 10 0% 0%
Group 2 45 10 0% 0%
Group 3 30 20-30 16.7% 50 %
Group 4 45 20-30 83.1% 16.7 %
Group 5 30 >40 50% 33.4%
Group 6 45 >40 100% 0 %
2:00 p.m.
1008-106 A Novel Method to Identify Complex Fractionated Atrial 
Electrograms
Dan Wichterle, Vaclav Kremen, Vlastimil Vancura, Robert Cihak, Josef Kautzner, 
Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Background: Progress in signal processing algorithms to identify complex fractionated 
atrial electrograms (CFAEs) is crucial for the development of atrial fibrillation (AF) ablation 
strategies.
Methods: Head-to-head comparison of two methods for quantification of atrial electrograms 
(A-EGMs) with different degree of fractionation was performed using representative 
set of 1.5s A-EGMs (n = 113) that were blindly ranked by 3 independent experts into 
4 categories: 1 - organized atrial activity; 2 - mild; 3 - intermediate; 4 - high degree of 
fractionation. First method (M1) assessed the average interval between discrete A-EGM 
spikes using algorithm previously implemented in commercially available electroanatomic 
mapping system. Second method (M2) employed a robust description of distribution of 
peak-to-peak atrial signal differences.
Results: Although of M1 method was comprehensively optimized (peak-to-peak voltage 
sensitivity, signal duration, and refractory interval criteria) with respect to particular 
experimental dataset, its discriminative power to detect CFAEs was not superior to that 
provided by the newly introduced non-parametric M2 algorithm. Correlations between 
averaged expert classification and M1 and M2 indices of fractionation are shown in the 
Figure. 
Conclusions: Novel method offers operator-independent description of A-EGMs 
complexity. It may easily be incorporated into real-time mapping systems to guide the 
AF substrate ablation.
2:00 p.m.
1008-107 Safety Implications of Irrigation Flow Rates Using 2mm 
and 4mm Tip Electrode for Ablation: Can the 2mm Tip 
Safely Create Large Lesions at Lower Power and Flow?
Mauricio Arruda, Joe Marak, Danielle Valoras, Laura Wilson, Irvin Narcisco, Alex 
Villanueva, Moataz El Hallage, Nabil Kanaan, Andrea Natale, Newark Beth Israel 
Medical Ctr, Newark, NJ, Cleveland Clinic, Cleveland, OH
Background: Smaller ablation tip electrode improves mapping resolution while open 
irrigation creates larger lesions with less char and thrombus, but requires large amounts 
of saline infusion.
We evaluated the impact of irrigation flow rates, RF power and time, tip electrode size and 
orientation on RF lesion size, char and steam pops occurrences.
Methods: In a porcine thigh muscle preparation, 322 RF applications (13 porcine) 
were randomized to irrigation flow (13 or 30ml/min), electrode orientation (parallel and 
perpendicular), power and tip size (2mm at 10, 15, 20, 25, 30, 35 and 40W; 4mm at 15, 
20, 30, 40 and 50W) for 20 or 60 secs.
Results: Using the 2mm tip at 20W/20sec there were no pops or charring. At 20W/60sec 
there were no thrombus/char but there were 25% pops. At ≥ 30W irrespective of irrigation 
rate and RF time, pop occurred > 75%. Using the 4mm tip at 40W and 50W also 
irrespective of flow rate and RF time, pops occurred in 50-100%. Although flow rate had 
no impact on lesion size, char/thrombus was seen in 50% of RFs with both 2 and 4mm 
tip electrode at powers ≥ 30W and low irrigation rate. Lesion size for 2 and 4mm tip at 15 
and 20W (see table).
Conclusions: Flow rate had no significant impact on lesion size. Longer RF time modestly 
increases lesion depth. RF lesions are larger with 2mm than 4mm tip in the perpendicular 
orientation. This may favor the use of the 2mm tip electrode (higher mapping resolution) 
at a lower power, lower irrigation flow rate and shorter RF time, particularly in the atria 
and in volume restricted patients.
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Results: We treated 147 p (45 women, mean age 59±10 years,136 with paroxysmal,11 
persistent af, left atrium 42±5 mm, 65 with lone af, 59 hypertension, 23 mild structural 
heart disease) with 23/28 mm balloon. Mean vein diameter was 18±4 mm angiographically. 
With a mean number of 2.4±0.7 impulses we isolated up to 87% of the left pv and the 
right upper pv and 82 % of the right lower pv with balloon only; in the last 40 p all 4 pv 
with balloon only could be isolated! In 30% we combined 23/28 mm balloon. We isolated 
100% of all pv during a procedure time of 185±38 min with x ray burden of 35±9 min. 
Phrenic nerve palsy in 6 p recovered within 3 to 9 months. During a mean follow-up of 8.5 
months and 1.1 procedures per p (12 redos) of 96 p controlled with serial 7-day holter and 
symptoms 78 % (75 p) were free of af. 16 showed marked reduction of af burden. In the 12 
redos 68 % of the 37 reconducting veins were initially isolated with the 28 mm balloon.
Conclusions: Cryoisolation of ostia and antrum of the pv with balloon technique is safe 
and shows a convincing outcome in long term experience. The superiority in comparison 
to substrate modification with RF will be an early and first line therapy of left atrial disease. 
Avoidance of phrenic nerve lesion and focus on improvement of balloon design may be 
essential.
2:00 p.m.
1008-111 Up-regulation of Toll-like Receptor 2 Expression Levels 
in non-Valvular Atrial Fibrillation: Comparison between 
blood samples from peripheral vein and left atrium
Yasuhisa Iriki, Koji Orihara, Sanemasa Ishida, Shuichi Hamasaki, Hitoshi Ichiki, Naoya 
Oketani, Yuichi Ninomiya, Hideki Okui, Keishi Saihara, Masakazu Ogawa, Tetsuro 
Kataoka, Takehiko Matsushita, Ryutaro Oba, Hiroyuki Hirai, Kinya Nagata, Chuwa Tei, 
Graduate School of Medicine, Kagoshima University, Kagoshima, Japan
Background:Many studies have suggested that an inflammation may participate in the 
pathogenesis of non-valvular atrial fibrillation (AF). Most recently we reported that Toll-
like receptor 2 (TLR2) levels on monocytes derived from peripheral venous blood in 
patients (n = 18) with paroxysmal/persistent non-valvular AF were significantly higher 
than those in patients (n = 24) with sinus rhythm (controls), simultaneously showing that 
non-valvular AF patients had significantly higher CRP levels than controls. Furthermore, 
ex vivo we have observed that T-helper type 1 (Th1) -cytokine, such as interferon-γ and 
tumor necrosis factor-α, have a potency to up-regulate TLR2 levels, and that interleukin-4 
down-regulates them.
Purpose:Our purpose is to test the hypothesis that there is a difference in TLR2 levels on 
monocytes between blood samples from peripheral vein and left atrium.
Methods:The consecutive 14 patients with non-valvular AF who were hospitalized for 
catheter ablation were enrolled in this study. Blood samples from peripheral vein and 
left atrium were taken at the same time just before catheter ablation. TLR2 levels on 
monocytes were assayed by using our developed flow-cytometric analysis system, and 
they were represented by the number of anti-TLR2 monoclonal antibody binding sites 
on a monocyte.
Results:TLR2 levels between blood samples from peripheral vein and from left atrium 
were compared in 14 patients with non-valvular AF by using Wilcoxon signed-rank test. 
TLR2 levels on monocytes from left atrium were significantly higher than those from 
peripheral vein (median, 4966 [95% CI, 4342 to 6690] vs. 5493 [95% CI, 4342 to 6690] 
sites/cell; p = 0.02).
Conclusions:Our results suggest that high level of TLR2 in non-valvular AF patients may 
be due not to systemic inflammation but to dominant inflammation in left atrium.
2:00 p.m.
1008-112 New Onset Atrial Fibrillation Following Myocardial 
Infarction is a Strong Independent Predictor of 
Mortality in Patients Treated with Primary Percutaneous 
Coronary Intervention
Renato D. Lopes, Harvey D. White, Judith Hochman, John R. Horton, Frans Van de 
Werf, Diego Ardissino, Torsten T. Nielsen, W. Douglas Weaver, Petr Widimsky, Paul W. 
Armstrong, Christopher B. Granger, Duke Clinical Research Institute, Durham, NC
Background: Little is know about the incidence of atrial fibrillation (AF) and its implications 
in patients (pts) with ST-segment elevation myocardial infarction (STEMI) treated with 
primary percutaneous coronary intervention (PCI).
Methods: We studied 5698 pts with STEMI treated with primary PCI enrolled in the APEX-
AMI trial. New onset AF during the initial hospitalization was defined as occurring in pts 
without a history of previous AF. A Cox proportional hazards model was used to identify 
significant baseline factors associated with mortality to 90 days. New onset AF was 
included as a time dependent covariate.
Results: The incidence of new onset AF was 6.2%. Compared to pts without AF, pts with 
AF were older, more often female, had higher baseline CKMB values, and lower baseline 
blood pressure. The predictors of 90-day mortality are shown in the table. New onset 
AF was associated with increased mortality compared to pts without AF (15% vs 3.5%, 
respectively). Similar results were observed for 30-day mortality, 30- and 90-day chronic 
heart failure and shock. Patients with new AF had more in-hospital bleeding (15.6%) and 
received more coronary artery bypass graft (CABG) surgery (8.5%) when compared with 
pts without AF (4.5% and 3%, respectively).
Conclusion: AF is an important independent predictor of higher mortality in STEMI pts 
treated with primary PCI. Patients with AF also have higher rates of in-hospital bleeding. 
Focus on improving outcome in this high-risk population is important.
2:00 p.m.
1008-108 Extracellular Matrix Alterations in Patients With 
Paroxysmal and Persistent Atrial Fibrillation. 
Biochemical Assessment of Collagen Type I Turnover
Eleftherios M. Kallergis, Emmanuel G. Manios, Emmanuel M. Kanoupakis, Hercules E. 
Mavrakis, Dimitris A. Arfanakis, Niki E. Malliaraki, Chrisovalantis E. Lathourakis, Panos 
E. Vardas, Heraklion University Hospital, Heraklion, Crete, Greece
Background: Structural alterations and fibrosis have been implicated in the generation 
and perpetuation of AF.
Methods: We investigated whether the serum markers of collagen turnover differed in 
various forms of atrial fibrillation (AF) and in sinus rhythm (SR) in humans.Serum C-terminal 
propeptide of collagen type I (CICP), C-terminal telopeptide of collagen type I (CITP), 
matrix metalloproteinase-1 (MMP-1), and tissue inhibitor of matrix metalloproteinases-1 
(TIMP-1) were measured as markers of collagen synthesis and degradation in 70 patients 
with AF and 20 healthy controls in SR.
Results: CICP and CITP were significantly higher in AF patients than in controls 
(91.37±27.26 ng/ml vs. 67.30±11.05 ng/ml, p<0.001 and 0.38±0.20 ng/ml vs. 0.25±0.08 
ng/ml, p<0.001, respectively). Persistent AF patients had higher levels of CICP, but not 
CITP, compared to those with paroxysmal AF, (105.06±27.57 ng/ml vs. 79.84±21.23 ng/
ml, p<0.001). Patients with persistent AF had lower levels of MMP-1 but increased levels 
of TIMP-1 compared with patients with paroxysmal AF, (11.90±4.79 ng/ml vs. 14.98±6.28 
ng/ml, p=0.03 and 154.90±44.91 ng/ml vs. 129.75±37.92 ng/ml, p<0.001, respectively). 
TIMP-1 levels were significantly lower in control subjects compared with both paroxysmal 
and persistent AF patients (102.10±15.13 ng/ml vs. 129.75±37.92 ng/ml vs. 154.90±44.91 
ng/ml, respectively, p<0.001).
Conclusions: Serum markers of collagen type I turnover differed significantly between 
patients with AF and SR. Furthermore these markers also differed significantly between 
paroxysmal and persistent AF patients, suggesting that the intensity of the extracellular 
synthesis and degradation of collagen type-I may be related to the burden or type of AF.
2:00 p.m.
1008-109 Hospitalization after First Atrial Fibrillation Diagnosis: 
Changing Trends and Relation to Practice Pattern
Yoko Miyasaka, Marion E. Barnes, Stephen S. Cha, Kent R. Bailey, Teresa S.M Tsang, 
Mayo Clinic, Rochester, MN
Background: Data suggest that there has been an increase in hospital admissions for 
cardiovascular reasons after first atrial fibrillation (AF). Whether this was related to a 
change in practice pattern remains uncertain.
Methods: Olmsted County, Minnesota residents diagnosed with first AF during 1980-
2000 were identified and hospital admissions for any cardiovascular causes after first 
AF diagnosis were reviewed and classified. For admissions specifically for the purpose of 
heart rate or rhythm control, we determined the specific mode of therapy that the patient 
received: initiation of antiarrhythmic or anticoagulation therapy, electrical cardioversion, 
device therapy (pacemaker or cardioverter-defibrillator implant), or catheter/surgical 
ablation procedures. The relationship of change in AF management over time to the trend 
of increased hospitalization over the last two decades was examined.
Results: Of a total of 4,618 subjects diagnosed with first AF (mean age 73 ±14 years; 
51% men), 2,503 (56%) were admitted at least once to the hospital for any cardiovascular 
causes following the first AF diagnosis (total number of admissions, 6,993) during a mean 
follow-up time of 5.5 ± 5.0 years. The age-and sex-adjusted rate of first hospitalization 
for any cardiovascular cause after first AF diagnosis increased, on average, by 2.5% a 
year, even after multivariable adjustment for comorbidities (P<0.0001). The age-and sex-
adjusted rate of first hospitalization with a primary reason of rhythm or rate control also 
increased significantly, on average, by 7.6% a year, even after multivariable adjustment 
(P<0.0001). When we excluded the hospital admissions for the purpose of rhythm or 
rate control, the increase in hospital admission was only 0.8% per year, which was not 
significant after multivariable adjustment (P=0.25).
Conclusions: The trend of increase in hospital admission after first AF diagnosis was 
largely related to changing practice pattern with AF management, independent of the 
changes over time in the distribution of age, sex, and comorbidities. With the anticipated 
increase in AF over the next few decades, these findings represent major socioeconomic 
burden to our healthcare system.
2:00 p.m.
1008-110 Long Term Experience in Cryoisolation of Pulmonary 
Veins with Balloon Technique in Paroxysmal Atrial 
Fibrillation
Juergen Vogt, Anja Dorszewski, Johannes Heintze, Ursula Scholz, Ulrike Wetzel, Sven 
Ottemöller, Lam Luong Thanh, Dieter Horstkotte, Department of Cardiology, Heart and Diabetes 
Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
Background: In the treatment of paroxysmal atrial fibrillation (af) circumferential substrate 
modification of the antrum of pulmonary veins (pv) seems superior in comparison to 
segmental methods. However, with radiofrequency energy, a risk of pv stenoses and 
esophago-left atrial fistula exists.This study reports on the long-term experience in 
isolating pv ostia and parts of the antrum with the cryoballoon technique.
Methods: After pv angiography isolation was performed with best fitting 28/23mm balloon 
(Arctic Front, Cryocath, Canada).The inflated over the wire balloon occluded the venous 
ostium and parts of venous antrum freezing down to - 75 ° C 6 minutes two times per vein 
with nitrous oxide. Lasso mapped rest potentials were eliminated with additional balloon 
freezes or 9 french Freezor Max catheter. Patients (p) were followed three monthly with 
7-day Holter.
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Predictors of 90-day Mortality
Predictors of 90-day 
Mortality χ
2 P-value Hazard Ratio
Lower 95% 
Confidence 
Interval
Upper 95% 
Confidence 
Interval
New onset AF 34.2 <.0001 2.71 1.94 3.78
Baseline Characteristics
Age (per 10 yrs) 112.6 <.0001 1.98 1.75 2.24
Systolic Blood 
Pressure (per 10 
mmHg)
56.9 <.0001 0.76 0.71 0.82
Killip Class III or IV 45.1 <.0001 3.62 2.49 5.26
Heart Rate (per 10 
bpm) 36.9 <.0001 1.36 1.23 1.51
Total ST-Segment 
Deviation (per mm) 15.7 <.0001 1.02 1.01 1.03
History of Diabetes 10.1 0.0015 1.59 1.19 2.13
2:00 p.m.
1008-113 Older Age and Sick Sinus Syndrome Predict Newly 
Diagnosed Atrial Fibrillation After Dual Chamber 
Pacemaker Implantation
Suneet Mittal, Kenneth Stein, F. Roosevelt Gilliam, Stacia Merkel, Shelly Christman, 
Boston Scientific CRM, St. Paul, MN
Background: Following dual chamber pacemaker (PPM) implant, atrial fibrillation (AF) is 
often diagnosed for the first time based on detection of stored atrial high rate episodes 
(AHRE). Predictors of newly diagnosed AF after PPM implant in patients with no history 
of AF remain obscure.
Methods: We evaluated data from the Silent Atrial Fibrillation Detection with Stored EGMs 
(SAFE) registry, which was a multi-center, prospective registry of patients undergoing 
dual chamber PPM implantation. No patient had prior history of AF. Device interrogations 
were performed at 2-week, 3-, 6-, and 12-months post-implant. An AHRE was defined as 
≥ 180 bpm lasting ≥ 5 minutes.
Results: 1482 patients (56% male, 74 ± 12 years) underwent dual chamber PPM 
implantation. 1050 (71%) patients were followed for ≥ 6 months, with a median follow-up 
time of 349 ± 147 days (mean=267 days). During 6 months of follow-up, 150 patients 
(10.1 %) were diagnosed with AF. The majority of AHREs lasted between 5 minutes and 
one hour (57%), while only 4% lasted greater than 24 hours. Patients ≥ 80 years of age 
were at greater risk of developing AF than patients < 65 years of age (p=0.019). Patients 
with sick sinus syndrome were at a greater risk of developing AF than patients without 
sick sinus syndrome (HR=1.512, p=0.034).
Conclusions: In the SAFE registry, 10.1% of patients followed for six months were 
diagnosed with AF for the first time. Age ≥ 80 years and presence of sick sinus syndrome 
were risk factors for development of AF in patients with no history of AF.
Baseline Characteristics
AF-No 
(n=1332)
AF-Yes 
(n=150) Hazard Ratio P-value
Gender 
Female 
Mal
602 (45%) 
730 (55%)
57 (38%) 
93 (62%) 0.756 0.097
Age (years) 
< 65 
≥ 65 and < 80 
≥ 80 
< 65 vs. ≥ 80 
≥ 65 and < 80 vs. ≥ 80
256 (19%) 
618 (47%) 
448 (34%)
19 (13%) 
70 (47%) 
61 (41%)
0.539 
0.821
 
 
0.019 
0.261
Structural Heart Disease 
Yes 
No
607 (46%) 
725 (54%)
78 (52%) 
62 (48%) 1.281 0.1305
Sick Sinus Syndrome 
Yes 
No
922 (69%) 
410 (31%)
116 (77%) 
34 (23%) 1.512 0.034
Heart Block 
Yes 
No
635 (48%) 
697 (52%)
62 (41%) 
88 (59%) 0.758 0.095
LVEF 
≤ 40 
> 40
143 (16%) 
746 (84%)
20 (19%) 
83 (81%) 1.356 0.219
NYHA 
No Symptoms 
I 
II 
III 
IV 
Unknown 
I vs. III/IV 
II vs. III/IV
8 (1%) 
511 (39%) 
375 (28%) 
76 (6%) 
6 (<1%) 
347 (26%)
0 (0%) 
63 (42%) 
43 (29%) 
5 (3%) 
0 (0%) 
39 (26%)
1.630 
1.622
0.293 
0.306
2:00 p.m.
1008-114 Magnetic Catheter Ablation of Right Atrial Flutter 
- the Importance of an 8mm Tip Electrode to Achieve 
Bidirectional Block
Sabine Ernst, Buelent Koektuerk, Julian KR Chun, Feifan Ouyang, Karl-Heinz Kuck, St. 
Georg General Hospital, Hamburg, Germany
Background:The novel magnetic navigation system (MNS) (Niobe, Stereotaxis) controls 
the distal magnetic tip of an ablation catheter in conjunction with a catheter advancer 
system. The aim of this study was to deploy a complete linear lesion to treat typical atrial 
flutter in a remote-controlled fashion.
Methods & Results: In a total of 36 pts (32 males, 62 ± 11 years) complete bidirectional 
right atrial isthmus block was attempted using a variety of magnetic ablation catheters. 
Three 4 mm tip and one 8mm tip catheter became successively available: First generation 
bipolar single magnet catheter (1M, n = 9 pts), second generation bipolar catheter with 
3 magnets (3M, n = 9), third generation quadripolar 3-magnet tip catheter (3M quad, n 
= 5) and finally a 3-magnet catheter with a large tip (3M 8mm, n = 13 pts) were used. 
Successful remote-controlled isthmus block was achieved in 33%, 66%, 0% and 92%, 
respectively. Besides the favourable ablation result, the use of the 3M 8mm catheter 
resulted in a marked decrease of total fluoroscopy duration (median 2.4, interquartile 
range 2.2 - 7.1) as well as exposure time for the investigator (median 2.2 min, 1.5 - 5.4). 
No complications occurred.
Conclusions: This is the first report of remote-controlled linear lesion deployment in the 
right-atrial inferior isthmus using magnetic navigation. In comparison to several 4mm tip 
magnetic catheters, superiority of the 8mm tip electrode to achieve bidirectional block with 
regards to effectiveness and fluoroscopy exposure was demonstrated.
2:00 p.m.
1008-115 Paracardioscopic Creation of a Comprehensive 
Biatrial Lesion Pattern During Minimally Invasive Atrial 
Fibrillation Treatment
Andy C. Kiser, Jerzy Sadowski, Boguslaw Kapelak, Krzysztof Bartus, Gerhard Wimmer-
Greinecker, Pinehurst Surgical, Pinehurst, NC
Background: Current minimally invasive (MI) treatments for atrial fibrillation (AF) focus 
on pulmonary vein isolation (PVI). Patients with structural heart disease and wavelet AF 
require a comprehensive, bi-atrial lesion pattern. Paracardioscopic access through the 
diaphragm in combination with a small right mid-axillary incision provides MI access and 
direct visualization to create a comprehensive bi-atrial lesion pattern.
Methods: Ten patients with isolated AF (persistent=4, permanent=6) underwent a 
Paracardioscopic Ex-Maze procedure (Figure). Epicardial lesions were created with radio 
frequency energy delivered through a novel vacuum-assisted device. All patients had 
lesions along the pericardial reflections (1,2,4,5,6) to isolate the pulmonary veins (PVs), 
and additional right and left atrial lesions (2,3,7,8) to complete the Ex-Maze pattern.
Results: A complete Ex-Maze lesion pattern was created in all patients. PVI was 
confirmed in all patients tested for exit block at 15 mA. The transdiaphragmatic access 
healed without event in all patients. Four patients have reached 1 month follow-up and are 
in sinus rhythm without cardioversion or class I or III antiarrhythmic drugs.
Conclusions: Paracardioscopy enables direct MI access and visualization of the posterior 
heart for creation of a comprehensive, bi-atrial lesion pattern. Early results with the 
Paracardioscopic approach are encouraging, and studies are ongoing to confirm the 
efficacy of the MI Ex-Maze lesion pattern. 
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Cardiac Rhythm Device Therapy
Monday, March 31, 2008, 8:00 a.m.-9:30 a.m.
McCormick Place, Room S403
8:00 a.m.
802-3 A Novel Pacing Paradigm for Cardiac 
Resynchronization Therapy in Desynchronized Acute 
LV Dysfunction during Atrial Fibrillation
Pascal Lim, Georges E. Yanulis, Youhua Yang, Richard A. Grimm, Don W. Wallick, 
Cleveland Clinic, Cleveland, OH, APH-HP Henri Mondor Hospital, Creteil-Paris, France
Background: Heart failure (HF) patients with drugs refractory atrial fibrillation (AF) may 
require ablation therapy to benefit from Cardiac Resynchronization Therapy (CRT). 
One alternative is CRT with coupled pacing (CRT-CP) which consists of delivering an 
additional stimulation after the refractory period.
Methods: CRT and CRT-CP were compared in 6 dogs with AF induced by atrial pacing and 
desynchronized HF by right ventricular (RV) pacing. For CRT-CP, an RV premature beat 
was systematically applied after CRT (170±19ms). AV node conduction was depressed 
by selective parasympathic nerve stimulation to allow CRT rate to be similar to CRT-CP. 
LV ejection fraction (LVEF), stroke volume (SV) and global peak strain (ε-peak, by speckle 
tracking) were used to assess contractility. Diastolic period and LV dyssynchrony were 
expressed as % of RR interval.
Results: Compared to sinus rhythm, RV pacing during AF increased LV dyssynchrony 
(7±2% vs. 19±3%, p<0.001) and reduced diastolic period (40±6% vs. 30±7%, p=0.01), 
LVEF (52±4% vs. 18±6%, p<0.001), SV (25±5ml vs. 12±3ml, p=0.006) and ε-peak (-
4±2% vs. -12±2%, p=0.0003). Importantly, CRT-CP slowed the ventricular rate by half 
(116±17bpm vs. 232±15bpm) and compared to CRT at similar rate, dramatically increased 
diastolic period (27±3% vs. 48±6%, p=0.02), LVEF (28±4% vs. 51±10%, p<0.001) and 
tended to improve SV and ε-peak.
Conclusions: CRT-CP slows the ventricular rate during AF and increases contractility and 
diastolic function compared to CRT at a similar rate. 
8:15 a.m.
802-4 Novel Technique of Atrioventricular Septal Pacing 
Promotes Ventricular Synchrony Without Crossing the 
Tricuspid Valve
Samuel J. Asirvatham, Charles J. Bruce, Benhur D. Henz, Susan B. Johnson, Masayoshi 
Kinoshita, Yasuo Okumura, Douglas L. Packer, Andrew J. Danielsen, Paul A. Friedman, 
Mayo Clinic, Rochester, MN
Right ventricular apex (RVA) pacing requires crossing the tricuspid valve (TV). It promotes 
tricuspid regurgitation, dyssynchrony, and ventricular dysfunction. Since the tricuspid valve 
is apical relative to the mitral valve, an atrioventricular septum exists which separates the 
right atrium (RA) from the left ventricle (LV). Stimulation at this site by a lead captures 
ventricular myocardium. The LV architecture is such that AVS pacing may rapidly excite 
the lateral LV. We sought to determine whether pacing the AVS with a novel lead --without 
crossing the TV- permits synchronous ventricular stimulation without atrial capture.
Methods: Three dogs were studied under general anesthesia with intracardiac 
echocardiographic (ICE) and fluoroscopic identification of the AVS. A novel bipolar 
screw-in lead was placed in the AVS as well as at a standard RV apical position. The 
QRS duration, endocardial and epicardial electro-anatomic activation sequence, and 
intracardiac echocardiographic measurements of synchrony were assessed during sinus 
rhythm, RVA pacing, and AVS pacing.
Results: The novel lead was successfully placed at the AVS, and resulted in ventricular 
capture without atrial capture or crossing the TV in all cases. The average QRS duration 
with AVS pacing was 106 +/- 11 ms vs. 140 +/- 21 ms with RVA pacing (p=0.03). The 
average interval from the start of the QRS to the latest endocardial or epicardial site in the 
left ventricle was 78 +/- 20 ms with AVS pacing vs. 121 +/- 30 ms with RVA pacing (p=0.05). 
The average interval from the mid septum to the free wall of the left ventricle endocardially 
or epicardially was 36 +/- 11 ms with AVS pacing vs. 68 +/- 18 ms with RVA pacing (p=0.02). 
These measurements were compared with those obtained with tissue Doppler imaging 
using ICE. There was no tricuspid regurgitation and no impact on atrioventricular conduction 
(PR interval 136 ms before and 142 ms following AV pacing [p = ns] ).
Conclusion: Pacing at the AVS permits a right atrial lead to capture the ventricles alone. 
Pacing at this site eliminates the need to cross the tricuspid valve or cannulate the 
coronary sinus and results in synchronous activation and contraction of the left ventricle 
compared to RV apical pacing.
8:30 a.m.
802-5 Transiliac ICD Implantation: Defibrillation Vector 
Flexibility Produces Consistent Success
Chi Keong Ching, Claude S. Elayi, Conor Barrett, Luigi Di Biase, David Martin, Walid 
Saliba, Oussama Wazni, Kanj Mohamed, David J. Burkhardt, Robert Schweikert, Bruce 
L. Wilkoff, The Cleveland Clinic, Cleveland, OH
Background: Transiliac approach to implant internal cardioverter defibrillators (ICD) is 
an alternative in patients for whom both pectoral placements are contraindicated. The 
defibrillation (DF) vectors are altered from pectoral implantation due to pulse generator 
(PG) placement in one of the upper abdominal quadrants and separate single-coil, active-
fixation, DF leads positioned in the high right atrium and right ventricular apex. The results 
of DF testing has not been described with this configuration.
Methods: 22 patients (15 male & 7 female, mean age of 65.7 ± 13.2 years) required 
transiliac approach to ICD placement. The leads are implanted through the iliac vein 
superior to the inguinal ligament. When required a subcutaneous coil (SC) was tunneled 
posterior to the LV from the left axilla.
Results: Right iliac vein was utilized in 73% vs 27% for left iliac vein. The PG was placed 
in the left upper quadrant in 68% vs 32% in the right upper quadrant. Atrial and ventricular 
lead characteristics were acceptable.. Initial defibrillation success (DS) with a safety 
margin of 10J was achieved in 64%. With the placement of additional SC, DS with a safety 
margin of 10J was increased to 86% while DS with a safety margin of 5J was achieved in 
all patients. Each shocking configuration is listed below. 
Shocking configuration
Number of 
patients Cathode + Anode -
8 RV RA/PG
3 RV RA/SC
2 RV PG/SC
2 RA/PG RV
2 RA RV
1 RV SC
1 RV RA
1 SC/PG RV
1 SC RV
1 RA/SC/Epicardial patch RV
Conclusion: The illiac vein approach to ICD implantation is an effective alternative 
technique. Flexibility in lead placement, DF vectors and careful DF testing is required to 
produce a consistently effective system.
8:45 a.m.
802-6 Acute versus Late Reduction in Mitral Regurgitation 
after Cardiac Resynchronization Therapy
Claudia Ypenburg, Patrizio Lancellotti, Laurens F. Tops, Eric Boersma, Gabe B. Bleeker, 
Eduard R. Holman, James D. Thomas, Martin J. Schalij, Luc A. Pierard, Jeroen J. Bax, 
Leiden University Medical Center, Leiden, The Netherlands, University Hospital Sart 
Tilman, Liege, Belgium
Background: The aim of the current study was to evaluate the relationship between 
presence of LV dyssynchrony at baseline and reduction in mitral regurgitation (MR) acute 
and late after cardiac resynchronization therapy (CRT).
Methods: Sixty-eight consecutive patients (ejection fraction 23±8%, 57% ischemic 
cardiomyopathy) with at least moderate MR were included. Echocardiography was 
performed at baseline, one day after CRT initiation and at 6 months follow-up. MR severity 
was graded semi-quantitatively (mild = jet area/LA area <10%, moderate = jet area/LA 
area 10-20%, moderately severe = jet area/LA area 20-45%, and severe = jet area/LA 
area >45%) and improvement in MR was defined as improvement of at least 1 grade. LV 
dyssynchrony was assessed using speckle tracking radial strain analysis and defined as 
the maximum delay between the 6 LV segments. The segment of latest activation was 
also noted.
Results: Twenty-nine patients showed an acute reduction in MR (“early responders”) 
and 12 patients showed a reduction in MR after 6 months of CRT (“late responders”). 
Both groups had similar extent of baseline dyssynchrony (209±115 ms vs. 190±118 ms, 
P=NS); however, the site of latest activation in early responders was mostly inferior (64%) 
or posterior (36%), adjacent to the posterior papillary muscle, whereas the lateral wall 
was the latest activated segment in late responders (92%). Of note, 25 patients showed 
no reduction in MR during follow-up; these patients had less LV dyssynchrony (99±74 ms, 
P<0.001 compared to early and late responders).
Conclusion: Presence of baseline LV dyssynchrony is related to improvement in MR after 
CRT. If LV dyssynchrony involves the posterior papillary muscle an immediate reduction 
in MR can be expected, whereas in patients with LV dyssynchrony not involving the 
posterior papillary muscle late improvement in MR can be expected.
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802-7 Heart Failure Decompensation and All-Cause Mortality 
in Relation to Percent Biventricular Pacing: Is a Goal of 
100% Biventricular Pacing Necessary?
Bruce A. Koplan, Stan Weiner, Andrew J. Kaplan, Paul W. Jones, Mylan Seth, Shelly A. 
Christman, Brigham and Women’s Hospital, Boston, MA
Background: Cardiac resynchronization (CRT) decreases the combined risk of death and 
heart failure (HF) hospitalization. However, the appropriate target for biventricular (BiV) 
pacing percentage is ill-defined.
Methods: Mortality and HF hospitalization from CRT patients (pts) in two trials (CRT RENEWAL 
& REFLEX; n=1,815) were analyzed in a post hoc fashion. Pts were grouped based on % BiV 
pacing using Kaplan-Meier survival analysis with a combined endpoint of HF hospitalization and 
all-cause mortality. A cut-point dividing the pts into two pacing groups with a maximally different 
survival pattern was found by an iterative search, maximizing the log rank statistic.
Results: Pt characteristics were: age 72 ± 11 years, 72% male, 67% CAD. Pts paced 
80-90% (n = 202) and 0-80% (n = 168) had similar outcomes (HR 0.87, p = 0.53). Pts 
paced 91-95% (n = 321) had a 37% reduction in risk of an event compared to ≤ 90% 
after adjusting for covariates (HR 0.63, p < 0.01). Pts paced > 95% (n = 1121) received 
no benefit over those paced 91-95% (HR 0.92, p = 0.59). The greatest magnitude of 
difference in survival free from an event was found with a cutoff of 92% BiV. Pts paced 
> 92% had a 43% reduction in odds of an event compared to ≤ 92% after adjusting for 
covariates (HR 0.57, p < 0.00001). Pts with a history of atrial arrhythmia were more likely 
to be paced ≤ 92% (p < 0.001).
Conclusions: For the CRT pts, the greatest magnitude of benefit was observed with a 
cutoff of > 92% vs. ≤ 92% BiV pacing. No incremental benefit was observed in pts paced 
>95% vs. 90-95%.
9:15 a.m.
802-8 Dynamic Time Warping: A Novel Algorithm for Rhythm 
Discrimination in ICDs
Baharan Kamousi, Bryant Lin, Gregory Lee, Amin Al-Ahmad, Henry H. Hsia, Paul C. 
Zei, Paul J. Wang, Stanford University School of Medicine, Stanford, CA
Background: Inappropriate shocks for supraventricular arrhythmias remain a major 
problem in the care of patients with ICDs. Pattern recognition algorithms have been 
successful for many non-medical applications. Dynamic Time Warping (DTW), originally 
used in automatic speech recognition, is a method to measure the overall similarity in 
pattern regardless of differences in time or speed by non-linearly warping them in the time 
dimension. In this study, we use DTW to distinguish Ventricular Tachycardia (VT) from 
other rhythms such as Supraventricular Tachycardia (SVT).
Methods: We examined 69 ICD episodes due to SVT or VT detection. The digital ICD 
electrograms were imported into a MATLAB program used to perform DTW on the 
individual ICD episodes. For each beat of the ICD episode, the DTW cost value was 
calculated. After the DTW algorithm was applied to each beat, the mean DTW value was 
calculated for the episode. Results: The DTW algorithm was able to correctly classify 67 
episodes, giving the accuracy of 97%. One SVT episode was classified as VT and one VT 
episode was classified as SVT. (See Figure)
Conclusions: The present data suggest that DTW may be a promising method for ICD 
rhythm classification and may decrease inappropriate shocks. Further modifications of 
DTW may increase the sensitivity while maintaining the excellent specificity. 
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1015-89 Plasma redox state and the recurrence of atrial 
fibrillation
Heather L. Bloom, Irfan Shukrullah, Jose R. Cuellar, Ravinder R. Valadri, Emir Veledar, 
Samuel C. Dudley, Jr., Emory University School of Medicine, Atlanta, GA, Atlanta VA 
Medical Center, Decatur, GA
Background: Recent studies have shown atrial fibrillation (AF) is associated with 
increased atrial and blood oxidative stress. If oxidative stress contributes to AF, plasma 
markers might be elevated in patients at high risk. We investigated whether plasma 
oxidative stress measured at cardioversion could predict which patients were likely to 
suffer arrhythmia recurrence. Methods: As part of the Statins for Prevention of Atrial 
Fibrillation trial (StoP-AF NCT00252967) blood was drawn on 54 subjects immediately 
prior to elective cardioversion for persistent AF or atrial flutter (AFlut). Exclusion criteria 
included hemodynamic instability, atrial fibrillation ablation within the last six months, 
hyperthyroidism, uncontrolled hypertension and implanted devices for designed for 
active management of atrial arrhythmias. Blood was analyzed for ratios of oxidized to 
reduced glutathione and cysteine, derivatives of reactive oxygen species (DROMs), and 
8-isoprostane at baseline and 1 month. Subjects were examined at 1, 2, 3, 6, and 12 
months and at any time the subject complained of palpitations, lightheadedness, syncope, 
or transtelephonic evidence of recurrent AF or AFlut. Examination included a 12-lead 
ECG. Ambulatory 24-hour Holter recordings were performed at 1, 6, and 12 months. The 
primary endpoint was the time to a first ECG confirmed recurrence of AF or AFlut. The 
time to first recurrence was analyzed with the Kaplan-Meier method of survival curves.
Results: At the time of analysis, 54 subjects had been enrolled. The median arrhythmia-
free duration was 29 d (95% CI, 18-36 d). Maximum likelihood analysis indicated that the 
ratio of reduced to oxidized plasma cysteine was negatively associated with arrhythmia 
recurrence (p=0.02). Moreover, the ratio was more oxidized in patients that recurred than 
those that did not. Finally, the ratio showed a 22% change at one month suggesting that 
cardioversion was associated with reduced oxidative stress.
Conclusion: Plasma oxidative stress as indicated by the reduced to oxidized cysteine 
ratio was associated with recurrence of AF. Improvement in this ratio after cardioversion 
suggests that this plasma marker may reflect changes in myocardial oxidation.
10:00 a.m.
1015-90 The “Single-Big-Cryo-Balloon” Technique For 
Pulmonary Vein Isolation In Paroxysmal Atrial 
Fibrillation
Julian KR Chun, Matthias Antz, Ilka Köster, Feifan Ouyang, Dietmar Bänsch, Sabine 
Ernst, Kazuhiro Satomi, Boris Schmidt, Roland Tilz, Buelent Koektuerk, Karl-Heinz 
Kuck, Hanseatic Heart Center, Hamburg, Germany
Background: Cryothermal-energy (CTE) applied via a balloon catheter (Arctic Front, 
Cryocath™) represents a novel technology which may facilitate accomplishing the 
challenging endpoint of complete electrial pulmonary vein isolation (PVI). However, 
as in all balloon based PVI approaches, phrenic nerve (PN) injury remains a concern. 
Therefore, we pursued the ,,single big cryo-balloon technique“ deploying proximal (antral) 
CTE to (1) achieve complete electrical PVI and (2) avoid PN palsy in patients (pts) with 
paroxysmal atrial fibrillation (PAF).
Methods: After double transseptal punctures one lasso catheter and the big 28 mm Cryo-
balloon catheter (10.5 F) using a steerable sheath (15F) were inserted into the left atrium 
(LA). PV angiographies and ostial lasso recordings from all PVs were obtained. Selective 
PV occlusion angiographies were used to evaluate balloon to LA-PV junction contact. 
One CTE freezing cycle lasted 300 seconds. To early identify PN injury, the PN was 
constantly paced (10 V, 2.9 ms) from the superior caval vein while applying energy at the 
right superior PV (RSPV). Follow up included weekly telephonic interviews, holter ECGs, 
office visits after 1, 3 and 6 months and additional daily tele ECG.
Results: Twenty-six pts (18 males, mean age: 56 ± 9, LA size: 41.5 ± 5.2) with highly 
symptomatic paroxysmal atrial fibrillation (mean duration: 6.7 ± 5.8 years) despite 
antiarrhythmic drug therapy (3 ± 1) were included in this study. Complete electrical PV 
isolation was achieved in 93/95 PVs (98%) using exclusively the big balloon technique. 
Mean procedural-, balloon- and fluoroscopy-time were 239 ± 99, 135 ± 66, and 56 ± 22 
min, respectively. One persistent PN palsy occurred due to an unanticipated ablation 
inside the RSPV (inner balloon defect). A total of 17 pts (62 %) remained in sinusrhythm 
during a mean follow up of 142 ± 114 days.
Conclusions: Using exclusively the “single big cryo-balloon” technique, the vast majority of 
all PVs (98%) can be electrically isolated resulting in an acceptable clinical success rate 
after one procedure. PN palsy is avoided as long ablation is performed at the proximal 
LA-PV junction.
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1015-91 Angiotensin Inhibitors Prevent Atrial Fibrillation after 
Cardiothoracic Surgery
James S. Kalus, Henry Ford Hospital, Detroit, MI, Wayne State University, Detroit, MI
Background: Approximately 30 % of patients undergoing cardiothoracic surgery (CTS) 
develop postoperative atrial fibrillation (AF). Cardiac remodeling likely plays a role in the 
pathophysiology of non-CTS AF and angiotensin-converting enzyme inhibitors (ACEIs) 
and angiotensin-receptor blockers (ARBs) prevent recurrence of non-CTS AF, possibly by 
reducing atrial remodeling. The importance of cardiac remodeling in the pathophysiology 
of postoperative AF is unclear; however, the presence of disease states associated with 
cardiac structural changes, such as systolic heart failure or valvular disease increases the 
risk for postoperative AF. We assessed the hypothesis that ACEI or ARB treatment for > 3 
months prior to CTS reduces the rate of postoperative AF.
Methods: Medical records of patients undergoing CTS were reviewed. Patients with a 
history of AF or who took an ACEI or ARB for < 3 months prior to CTS were excluded. 
Those taking ACEI or ARB for at least 3 months prior to CTS were included in the 
treatment group and those not exposed to ACEI or ARB during the year before CTS 
made up the control group. Data were collected for 125 treatment and 250 control 
patients. Propensity scores were used to match the treatment and control groups (1:1) for 
age, gender, type of surgery, use of antiarrhythmic drugs after surgery and presence of 
hypertension, diabetes, or heart failure. Rate of postoperative AF was compared between 
the treatment and control groups in 250 matched patients (67.7 ± 11.0 years, 68% male, 
31.6% valve surgery).
Results: The treatment group was more likely to have diabetes, coronary artery disease 
and heart failure. Other demographics were similar between groups. Patients in the 
treatment group used ACEIs or ARBs for 58.7 ± 45.8 mos. Rate of postoperative AF was 
lower in the treatment group than in the control group (19.2% vs. 33.6%, p= 0.01). Use of 
antiarrhythmic drugs at discharge was less common in the treatment group as well (39% 
vs. 61%, p = 0.053). Length of stay was similar between groups (p = 0.760).
Conclusion: Use of ACEI/ARB for at least 3 months prior to cardiothoracic surgery is 
associated with a reduction in postoperative AF.
10:00 a.m.
1015-92 First Human Experience with Real Time Integration 
of Intracardiac Echocardiography and 3D 
Electroanatomical Imaging to Guide Pulmonary Vein 
Antrum Isolation
Yaariv Khaykin, Ofer Klemm, Bonnie Whaley, Catherine Seabrook, Marianne Beardsall, 
Zaev A. Wulffhart, Atul Verma, Southlake Regional Health Center, Newmarket, ON, Canada
Background: Catheter ablation of atrial fibrillation (AF) is typically guided by 3D mapping. 
This involves point-by-point reconstruction of the 3D virtual anatomy and may be time 
consuming and require substantial fluoroscopy exposure. Intracardiac echocardiography 
(ICE) affords real time imaging of the cardiac structures during mapping and ablation.
Methods: Between February and September 2007, 15 patients presenting for AF ablation 
were offered mapping using a novel system integrating 3D mapping and ICE. A modified 
ICE probe with location sensor tracked by the mapping system was positioned in the 
right atrium (RA). This allowed acquisition of ECG gated images of the left atrium (LA). 
Endocardial contours were traced on each image and were used to generate a registered 
3D map.
Results: 3D maps took a mean of 45 min (13-110) to create, PRIOR to entering the LA 
and without fluoroscopy. Pulmonary veins and the esophagus were rendered in 3D. A 
complete map was built from a mean of 42 contours (20-93). Figure depicts a 3D map of 
the LA. Green lines represent individual registered contours traced on ICE.
Conclusions: A mapping system combining ICE and 3D electroanatomical mapping can 
feasibly reconstruct a 3D shell of the LA and the pulmonary veins without the need to 
enter the left heart. 
10:00 a.m.
1015-93 Ranolazine Shortens Repolarization and Improves 
Myocardial Relaxation in Patients With Type-3 Long QT 
Syndrome
Arthur J. Moss, Wojciech Zareba, Karl Q. Schwarz, Spencer Rosero, Scott McNitt, 
Jennifer L. Robinson, University of Rochester Medical Center, Rochester, NY
Background: One form of the hereditary long QT-syndrome, LQT3-deltaKPQ, is 
associated with sustained inward sodium current during membrane depolarization, and 
we hypothesized that therapy with ranolazine would have favorable electro-mechanical 
effects in patients with this genetic disorder.
Methods: Five patients with this LQT3 mutation were prospectively investigated during 8-
hour intravenous infusions of ranolazine, with ECG and ECHO evaluation before, during, 
and after ranolazine.
Results: Over the entire 8-hour ranolazine infusion, the mean reduction in QTc from 
baseline was 26+/-3ms (p<0.0001), i.e., from 558+/-55ms at baseline to 532+46/-ms 
during ranolazine. As shown in the figure, QTc shortened in a concentration-dependent 
manner with an average slope of QTc vs. ranolazine plasma concentration of -24 ms per 
1000 ng/ml (p=0.008). At peak ranolazine infusion, there was significant 13% shortening 
in left ventricular isovolumic relaxation time and a significant 25% increase in mitral E-
wave velocity. No adverse effects of ranolazine were observed.
Conclusions: Ranolazine shortens the QTc interval and improves myocardial relaxation in 
LQT3 patients with the SCN5A-deltaKPQ mutation. 
10:00 a.m.
1015-94 Long QT Syndrome in Patients Over 40 Years of Age: 
Increased Risk for LQTS-Related Cardiac Events in 
Patients With Coronary Disease
Edward Y. Sze, Arthur J. Moss, Ilan Goldenberg, Scott McNitt, Christian Jons, Wojciech 
Zareba, Ming Qi, Jennifer L. Robinson, International Long QT Syndrome Investigative 
Group, University of Rochester Medical Center, Rochester, NY
Background: Previous studies of Long QT Syndrome (LQTS) have focused primary on the 
clinical course of affected patients within the first four decades of life.
Methods: The study population involved 641 patients older than age 40 who had 
QTc>449ms. Patients were identified as having coronary disease if they had a history 
of hospitalization for myocardial infarction, coronary angioplasty, coronary artery bypass 
graft surgery, or were treated with medication for angina. LQTS-related cardiac events 
included the first occurrence of syncope, aborted cardiac arrest, or sudden cardiac 
death without evidence suggestive of an acute coronary event. Cox proportional hazards 
regression modeling was used to analyze the independent contribution of coronary 
disease to LQTS-related cardiac events.
Results: Time-dependent coronary disease was associated with an increased risk of 
LQTS-related cardiac events as shown in the Mantel-Byar graph and by Cox analysis 
(hazard ratio 2.24, 95% confidence interval 1.24-4.04, p=0.008) after adjustment 
for syncopal history before age 40, QTc, and gender. Factors such as diabetes and 
hypertension that increase the risk for coronary disease were not associated with an 
increased risk for LQTS-related cardiac events.
Conclusions: This is the first study to demonstrate that coronary disease augments the 
risk for LQTS-related cardiac events in LQTS. The findings highlight the need for more 
focused preventive therapy in LQTS patients above the age of 40. 
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1015-94A Long QT Syndrome: Increased Risk of LQTS-related 
Cardiac Events With Beta-agonist Therapy for Asthma
Princy Thottathil, Jay Acharya, Christian Jon, Arthur J. Moss, Scott McNitt, Ilan 
Goldenberg, Wojciech Zareba, Ming Qi, Jennifer L. Robinson, International Long QT 
Syndrome Investigative Group, University of Rochester Medical Center, Rochester, NY
Background: The clinical course and risk factors associated with beta-agonist therapy for 
asthma has not been previously investigated in the LQTS population.
Methods: The risk of a first LQTS-related cardiac event due to beta-agonist therapy was 
examined in 3,287 patients with QTc>449ms enrolled in the International LQTS Registry. 
The Cox proportional hazards analysis was used to assess the independent contribution 
of clinical factors for first cardiac events (syncope, aborted cardiac arrest, or sudden 
death) from birth through age 40.
Results: Beta-agonist therapy for asthma was associated with an increased risk for cardiac 
events (hazard ratio [HR] = 2.00, 95% confidence interval 1.26-3.15, p = 0.003) after 
adjustment for relevant covariates including time-dependent beta-blocker use, sex, QTc, 
and history of asthma. This risk was augmented within the first year after the initiation of 
beta-agonist therapy (HR = 3.53; p = 0.006). The combined use of beta-agonist and anti-
inflammatory steroids was associated with an elevated risk for cardiac events (HR = 3.66; 
p < 0.01). Beta-blocker therapy was associated with a considerable reduction in cardiac 
events in those using beta-agonists (HR = 0.14; P = 0.05).
Conclusions: Beta-agonist therapy was associated with an increased risk for cardiac 
events in asthmatic patients with LQTS, and this risk was diminished in patients receiving 
beta-blockers. 
10:00 a.m.
1015-97 Thiazolidinedione Drugs Block Cardiac KATP Channels 
and May Increase the Propensity for Ischemic 
Ventricular Fibrillation in Pigs
Li Lu, Michael J. Reiter, Ya Xu, Clifford R. Greyson, Gregory G. Schwartz, VA Medical 
Center and University of Colorado Health Sciences Center, Denver, CO
Background: Cardiac ATP-sensitive potassium (KATP) channels ordinarily open during 
myocardial ischemia, a response that is generally believed to be adaptive and protective. 
Conversely, blockade of cardiac KATP channels may predispose to ischemic injury and 
increase the propensity for ischemic arrhythmias. Thiazolidinedione (TZD) drugs block 
KATP channels in non-cardiac cells in vitro. In this study, we determined the effects of TZDs 
on the cardiac KATP channel and action potential and occurrence of ischemic ventricular 
fibrillation (VF) in vivo. Methods and Results: Three types of experiments were performed: 
1) Epicardial monophasic action potential (MAP) was recorded in 30 pigs subjected to 
90 min regional low-flow ischemia under treatment with inert vehicle, troglitazone (TRO, 
10 mg/kg IV), or rosiglitazone (ROS, 0.1 or 1.0 mg/kg IV). With vehicle, MAP duration 
(time to 90% recovery) shortened with ischemia by 44±9 ms. MAP shortening with 
ischemia was attenuated to 12±8 and 6±6 ms with TRO and ROS, respectively, both 
p<0.01 compared with vehicle. These findings suggested that TRO and ROS act as KATP 
blockers. 2) To confirm this effect, epicardial MAP was recorded in 17 pigs in response to 
intracoronary infusion of a KATP channel opener (levcromakalim 1µg/kg/min) before and 
after treatment with TRO or ROS at above doses, or with pioglitazone (PIO, 1 mg/kg IV). 
Levcromakalim shortened MAP by 37±10 ms in the absence of TZD treatment; this effect 
was attenuated to 12±8, 13±4 and 9±5 ms respectively in the presence of TRO, ROS, or 
PIO. This finding confirmed that all three TZDs block cardiac KATP. In both experiments 1 
and 2, effects of ROS 0.1 and 1.0 mg/kg were similar. 3) Complete coronary occlusion 
was performed in 12 pigs (6 ROS, 6 vehicle). Median time to development of VF was 6 
min with ROS, compared with 30 min with vehicle (p=0.03), indicating that ROS may have 
a pro-fibrillatory effect in ischemia. Conclusions: TZD compounds block the cardiac KATP 
channel at clinically relevant doses and may increase the propensity for ischemic VF. 
These findings may provide an explanation why clinical outcomes with TZDs have been 
less favorable than might have been predicted on the basis of their metabolic effects.
10:00 a.m.
1015-98 Incidence of Ventricular Arrhythmias in Ischemic 
Secondary Prevention ICD Recipients: Long-term Follow-
up of the Leiden Out-of-Hospital Cardiac Arrest Study
C. Jan Willem Borleffs, Lieselot van Erven, Philippine Kiès, Alida E. Borger van der Burg, 
Ernst E. van der Wall, Martin J. Schalij, Jeroen J. Bax, Leiden University Medical Centre, 
Leiden, The Netherlands
Background: Survivors of life-threatening ventricular arrhythmias (VAs) are at high risk 
for recurrent events. The aim of the current study was to determine the actual rate of 
VA recurrence during long-term follow-up in a large cohort of ischemic patients with 
implantable cardioverter defibrillators (ICDs).
Methods: A total of 479 consecutive patients (411 male, 65±10 years) were evaluated. 
All patients received an ICD (14% biventricular) for secondary prevention. During follow-
up, all events triggering device therapy (both anti-tachycardia pacing (ATP) and shocks) 
were noted.
Results: During a mean follow-up of 46±33 months (range 1 to 144 months), 207 patients 
(43%) received appropriate ICD therapy for VA. Mean time to first therapy was 21±24 
months and number of appropriate therapies ranged from 1 to 539, with a mean of 18±58 
therapies per patient. Therapy-free survival at 1-year was 72% (figure). Furthermore, 64 
patients (13%) experienced inappropriate shocks.
Conclusions: Ischemic secondary prevention patients exhibit a high risk of VA recurrence. 
Still, 57% did not experience appropriate ICD therapy during long-term follow-up. 
10:00 a.m.
1015-99 MRI Findings in Idiopathic Outflow Tract Arrhythmias: 
A Reappraisal
Steven M. Markowitz, Jonathan W. Weinsaft, Kenneth M. Stein, Sei Iwai, Bindi K. Shah, 
Bruce B. Lerman, Cornell University Medical Center, New York, NY
Background: Previous studies have demonstrated subtle MRI abnormalities of the RV in 
pts with idiopathic outflow tract (OT) tachycardia, including RV dilatation, focal wall motion 
abnormalities, and fat deposition. The significance of these findings remains unclear, 
and it is unknown if previously reported abnormalities were artifact related to early MRI 
technology.
Methods: Cardiac magnetic resonance (CMR) imaging was performed on sequential 
pts presenting with documented idiopathic OT tachycardia and compared to a cohort of 
healthy controls. No patient met task force criteria for ARVC. In all pts, MRI was performed 
using a 1.5T scanner with protocols consisting of (1) functional assessment via steady 
state free precession MRI, (2) myocardial fat assessment via T1 weighted spin echo MRI, 
(3) myocardial scar assessment via delayed enhancement inversion recovery MRI.
Results: Among 24 pts (age 48 ± 13, 16 F), ventricular arrhythmias arose from the RVOT 
or RV inflow in 19 and LVOT in 5. Clinical arrhythmias were PVCs and/or nonsustained VT 
(14), repetitive monomorphic VT (3), and sustained VT (7). CMR demonstrated normal 
RV structure, dimensions, and systolic function in 22/24. Two pts had mildly reduced RV 
systolic function with areas of aneurysmal dilatation (in the apex and inferior RV free 
wall). Two additional pts with RVOT arrhythmias demonstrated abnormalities of LV size or 
systolic function No pt was found to have scar or fat deposition in either ventricle. All 17 
control subjects (age 45 ± 14, 11 F), demonstrated normal RV size and function, without 
evidence for scar or fat deposition.
Conclusions: This study does not confirm earlier reports of a high incidence of RV 
abnormalities in idiopathic outflow arrhythmias. These results support the concept that, 
unlike arrhythmogenic RV cardiomyopathy, the majority outflow tract arrhythmias are due 
to an electrical disorder not explained by RV structural abnormalities. A minority have 
structural abnormalities of uncertain prognostic significance.
10:00 a.m.
1015-100 Improved Risk Stratification by Tissue Doppler Imaging 
in High Risk Patients With Long QT Syndrome
Kristina H. Haugaa, Thor Edvardsen, Trond P. Leren, Otto A. Smiseth, Jan P. Amlie, 
Rikshospitalet, Oslo, Norway
Background: The long QT syndrome (LQTS) predisposes to life-threatening arrhythmias. 
Risk stratification in LQTS patients is based on corrected QT interval (QTc). There is, 
however, need for better risk markers for ventricular arrhythmias in these patients. Tissue 
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Doppler imaging (TDI) provides accurate quantification of regional myocardial velocities 
and time intervals. Since LQTS is associated with heterogenic prolongation of action 
potentials we investigated if prolonged myocardial contraction and heterogeneity in 
duration of contraction assessed by TDI may serve as markers of risk in LQTS patients.
Methods: Sixty patients with molecularly defined LQTS were studied. Of these, 31 patients 
had syncope or cardiac arrest and 29 were asymptomatic. We used 20 healthy individuals 
as a control group. Myocardial contraction time and regional dispersion in contraction time 
were assessed by TDI. Furthermore, we measured post ejection velocity which reflects 
myocardial shortening after aortic valve closure.
Results: Prolonged contraction time was better related to severe arrhythmia compared 
to QTc (area under curve by ROC analysis 0.74 versus 0.68). Regional contraction time, 
showed significantly greater intraindividual differences in LQTS patients than in healthy 
individuals (41±19 versus 14±13 ms, p<0.001), reflecting dispersion of contraction. Post 
ejection velocity was greater in symptomatic compared to asymptomatic LQTS patients 
(2.3±1.3 versus 1.5±1.2 cm/s, p<0.001).
Conclusions: This study shows that dispersion of myocardial contraction is increased in 
LQTS patients. TDI can be of incremental value in risk stratification in these patients. 
Prolonged cardiac contraction time and augmented post ejection velocity assessed by 
echocardiography were better related to ventricular arrhythmias compared to QTc and 
should be assessed in the management of LQTS patients.
10:00 a.m.
1015-101 Susceptibility to Ventricular Fibrillation Produced by 
Chest Blows (Commotio Cordis) Is Related to the 
Length of the QT Interval
Alawi A. Alsheikh-Ali, Christopher Madias, Barry J. Maron, Jonathon Weinstock, N. A. Mark 
Estes, III, Mark S. Link, TUFTS-NEW ENGLAND MEDICAL CENTER, BOSTON, MA
BACKGROUND: Precordial blows can rarely trigger ventricular fibrillation (VF) or sudden 
cardiac death (Commotio Cordis). Although factors such as timing, placement, and 
energy of impact are critically important and likely account for most of the low incidence of 
commotio cordis, we also hypothesize that there is individual variation in susceptibility to 
VF produced by chest wall impact. Abnormalities in repolarization such as demonstrated 
by QT prolongation may account for some of the variability. Utilizing an experimental 
model of commotio cordis we sought to define the degree of variation in vulnerability to 
VF, and its relation to the QT interval. 
METHODS: The present analysis included 79 juvenile swine (8 to 25 kg), who were 
anesthetized, and placed prone in a sling to receive chest-wall strikes with a baseball 
propelled at 30 to 40 mph. Each animal received at least 4 impacts over the cardiac 
silhouette, all timed to a narrow vulnerable window 10 to 40 ms before the peak of the T 
wave. Corrected QT interval (QTc) in the beat preceding the strike was calculated using 
Bazett’s formula. Vulnerability to VF was defined as % impacts resulting in VF.
RESULTS: Of 888 strikes (mean 11 per animal), 293 (33 %) resulted in VF. There was 
wide variation in individual animal vulnerability to VF (range 0 % to 100 %). In strikes that 
triggered VF, the median QTc in the preceding beat was significantly longer compared to 
the corresponding interval in strikes that did not result in VF (466 ms versus 455 ms, p = 
0.001). Animals who were most vulnerable to VF (> 90% of strikes resulting in VF), had 
a significantly longer QTc compared to the least vulnerable animals (< 10% of strikes 
resulting in VF); median QTc 476 ms versus 449 ms, respectively, p < 0.05.
CONCLUSION: In an animal model of commotio cordis, greater length of the QT interval 
before chest impact affects individual vulnerability to VF and sudden death.
10:00 a.m.
1015-102 Post-Infarction Ventricular Arrhythmias Originating in 
Papillary Muscles
Thomas C. Crawford, Benoit Desjardins, Jean-Francois Sarrazin, Darryl Wells, Michael 
Kuhne, Nagib Chalfoun, Eric Good, Krit Jongnarangsin, Hakan Oral, Aman Chugh, 
Frank Pelosi, Fred Morady, Frank Bogun, University of Michigan, Ann Arbor, MI
Background: The role of the papillary muscles in the genesis of post-infarction ventricular 
arrhythmias has not been well-defined.
Methods: In a series of 8 patients (age: 65±10 years, EF: 0.34±0.1) with post-infarction 
ventricular arrhythmias, electroanatomic mapping in conjunction with intracardiac echo 
demonstrated that one of the papillary muscles (PAP) was involved in the arrhythmia. 
Magnetic resonance imaging with delayed enhancement (DEMRI) was performed in all 
patients without contraindications. A consecutive series of 9 patients (age: 64±8 years, 
EF: 0.32±0.14) with ventricular arrhythmias that did not originate from the PAP served as 
a control group and also underwent DEMRI.
Results: Heterogeneous uptake of gadolinium during magnetic resonance imaging was 
observed more frequently in arrhythmogenic PAPs than in PAPs that were not involved 
in ventricular arrhythmias (p=0.01). The PAPs in the control patients did not take up 
contrast or showed homogeneous contrast uptake. Radiofrequency ablation eliminated 
all arrhythmias originating from papillary muscles. Echocardiography after the ablation 
showed no new or worsened mitral regurgitation.
Conclusions: Papillary muscles that lie within an infarct zone may give rise to ventricular 
arrhythmias. Heterogeneous uptake of gadolinium in magnetic resonance images may be 
predictive of arrhythmogenic papillary muscles. Radiofrequency catheter ablation of ventricular 
tachycardia and ventricular ectopy arising in a papillary muscle has a high success rate.
10:00 a.m.
1015-104 Is J-Point Elevation a Specific Electrocardiographic 
Marker of Idiopathic Ventricular Fibrillation?
Raphael Rosso, Ori Rogowski, Bernard Belhassen, Melvin M. Scheinman, Sami Viskin, Tel 
Aviv Medical Center, Tel Aviv, Israel, University of California San Francisco, San Francisco, CA
Background: Marked J-point elevation in the inferior leads during sinus rhythm has 
been proposed as a marker of idiopathic ventricular fibrillation (VF). However, data on 
the presence of J-point elevation in idiopathic VF comes exclusively from case reports 
and there are no series determining the frequency of J-point elevation in consecutive 
patients with idiopathic VF in a controlled fashion. This limitation is important because 
J-point elevation (usually termed “early repolarization”) may also be present in healthy 
individuals. 
Methods: The study group consisted of 33 consecutive patients with idiopathic VF. Patients 
with ST elevation in the precordial leads were considered to have Brugada syndrome 
and were excluded from this series. All patients (age 31 ± 17 years) have documented 
spontaneous VF. The control group consisted of 162 age- and gender-matched healthy 
controls (5 controls per patient). Electrocardiograms were compared by readers blinded to 
patient allotting. Specifically, the presence and amplitude of J-point elevation, ST elevation 
(“high-take off” type) and terminal slurring of the R-wave were recorded. “Large J waves” 
were considered to be present when the J-point elevation exceeded 0.1 mVolts.
Results: Altogether, J-point elevation was observed with similar frequency among patients 
with idiopathic VF and controls. This was true for J-point elevation in the inferior leads (26% 
of idiopathic VF vs. 22% of controls, p=NS) and for J-point elevation in lateral leads (15% 
vs. 11%, p=NS). However, “large J waves” in the inferior leads were more commonly seen in 
the idiopathic VF group (14% vs. 5%, p=0.043). Similarly, large J waves in lateral leads were 
rarely seen in the idiopathic VF group, but were never seen in controls (6% vs. 0, p=0.002). 
High take-off ST-elevation and R-wave slurring did not identify patients with idiopathic VF.
Conclusions: Large J-waves (marked J-point elevation) are more commonly seen among 
patients with idiopathic VF than among controls. Although the difference is statistically 
significant, the clinical relevance of this finding is limited by poor sensitivity and/or 
specificity.
10:00 a.m.
1015-105 Prognostic Value of Microvolt T-wave Alternans in 
Patients With Moderate Ischemic Left Ventricular 
Dysfunction: Results From the MASTER II Trial
Theodore Chow, Dean J. Kereiakes, John Onufer, Alan Woelfel, Sinan Gursoy, Brett 
J. Peterson, Mark L. Brown, Wenji Pu, David G. Benditt, on behalf of the MASTER 
Investigators, Lindner Center at The Christ Hospital, Cincinnati, OH
Background: Microvolt T-wave alternans (MTWA) has been proposed as a risk stratifier 
for life threatening ventricular tachyarrhythmic events (LTVTE), particularly in patients with 
left ventricular ejection fraction (LVEF) ≤ 30%. However, relatively little data exist on the 
prognostic ability of MTWA in patients with moderate ischemic left ventricular dysfunction 
(ILVD) (i.e. LVEF 31-40%).
Methods: MASTER II is a prospective registry conducted at 50 US centers studying 
primarily community-based post-infarction patients with LVEF 31-40%. Baseline MTWA 
tests were classified according to standard criteria by a blinded expert reader, with repeat 
testing of indeterminate tests. According to the study protocol, only patients with a positive 
or negative MTWA test were included in analysis. Patient treatment, including ICD implant 
and programming, was left to physician discretion. Clinical and ICD events were classified 
by a physician committee blinded to patient characteristics. The primary outcome was 
LTVTE, defined as sustained spontaneous VT/VF, sudden cardiac death, or appropriate 
ICD discharge. Cox proportional hazards analyses were stratified according to whether 
or not an ICD was implanted.
Results: After exclusion of 45 patients testing indeterminate for MTWA, analyses were 
conducted on 303 patients (85% males, mean age=64 ± 10, mean LVEF= 36% ± 3%) 
who were followed for 2.2 ± 0.7 years. The final distribution of MTWA test results was 
“positive” in 132 (44%), and “negative” in 171 (56%). ICDs were implanted in 48% of 
patients. During follow-up LTVTEs occurred in 7 MTWA positive and 4 MTWA negative 
patients with actuarial event rates being 2.3%/yr and 1.0%/yr, respectively (p=0.25). A 
positive MTWA test was not associated with increased LTVTE (stratified HR=1.22; 95% 
CI: 0.34-4.39, p=0.76), including after multivariate adjustment (stratified HR=1.20; 95% 
CI: 0.33-4.31, p=0.79). However, the ability to detect a significant difference may have 
been affected by the low event rate.
Conclusions: MTWA test result does not significantly discriminate risk of LTVTE in patients 
with ILVD and LVEF 31-40%. However the incidence of LTVTE among these patients in 
contemporary community practice is low.
10:00 a.m.
1015-106 Evaluation of Microvolt T-Wave Alternans Test Result 
Concordance Over Time in the MASTER Trial
Theodore Chow, Dean J. Kereiakes, John Onufer, Sinan Gursoy, Anastasios Manaris, 
Fei Lu, Brett J. Peterson, Mark L. Brown, Wenji Pu, David G. Benditt, on behalf of the 
MASTER Investigators, The Lindner Center at The Christ Hospital, Cincinnati, OH
Background: Microvolt T-wave alternans (MTWA) results may change over time in 
individual patients. However, while the frequency of MTWA change in specific patient 
populations is not well characterized, such changes impact clinical utility and strategies 
for testing, including periodic re-testing.
Methods: MASTER I and II are prospective trials conducted at 50 US centers in which 
patients with ischemic left ventricular (LV) dysfunction (ILVD) and LV ejection fraction 
≤ 40% underwent annual MTWA testing. The protocol requested the same method of 
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heart rate (HR) elevation be utilized for baseline and follow-up tests (treadmill exercise in 
80%). All tests were interpreted by a Core Lab blinded to patient characteristics. MTWA 
indeterminates were excluded from analysis.
Results: 628 patients had at least one follow-up MTWA test. Baseline testing was “+” in 
346 (55%) and “-” in 282 (45%). For patients testing “-” at baseline, an estimated 30% 
tested “+” at their 1st annual test and after their 2nd annual test, 60% had tested “+” 
at least once. For patients testing “+” at baseline, an estimated 34% tested “-” at their 
1st annual test and after their 2nd annual test, 61% had tested “-” at least once. Annual 
change in MTWA was more common if beta-blocker treatment status also changed (41% 
vs. 32%, p=0.04). Maximum negative HR during testing did not predict MTWA “-” to “+” 
conversion. However, MTWA “+” to “-” conversion was associated with a slightly higher 
onset HR for alternans (103.5 bpm vs. 101.1 bpm, p=0.01).
Conclusions: Year-to-year change in MTWA is common in patients with ILVD. The time 
course and clinical significance of MTWA changes has important implications for patient 
testing, and requires further study.
10:00 a.m.
1015-107 Cardiac Arrest Survivors With Concomitant Myocardial 
Infarction Continue to Have a High Recurrence of 
Ventricular Arrhythmia
Kevin J. Makati, Benjamin Kalsmith, Sara Baig, Emily Mackey, John Kalin, Munther 
Homoud, Jonathon Weinstock, N.A. Mark Estes, III, Mark S. Link, Tufts University-New 
England Medical Center, Boston, MA
Background: Patients presenting with cardiac arrest (CA) or sustained ventricular 
arrhythmia in the setting of STEMI are considered reasonably low risk for future SCD. 
Whether this low risk is conferred to patients with NSTEMI in the era of sensitive 
biomarkers is unclear.
Methods: Using a prospectively maintained ICD registry, 348 ICD recipients of 1800 from 
1996 to 2006 were identified who presented with CA or sustained ventricular arrhythmia 
in the absence of STEMI. Patients were divided by enzyme status into 3 categories: 1. TnI 
<0.1mg/dL, 2. TnI 0.1 - 4.9 mg/dL and 3. TnI ≥ 5 mg/dL. Time to first appropriate device 
therapy for lethal arrhythmia defined as VF/ventricular flutter with cycle lengths <260ms 
were estimated by the Kaplan Meier method and compared by the Log-rank test.
Results: Of 348 patients, 176 (45%) had TnI <0.1mg/dL, 69 (18%) had TnI 0.1 - 4.9 mg/
dL, and 87 (22%) had TnI levels ≥ 5mg/dL. Appropriate device therapy was delivered in 
13.8% of patients for potentially lethal arrhythmias over follow up of 30.2 ± 32.1 months. 
Lethal arrhythmia were equivalent between groups regardless of TnI threshold values.
Conclusions: Patients with CA or sustained ventricular arrhythmias and NSTEMI should 
be considered for ICDs to prevent subsequent SCD. Prospective studies are needed to 
identify high-risk features in this subset of patients. 
10:00 a.m.
1015-108 Mapping and Ablation of Frequent Post-Infarction 
Premature Ventricular Complexes
Jean-Francois Sarrazin, Eric Good, Michael Kuhne, Darryl Wells, Nagib Chalfoun, 
Thomas Crawford, Sujoya Dey, Warangkna Boonyapisit, Hakan Oral, Frank Pelosi, 
Aman Chugh, Krit Jongnarangsin, Fred Morady, Frank Bogun, University of Michigan, 
Ann Arbor, MI
Background: Premature ventricular complexes (PVCs) occur frequently in patients 
with heart disease. Neither site of origin nor feasibility of mapping and ablation of post 
myocardial infarction (MI) PVCs has been systematically assessed.
Methods: In 24 consecutive patients (22 men, age 60 ± 9, EF 0.36 ± 0.14) with prior 
MI, mapping and ablation of frequent PVCs was attempted using a 3.5-mm irrigated tip 
catheter in conjunction with an electroanatomic mapping system (CARTO, Biosense). 
PVCs occurring frequently (bigeminal to quadrigeminal patterns) were mapped with 
activation mapping, and PVCs occurring less frequently were mapped with pace-mapping. 
The site of origin (SOO) was determined to be within low voltage (scar) tissue (amplitude 
< 1.0 mV) or tissue with preserved voltage (> 1.0 mV).
Results: The SOO in 20/24 (83%) patients was confined to scar tissue. At the SOO, the 
local endocardial activation preceded the PVC by 60 ± 12 msec, and the electrogram 
amplitude during sinus rhythm was 0.44 ± 0.3 mV. The SOO was in preserved tissue in 
3/24 patients. The SOO could not be identified in one patient. PVCs could be effectively 
ablated in 20/24 patients resulting in a decrease of PVC burden from 13.4 ± 12.1 to 2.8 
± 7.4% (p=0.006). The most frequent SOO was from the septum (7 patients), followed by 
the papillary muscle (6 patients), the left ventricular outflow tract (3 patients), the inferior 
or posterior wall (2 patients), and the antero-lateral wall (2 patients). Other less common 
sites were the aorto-mitral continuity, the coronary sinus, and the epicardium. The only 
complication was 2:1 AV block with new LBBB during ablation around the left posterior 
fascicle in a patient with know RBBB and prolonged HV interval. This patient already had 
an implantable cardioverter defibrillator.
Conclusions: Similar to post-MI ventricular tachycardia, PVCs after prior MI most often 
originate from scar tissue. Mapping and ablation can be performed with a high success rate.
10:00 a.m.
1015-109 Search for Cardiac Calcium Cycling Gene Mutations 
in Familial Ventricular Arrhythmias Resembling 
Catecholaminergic Polymorphic Ventricular Tachycardia
Annukka Marjamaa, Päivi Laitinen-Forsblom, Kimmo Kontula, Lauri Toivonen, Heikki 
Swan, University of Helsinki, Helsinki, Finland
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) caused by 
mutations in the ryanodine receptor type 2 (RYR2) gene is a severe inherited cardiac 
disorder presenting with stress-induced syncope and sudden death. We examined 
whether mutations in genes affecting cardiac calcium cycling were detectable in CPVT 
and in less typical familial exercise-related ventricular arrhythmias.
Methods: We recruited 33 consecutive patients who had frequent ventricular premature 
complexes (VPCs) occurring during exercise and often history of syncope or sudden 
death in family. None had structural heart disease or prolonged QT interval. Exercise 
stress test, echocardiography and 24-hour ECG recording were performed to each 
proband and family member (n=232). We sequenced all the coding exons of the RYR2, 
FKBP12.6, ATP2A2 and NCX1 genes from the index patients. A total of 300 healthy 
blood donors served as controls. Single channel recordings of the mutant RYR2s were 
conducted in planar lipid bilayers.
Results: Sixteen of the probands presented features typical of CPVT (Group A). The 
remaining 17 subjects had frequent VPCs and often salvos of VPCs also at rest, thus 
differing from CPVT phenotype (Group B). Familial background was evident in 42% of 
cases (n=14). The probands in group B had statistically significantly more VPCs/24 h 
(13800 ± 11100 vs. 560 ± 800, p<0.001) and more consecutive VPCs/24 h (5 ± 6 vs. 1 ± 1, 
p<0.01) than those in group A. No statistically significant difference was evident between 
the groups in the occurrence of syncope or sudden juvenile deaths in family. CPVT 
patients exhibited two novel RYR2 missense mutations R1051P and S616L explaining 
13% of the phenotypes. A rare variant RYR2 N3308S with open probabilities similar to the 
wild type channels in vitro, was detectable in group B. No disease-causing variants were 
evident in the FKBP12.6, ATP2A2 or NCX1 genes.
Conclusions: We report two novel CPVT-causing RYR2 mutations in 13% of the CPVT 
probands and a novel RYR2 variation with improbable phenotypic effects in a patient 
with abundant resting VPCs. FKBP12.6, ATP2A2 and NCX1 genes mutations are rarely 
involved in familial malignant arrhythmia syndromes of unknown etiology.
10:00 a.m.
1015-110 Microvolt T-wave Alternans and Electrophysiological 
Testing Predict Different Arrhythmia Outcomes: 
Lessons from the Alternans Before Cardioverter 
Defibrillator (ABCD) Trial
Guy Amit, Otto Costantini, Dennis M. Super, David S. Rosenbaum, MetroHealth 
Campus of Case Western Reserve University, Cleveland, OH
Background: Although microvolt T-wave Alternans (MTWA) and electrophysiological 
study (EPS) are both markers for sudden cardiac death (SCD), the ABCD trial, found 
the combination to be more predictive than each alone. Therefore, we hypothesized that 
the two tests measure elements of the arrhythmogenic substrate, which lead to different 
arrhythmic outcomes.
Methods: The ABCD Trial included 566 patients with ischemic cardiomyopathy, left 
ventricular ejection fraction (LVEF) ≤ 0.40, and documented non-sustained ventricular 
tachycardia. All patients underwent both MTWA test and EPS at enrollment. Implantable 
cardioverter defibrillators (ICD) were implanted in 87% of patients. The primary end-point 
was first appropriate ICD therapy or SCD. MTWA and EPS Core Laboratories blinded to 
outcomes adjudicated the tests, and an Events Committee blinded to the results of the 
tests adjudicated all events. Using Kaplan-Meier event rates and the log rank test, we 
analyzed the performance of MTWA and EPS in predicting distinct arrhythmic outcomes: 
1. monomorphic ventricular tachycardia (MVT) vs. 2. the combination of polymorphic 
ventricular tachycardia (PVT) or ventricular fibrillation (VF) or SCD.
Results: MTWA was normal in 29% and abnormal in 71%, and EPS was negative in 61% 
and positive in 39% of patients. There were 42 MVT events and 24 PVT/VF/SCD events, 
(8.8% and 5.6% 2-year event rate, respectively). At 1-year, MTWA predicted PVT/VF/SCD 
(event rate: 2.7% vs. 0% for MTWA abnormal vs. normal; p=0.04), but not MVT. In contrast, 
EPS predicted MVT (event rate 9.7% vs. 2.2% for EPS + vs. EPS -; p<0.01), but not PVT/
VF/SCD. At 2 years MTWA was not a significant predictor of either arrhythmia outcome, 
but a positive EPS remained predictive of MVT (14.7% vs. 4.7%; p<0.01). Finally, LVEF 
(dichotomized by LVEF ≤ 0.30) was not predictive of either arrhythmia outcome.
Conclusions: MTWA and EPS differ in the arrhythmic outcome they predict, and the time 
frame of prediction, suggesting that they identify different arrhythmogenic substrates. These 
data further suggest that multiple risk markers used in combination may better define and 
predict the complex electro-anatomical substrates which underlie the risk of SCD.
JACC March 11, 2008 ABSTRACTS - Cardiac Arrhythmias  A19 
C
ardiac A
rrhythm
ias
10:00 a.m.
1015-111 Follow-Up Left Ventricular Ejection Fraction in 
the DEFINITE Trial Population Predicts Outcome 
Regardless of Cardioverter-Defibrillator Status
Jorge E. Schliamser, Alan Kadish, Haris Subacius, Alaa Shalaby, Andi Schaechter, 
Joseph H. Levine, Jeffrey J. Goldberger, Northwestern Memorial Hospital, Feinberg 
School of Medicine, Northwestern University, Chicago, IL
Background 
The DEFINITE Trial demonstrated that in nonischemic dilated cardiomyopathy (NIDCM), 
implantation of a cardioverter-defibrillator (ICD) reduced sudden death and was 
associated with a non-significant reduction in all-cause mortality.
Methods: This substudy characterizes the outcome in DEFINITE based on follow-up (f/u) 
of left ventricular ejection fraction (LVEF) measurements obtained 90-730 days after trial 
enrollment. Of 458 patients enrolled, 176 (38%) had f/u LVEF (95 randomized to the ICD 
arm). Mean age was 56.6±12.2 years and 132 were male. Patients were divided into 3 
groups based on the change in LVEF: Group I-LVEF increase by >5%, Group II-LVEF 
change ≤5%, Group III-LVEF decrease by >5%.
Results: There was no difference in survival between group I and II: these groups were 
then combined for further analysis. Group III had increased mortality versus groups I/II 
(Figure). There was no difference in time to first appropriate shock in the 3 groups. There 
was no difference in ICD benefit in each group.
Conclusions
In patients with NIDCM, LVEF decline is associated with worse outcome, but not increased 
shocks or a change in ICD benefit. In these patients, LVEF may serve less as a predictor 
of arrhythmic events and more as a predictor of death from competing causes. 
10:00 a.m.
1015-112 Mortality Risk Increases for Each Subsequent 
Ventricular Arrhythmia Treated with an ICD Shock: 
Results from the Sudden Cardiac Death in Heart 
Failure Trial
Wai Shun Wong, Jeanne E. Poole, Anne S. Hellkamp, George W. Johnson, Jill 
Anderson, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy, University of Washington 
Medical Center, Seattle, WA
Background: We have previously demonstrated an increased mortality in the Sudden 
Cardiac Death in Heart Failure Trial (SCD-HeFT) patients who received at least one 
ICD shock intervention for high rate rhythm triggers. This was true both for appropriate 
(ventricular tachycardia, ventricular fibrillation) and inappropriate (supraventricular 
rhythms or over-sensing) rhythm triggers. To evaluate whether multiple rhythm events or 
cumulative ICD shock energy further worsens risk, we evaluated the association between 
cumulative shock energy, cumulative ventricular arrhythmia (VA) episodes, and mortality 
in patients who received an ICD in the SCD-HeFT.
Methods: Date, time, number, and energy of shocks delivered were recorded from all 
rhythm events triggering ICD shock therapy. Cox proportional hazards modeling adjusting 
for baseline prognostic factors evaluated the relationship between mortality and 2 time-
dependent variables, cumulative shock energy and cumulative episodes of VA. Patients 
who had their ICD removed during follow-up were censored at the time of device removal.
Results: Of the 2,521 patients in SCD-HeFT, 811 patients received an ICD. A total of 
173 deaths occurred including 10 deaths in patients whose devices were removed for 
transplant or other reasons. Of the 811 patients, 33.8% had one or more ICD shocks for 
any cause, with a median of 2 rhythm episodes requiring shock therapy/patient (inter-
quartile range 1, 4), 1 shock/episode (1, 1), 20 J of shock energy/episode (20, 30), and 
3 shocks/patient (1, 6). The relative risk of death was 20% higher with each additional 
episode of VA [HR 1.20 (95% CI 1.10-1.30), p < 0.0001]. Cumulative shock energy was 
not found to be associated with mortality [HR 1.02 for each 50 J increase (95% CI 0.92-
1.14), p = 0.70] after adjusting for the number of VA episodes.
Conclusions: Mortality in SCD-HeFT patients increased significantly for each recurrent 
episode of ventricular tachycardia or ventricular fibrillation triggering ICD shock 
interventions. Cumulative joules of ICD shock energy did not increase the risk independent 
of the risk associated with cumulative episodes of ventricular arrhythmia.
10:00 a.m.
1015-113 Impact of Transvenous Ventricular Pacing Leads on 
Tricuspid Regurgitation in Pediatric and Congenital 
Heart Disease Patients
Gregory Webster, Renee Margossian, Mark E. Alexander, Frank Cecchin, John K. 
Triedman, Edward P. Walsh, Charles I. Berul, Children’s Hospital, Boston, Boston, MA
Introduction: Transvenous ventricular pacing leads across the tricuspid valve may cause 
or exacerbate tricuspid regurgitation (TR). The literature in adults is inconclusive and 
no studies have investigated the association between pacing leads and TR in children. 
We hypothesize that TR may be more clinically significant in children due to growth and 
the higher incidence of congenital heart disease (CHD). Methods: A retrospective chart 
review was conducted at a large children’s hospital, yielding 1106 patients implanted 
between 2000 - 2006. 123 underwent initial placement of a transvenous lead across their 
tricuspid valve and had both pre- and post-procedure echos available for review. The 
pre-procedure echo was compared both to the first echo after lead placement and the 
most recent echo. TR was recorded on an ordinal scale (0 = absent, 1 = trivial, 2 = 
mild, 3 = moderate, 4 = severe). Results: The median age was 16 years (range 2-52) 
at time of lead placement. The change in TR was not significant by age, either ≥18 or 
<18 yrs (p=0.09). Median time was 242 days from implant to first echo, and 827 days to 
most recent echo. There was no difference in TR between the pre-procedure echo and 
first follow-up echo (p=0.97). However, TR was more likely to progress mildly between 
the pre-procedure echo and the most recent echo (p<0.02) with a mean increase from 
1.54 to 1.69 on the 0 to 4 ordinal scale. There were 76 pts (62%) with CHD. Mean pre-
procedure TR was 1.82 in right-sided CHD (e.g., tetralogy of Fallot, repaired AV canal) 
vs. 1.43 without right-sided CHD (P<0.01). TR did not increase in pts with right-sided 
CHD, but did increase in pts without right-sided CHD (p<0.05). No patients progressed 
from 0 or 1 on the ordinal scale to moderate or severe TR. Conclusions: In patients with 
transvenous ventricular leads across the tricuspid valve, echocardiography demonstrates 
unchanged TR after lead placement; however, after extended follow-up, the increase 
in TR is statistically significant, albeit likely of no significant clinical consequence. The 
detected change is minimal, suggesting that there is little impact of transvenous leads on 
TR, even in growing children or patients with right-sided structural heart disease.
10:00 a.m.
1015-114 Impact of Scar Burden and Dyssynchrony on Response 
to Cardiac Resynchronization Therapy In Ischemic 
Cardiomyopathy
Glen Miske, Hidekazu Tanaka, Evan Adelstein, Masaki Tanabe, Prem Soman, Samir 
Saba, John Gorcsan, III, University of Pittsburgh, Pittsburgh, PA
Background: Although mechanical dyssynchony is assoicated with response to 
resynchronization therapy (CRT), patients with ischemic cardiomyopathy (ICM) respond 
less favorably than non-ischemics. Our objective was to test the hypothesis that a high scar 
burden may impact response to CRT in patients with ICM, regardless of dyssynchrony.
Methods: Forty-five ICM patients (age 67±9 yrs, ejection fraction (EF) 27±8%, QRS 
duration 166±31 ms) were studied who had resting SPECT thallium studies before CRT. 
Echocardiography was performed before and 9±8 months after CRT.Dyssynchrony was 
assessed as the opposing wall delay > 65 ms for longitudinal and anterior-septum and 
posterior wall delay > 130 ms for radial.Scar burden was assessed by resting SPECT 
thallium as sum perfusion scores (SPS).
Results: : Response rate to CRT among these ICM patients was 54% (24/45) defined as 
an absolute increase in EF≥5% (EF units). Although overall EF improved from 27±8% 
to 33±11% (p<0.005), EF improved less in those with a high scar burden: follow-up EF 
28±11%* for SPS > 28 vs. EF 36±11% for SPS < 28, *p<0.05. Although a few high scar 
burden patients still responded, SPS > 28 had a sensitivity of 83% and specificity of 57% 
for predicting EF non-response. Dyssychrony analysis did not improve predictive value in 
these high scar burden patients.
Conclusions: ICM patients with a high scar burden have a low response to CRT regardless 
of the presence of dyssynchrony. These observations may have clinical implications in 
patients with ICM. 
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1015-115 Female gender is Associated with a more Favourable 
Response to Cardiac Resynchronization Therapy
Paul William Foley, Kayvan Khadjooi, Shajil Chalil, Nick Irwin, Russell EA Smith, Michael 
P. Frenneaux, Francisco Leyva, Good Hope Hospital, University of Birmingham, Sutton 
Coldfield, United Kingdom
Background: Limited data suggests that female gender is associated with a better response 
to cardiac resynchronisation therapy (CRT). We explored the relationships between gender 
and both mortality and morbidity in consecutive patients undergoing CRT. 
Methods: 311 patients [age 67.1 ± 10.6 yrs (mean ± SD), 62 female (F), QRS duration 
≥ 120 ms, LVEF<35%] with heart failure (HF) due to ischemic (n=221) or non-ischemic 
(n=90) cardiomyopathy in NYHA class III (n= 210) or IV (n=101) underwent CRT. Clinical 
events were collected over a follow-up period of 6.5 years following implantation.
Results: In Kaplan-Meier survival analyses, males (M) were more likely to reach the 
composite endpoints of death from any cause or HF hospitalizations (F: 13/62 vs M: 
92/249, log-rank p=0.007, see Figure) as well as death from any cause (F: 11/62, M: 
79/249; p=0.0116) and cardiovascular death [F: 9/62 vs M: 68/249, p=0.0145). Changes 
from baseline in NYHA class (F: -1.3 ± 0.9, M: -1.2 ± 0.8), 6-min walking distance (F: 87.7 
± 15.0, M: 88.5 ± 116.0 m) and quality of life scores (Minnesota Living with Heart Failure 
questionnaire, F: -27.0 ± 28.8, M:-18.7 ± 26.0) left ventricular end-systolic (F: -35.1 ± 
55.3, M:-26.3 ± 61.3 mL) and end-diastolic (F: -29.6 ± 62.0, M:-19.7 ± 61.2 mL) volumes, 
and LVEF (F: 6.3 ± 14.5, M: 4.6 ± 13.1 %) were comparable.
Conclusions: Female gender is associated with a more favourable response to CRT, in 
terms of heart failure hospitalizations and mortality. Symptomatic improvement is similar 
to that observed in males. 
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2:00 p.m.
1022-89 Novel Method for Assessing Intraventricular 
Dyssynchrony Using Quantitative Analysis of 
Regional Wall Thickness by Multi-Detector Computed 
Tomography
Quynh A. Truong, Ammar Sarwar, Christopher P. Cannon, Khurram Nasir, Mark 
Handschumacher, Mannudeep Kalra, Antonio Sorgente, Cristina Conca, Francesco 
Faletra, Angelo Auricchio, Tiziano Moccetti, Jagmeet P. Singh, Udo Hoffmann, 
Massachusetts General Hospital, Boston, MA, Cardiocentro Ticino, Lugano, Switzerland
Background: The degree of intraventricular dyssynchrony has been suggested as 
a predictor of response to cardiac resynchronization therapy (CRT), but no imaging 
modality has proved reliable enough to become the gold standard. We aimed to use a 
novel CT-based method to quantify dyssynchrony.
Methods: In this case-control study, we measured the extent of LV dyssynchrony in 16 
subjects with heart failure (HF) meeting Echo and ECG criteria for CRT (EF <35%, QRS 
>120 ms) and 11 age-matched controls (EF >55%, QRS <120 ms). All subjects underwent 
ECG gated contrast enhanced 64-slice MDCT and 8mm thick short axis images were 
reconstructed in 10% increments over the entire RR- cycle. After delineation of endo- 
and epicardial boundaries, the time from R-wave to maximal LV wall thickness was 
measured in six standardized segments per slice using dedicated software. The standard 
deviation of these measurements per slice was averaged across the entire heart and was 
defined as the CT dyssynchrony index (DI) per patient. On average, 500 datapoints (9 ± 
3 slices, 6 segments, 10 phases) were analyzed per patient. Two readers performed both 
reconstructions and measurements independently.
Results: The DI inter- and intraobserver reproducibility was excellent (r=0.89 and r=0.93, 
both p<0.0001). The extent of LV dyssynchrony was significantly higher in the HF group 
as compared to controls (mean DI: 152 ± 44 vs. 65 ± 12 ms, p<0.0001). In a subgroup 
analysis of HF patients, mean DI was significantly higher in those whose QRS duration 
was above the median of 161 ms and those with pacemakers (174 ± 38 vs. 130 ± 40 
and 189 ± 38 vs. 130 ± 30 ms; p=0.04 and 0.004; respectively) but did not differ when 
subgrouped by median EF of 19.5%, presence of CAD, LBBB, or NYHA class. In adjusted 
multivariate analysis, median QRS duration was no longer significant and only pacemaker 
remained an independent predictor of higher DI (p=0.03).
Conclusions: We demonstrate that quantitative CT analysis of LV dyssynchrony using 
regional changes in LV wall thickness is feasible and reproducible. Our initial results 
suggest that CT may detect differences in dyssynchrony independent of EF and QRS 
duration. Further studies are needed to correlate this method to CRT response.
2:00 p.m.
1022-90 Effects of Electrocautery on Transvenous Lead 
Insulations
Kiam-Khiang Lim, Shantanu Reddy, Shrojal Desai, Eric Kessler, Chotikorn Khunnawat, 
Matthew Smelley, Susan S. Kim, John Beshai, Albert C. Lin, Martin C. Burke, Bradley P. 
Knight, University of Chicago Hospitals, Chicago, IL, Boston Scientific, St Paul, MN
Background. Electrocautery is commonly used during cardiac device implantation and 
pulse generator changes. The purpose of this study was to examine the effects of cautery 
on a variety of insulation materials.
Methods. Commercially available cardiac transvenous leads were selected to include 
Polyurethane 55D (PU55D), silicone rubber, or a silicone/polyurethane co-polymer 
outer insulation materials. Each lead was tunneled through grounded chicken breast 
tissue leaving a thin layer of tissue covering the lead. An electrocautery pen blade 
and a monopolar cautery unit (Surgistat II; Valleylab; Boulder, Colorado) were used 
to dissect a segment of the lead from the tissue with the cutting mode and outputs 
of 10, 20, and 30 Watts. Cautery durations were 3 and 6 seconds with both a parallel 
and perpendicular blade tip orientation. The insulation was inspected microscopically. 
Damage was graded using a scale of 1 to 4. (1 = None, 2 = Minimal, 3 = Significant 
without Breach, 4 = Breach).
Results. 
Make Model Outer Insulation
10W/3s/ 
Para
10W/6s/ 
Para
20W/3s/ 
Para
20W/6s/ 
Para
30W/3s/ 
Para
30W/6s/ 
Para
10W/3s/ 
Perp
20W/3s/ 
Perp
30W/3s/ 
Perp
MDT 4076 PU55D 1 4 3 4 4 4 4 4 4
BSC 4471 PU55D 3 2 4 3 4 4 4 4 4
MDT 6947 PU55D 1 4 4 4 4 4 4 4 4
SJM 1056T PU55D 3 3 2 3 4 3 4 4 4
MDT 4194 PU55D 2 4 4 4 4 4 4 4 4
BSC 4543 PU55D 4 3 4 4 4 3 4 4 4
MDT 5076 Silicone 1 1 1 1 1 1 4 4 4
BSC 4088 Silicone 1 1 1 1 1 1 1 2 4
SJM 1688T Silicone 1 1 1 1 1 1 1 4 4
BSC 0176 Silicone 1 1 1 1 1 1 1 2 4
SJM 7020 Copolymer 2 2 4 4 3 4 4 4 4
Abbreviations: Para = Parallel Perp = Perpendicular
BSC = Boston Scientific MDT = Medtronic SJM = St. Jude Medical
Conclusions. Polyurethane outer insulation has low thermal stability and is highly 
susceptible to thermal damage during electrocautery, even at low cutting power. Silicone 
is resistant to damage by cautery, but can be mechanically damaged when the blade is 
used perpendicularly. These findings should be considered when implanting transvenous 
leads and during pulse generator replacements.
2:00 p.m.
1022-91 Greater Anatomic and Electrical Interelectrode 
Distance Predicts Clinical Response to Chronic 
Resynchronization Therapy
Ian L. Weisberg, Binu Jacob, M. Kamran Aslam, Lori McMullan, Alan B. Miller, Robert 
Percy, Steve S. Hsu, University of Florida, Jacksonville, FL
Background: Cardiac resynchronization therapy (CRT) in heart failure leads to a significant 
improvement in quality of life; however, 20-30% of patients are non-responders. Although 
there are echocardiographic parameters of dyssynchrony that suggest which patients will 
respond to CRT, anatomy may preclude placing the left ventricular lead in the desired 
region. There is minimal prospective data on intraprocedural parameters that can predict 
clinical response to CRT. We assessed the hypothesis that greater left ventricular (LV) to 
right ventricular (RV) anatomic and electrical interelectrode distances would predict an 
improved clinical response to CRT.
Methods: We prospectively studied 36 patients who met criteria for CRT and received 
endovascular leads. At implant, simultaneous orthogonal images of the LV to RV 
interelectrode tip distances, with a tape ruler at cardiac level to standardize the anatomic 
distance, as well as the electrical distance between the LV and RV leads at baseline and 
during RV and LV pacing were obtained. A blinded heart failure physician determined 
responders (n=23) and non-responders (n=13) based on improvement in New York Heart 
Association (NYHA) functional class. There was no baseline difference between the two 
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groups with respect to age, gender, functional class, etiology of cardiomyopathy, LV end 
diastolic dimension, and ejection fraction. Analysis was performed using two tailed t-tests 
and an ROC curve.
Results: At an average follow-up of 6.1 ± 3.1 months, responders improved by an 
average of one NYHA functional class while non-responders showed no change in NYHA 
functional class. There was a significantly greater interelectrode anatomical distance 
(140.8 ± 24.2 mm vs. 107.0 ± 18.9 mm, p=0.0001) and LV to RV electrical distance (131.2 
± 19.5 ms vs. 105.8 ± 24.4 ms, p=0.04) in responders vs. non-responders, respectively. 
Measuring interelectrode distance as a discriminator of response to CRT using an ROC 
curve (AUC = 0.823), the optimal threshold was 120mm giving a sensitivity of 0.723 and 
specificity of 0.741.
Conclusions: Greater anatomic and electrical (LV to RV) interelectrode distances are 
intraprocedural parameters that can predict clinical response to CRT.
2:00 p.m.
1022-92 Independent AV/VV Pacing Optimization Requires 
Operation Along Mechanical AV Delay Isochrones
Robert G. Turcott, Ronald Witteles, Paul J. Wang, Euan A. Ashley, Stanford School of 
Medicine, Stanford, CA
Background: Pacing interval optimization improves hemodynamics in patients with 
biventricular devices. Optimization of atrio-ventricular delay (AVD) and interventricular 
interval (VVI) are frequently performed independently under the assumption that these 
parameters independently determine preload and dyssynchrony. We hypothesize 
that the timing from atrial event to onset of left ventricular systole, ie, the mechanical 
AVD, determines loading conditions and is distinct from the nominal programmed AVD. 
Methods: The dependence of mechanical AVD on A-LV and A-RV pacing intervals was 
modeled using 5 different assumptions: mechanical systole depends on time to 1) LV 
pace only, 2) RV pace only, 3) first ventricular pace, 4) both LV, RV pace with linear 
or 5) radial propagation. The relationship among A-LV, A-RV and mechanical AVD was 
determined. Results: Families of curves of A-LV and A-RV combinations that yield the 
same mechanical AVD were derived. These vary markedly among the models. One sample 
curve from each model is shown below. Conclusion: The relationship of mechanical 
AVD and A-RV/A-LV intervals depends sensitively on the model and is distinct from the 
nominal AVD and VVI. This result has critical implications for optimization methods. In 
particular, maintaining fixed preload while optimizing VVI requires changes in A-RV and 
A-LV that maintain a fixed mechanical AVD. Empirically identifying the appropriate model 
will yield important insights into the relative contribution of AV and VV timing. 
2:00 p.m.
1022-93 Registration of Three-Dimensional Coronary Venous 
System Computed Tomographic Images With Projection 
Images Obtained Using Fluoroscopy
Antonio Sorgente, Francesco F. Faletra, Cristina Conca, Elisabeth Soubelet, Regis 
Vaillant, Elena Pasotti, Giovanni B. Pedrazzini, Tiziano Moccetti, Angelo Auricchio, 
Cardiocentro Ticino, Lugano, Switzerland, GE Healthcare, Buc, France
Background: Coronary sinus (CS) and coronary veins (CV) are not usually delineated 
by fluoroscopy. Their representation obtained from computed tomography (CT) and 
subsequent projection of these images over the fluoroscopy system may help in 
cannulation of CS and its branches during cardiac resynchronization therapy (CRT) 
procedures.
Methods: In this feasibility study, in vitro experiments were performed with a plastic heart 
model (phantom). Subsequently, 18 consecutive patients underwent contrast-enhanced, 
ECG-gated CT scanning. CS and CV together with the superior vena cava, the distal 
portion of the trachea and of the two bronchi generated from the reconstructed data at 
75% of the R-R interval of the cardiac cycle were registered and superimposed over the 
coronary sinus angiogram obtained from fluoroscopy. Registration accuracy was verified 
by assessing the overlap of CS borders seen both in the CT and the fluoroscopy images 
after contrast medium injection.
Results: The mean registration error was 0.73 mm (range 0.01 to 2.22 mm) for the body 
of CS while it was 0.8 mm (range 0.06 to 2.64 mm) for first order branches of CS. No 
differences were found in the measurements of the diameter of CS (p =0.463) and first 
order coronary veins (p=0.479) obtained respectively with CT and fluoroscopy .
Conclusions: Registration of 3D models of the CS and coronary veins with fluoroscopic 
images of the same structure is feasible and could accelerate appropriate localization of 
coronary venous system during CRT procedures. 
2:00 p.m.
1022-94 Chronic Alternate Site Pacing Efficacy of a New Stylet-
less, Catheter-Delivered Lead in Congenital Heart
Peter P. Karpawich, Kathleen Zelin, Children’s Hospital of Michigan, Detroit, MI, Wayne 
State University School of Medicine
Background: Since ventricular apical and atrial appendage pacing can alter paced 
myocardial function, alternate site pacing (ASP) at septal sites has interest. However, due 
to diverse anatomies, ASP may be difficult to achieve in patients with congenital heart 
defects (CHD) with stylet-guided leads.
Methods: Using a new catheter-delivered, stylet-less, steroid-eluting, 4.1 Fr diameter lead 
(Model 3830, Medtronic, Inc), 42 consecutive pts, ages 5-48y (median 19), received 62 
leads (32 atrial; 30 ventricular) and followed from 1-24 months (median 12). Repaired 
CHD included D-transposition (TGA) (n=13), septal defects (n=8), single ventricle/Fontan 
(n=3), aortic stenosis (n=3); also congenital AV block (n=10), cardiomyopathy (3), long 
QT (n=1), sick sinus (n=1). DTGA pts included 6 concomitant Mustard venous baffle 
devices (1 AmplatzerTM, 5 stents). Based on measured implant hemodynamics, best 
ASP locations included high septal right atrium (n= 22), high left atrium (n=10), RV 
septum (n=22), LV septum (n=8).
Results: Regardless of CHD, all pre-selected ASP implant locations were readily achieved 
using the delivery catheter with minimal fluoroscopy time (0.6-9 minutes (median 2). There 
were no implant or follow-up complications. Chronic pacing and sensing indices showed 
lead stablity or improvements and no dislodgements (Table) (# p < 0.05 with implant).
Chronic Lead Performance (mean +/-sem)
ASP Site N R/P(mv) Implant
Threshold (V) 
Implant 
Impedance (Ω) 
Implant 
RV septum 22 12.2 ± 1.5 0.5 ± 0.2 926 ± 54
LV septum 8 12.4 ± 1.5 0.8 ± 0.1 953 ± 55
RA septum 22 3.7 ± 0.5 0.6 ± 0.05 776 ± 38
LA high 10 3.1 ± 1.5 0.9 ± 0.1 1054 ± 80
N Chronic Chronic Chronic
RV septum 22 11.4 ± 1.2 0.4 ± 0.04 587 ± 21#
LV septum 8 9.1 ± 1.3 0.5 ± 0.04# 702 ± 46#
RA septum 22 3.6 ± 0.4 0.4 ± 0.03# 570 ± 17#
LA high 10 3.7 ± 0.7 0.5 ± 0.1# 734 ± 67#
Conclusion: In spite of anatomical CHD challenges, the new catheter-delivered lead 
facilitates ASP implants and provides chronic stability.
2:00 p.m.
1022-94A The Comparison of the Efficacy of Over-the-Wire and 
Monorail Balloon System for Intracoronary Pacing
Wei Cui, Fan Liu, Ruiqin Xie, Jingchao Lu, Guoqiang Gu, Hongmei Zheng, Baohua Li, 
Jinfeng Wu, Jun Du, The Second Hospital of Hebei Medical University, Shijiazhuang, 
People’s Republic of China
Background: Temporary transcoronary pacing has recently been proposed as a safe and 
reliable alternative method to treat severe bradycardia during percutaneous coronary 
intervention (PCI). The previous study usually used a over-the wire system for intracoronary 
pacing, which is less used in the current clinical practice, and therefore limits its use in 
emergency situations. The aim of this study is to test the validity of the commonly used 
monorail balloon system for intracoronary pacing, and to compare the efficacy of these 
two balloon systems in transcoronary pacing during different conditions.
Methods: Eleven York pigs were randomly assigned to the monorail balloon group or 
the over-the-wire balloon group. A 0.014 inch BMW (Cordis) guidewire together with the 
OTW balloon was inserted deeply into the distal left anterior descending artery (LAD) 
or its branch and as a pacing lead. Acute ischemia/reperfusion was induced by routine 
percutaneous balloon angioplasty technique. Pacing thresholds were measured at 
baseline, 10 minutes after LAD occlusion by balloon inflation, as well as 10 minutes after 
reperfusion by balloon deflation, which were demonstrated by coronary angiography.
Results: Ventricular capture by transcoronary pacing was successful in all pigs in boths 
groups at baseline, during ischemia and reperfusion. There were no significant differences 
with respect to pacing threshold between the monorail balloon group and the over-the-
wire balloon group (0.88±0.24V vs 0.72±0.26V at baseline, 1.05±0.44V vs 0.80±0.27V 
during ischemia, and 1.36±0.26V vs 1.67±0.31V. all p>0.05) .
Conclusions: Both the monorail and the over-the-wire balloon systems can be effectively 
used for transcoronary pacing during PCI with equal efficacy.
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2:00 p.m.
1022-97 Preclinical Evaluation of Dexamethasone (DX) Release 
From Left Ventricular Heart Failure (LVHF) Lead
Linda J. Wojcik, Ronald W. Heil, Jr., Boston Scientific Corporation, St. Paul, MN
Background: Release of DX from LVHF steroid eluting (SE) leads has not been fully 
reported. This 60 day study evaluated in vivo DX release from a SE LVHF pacing lead 
(EasyTrak 3 DS, unipolar, 4 Fr) in a purpose-bred canine model. The study provides 
information on the fate of DX that cannot be collected in vitro. Systemic (plasma) and 
vein tissue DX concentrations [DX] were measured. The residual dexamethasone acetate 
(DMA) doses in the SE collars at explant were also measured.
Methods: Two groups of animals were implanted with LV leads using standard methods. 
Animals in the test group (DMA: 0.45 mg, n = 22), were sacrificed at days: 3, 7, 14, 21, 28, 
and 44 days (n = 3 for all) and 60 days (n = 4). For the control group (identical lead without 
SE collar, n = 2), animals were sacrificed at 60 days. Systemic [DX] were measured at 
frequently during the first 48 hours post-implant and at times of electrical assessments 
(voltage threshold, impedance, R-wave). Vein tissue [DX] and residual collar DMA doses 
were measured at termination.
Results: Collar DMA decreased to 0.39 mg (87% dose) remaining at 60 days. [DX] in vein 
tissue reached a maximum (16 ng/g) at 14 days followed by general decline (3.7 ng/g 
at 60 days). Plasma [DX] were uniformly below the detection limit (0.1 ng/ml). Voltage 
thresholds plateaued at 7 days, a profile consistent with other SE leads. The correlation 
between voltage threshold and tissue [DX] at explant was poor (r = 0.174). Using a 
monolithic release model, DMA exhaustion from the SE collar would occur at 11 years.
Conclusions: This preclinical study is the first published attempt to characterize DX release 
from LVHF leads. Tissue [DX] peaked at 14 days and declined while thresholds remained 
constant after 7 days. Steroid influence was achieved with only 0.06 mg of the original 
DMA dose. Poor correlation between tissue [DX] and threshold suggests a very slow 
release may maintain low voltage thresholds. Eleven year DMA release is predicted.
Note: This lead is currently under clinical investigation.
2:00 p.m.
1022-98 Improvements in Systolic Function and Dyssynchrony 
in Previously Right Ventricular Paced Patients 
Upgraded to Cardiac Resynchronization Therapy
Christopher L. Kaufman, Kevin V. Burns, Daniel R. Kaiser, Aaron S. Kelly, Andrea M. Thelen, 
Alan J. Bank, St. Paul Heart Clinic, Saint Paul, MN, Medtronic, Inc., Minneapolis, MN
Background: Previously right ventricular (RV) paced patients with reduced ejection fraction 
(EF) benefit from cardiac resynchronization therapy (CRT), but no prior studies have 
examined the effect of CRT on systolic function and dyssynchrony in all three orthogonal 
planes of cardiac motion. The purpose of this study was to examine the effect of CRT 
upgrade on measures of longitudinal, radial, and circumferential function and dyssynchrony 
in these patients. Methods: Standard echocardiograms were performed before and after 
chronic CRT (mean follow-up = 6.1 ± 1.8 months) in 21 previously RV paced (duration = 
5.8 ± 2.8 yrs; 76% apex, 24% mid-septum) heart failure patients (age = 74±13 year; 16 
male). Using tissue Doppler imaging in 12 segments from three apical views, global systolic 
contraction amplitude (GSCA; average longitudinal displacement) and dyssynchrony (TT-
12; standard deviation of time to peak myocardial displacement) were measured. Using 
short axis views and speckle-tracking methods, radial and circumferential systolic function 
(mean strain) and dyssynchrony [standard deviation of time to peak radial (Ts-6
rad) and 
circumferential strain (Ts-6
circ)] in six myocardial segments were calculated. Echo response 
was defined as > 15% decrease in left ventricular end systolic volume (LVESV). Clinical 
response was defined as a reduction > 1 NYHA class. Results: The echo and clinical 
response rates were 76% and 80%, respectively. CRT significantly (p < 0.05) improved EF 
(28 ± 6 to 42 ± 11%), left ventricular end-diastolic volume (154 ± 51 to 127 ± 49 mL), and 
LVESV (112 ± 41 to 77 ± 41 mL). Systolic function was significantly (p < 0.05) improved 
in all three planes of motion (GSCA = 3.2 ± 1.6 to 5.4 ± 1.8 mm; radial strain = 19 ± 13 to 
27 ± 16%, circumferential strain = -12 ± 7 to -15 ± 4 %). TT-12 (81 ± 32 to 54 ± 33 msec) 
and Ts-6
rad (71 ± 43 to 38 ± 38 msec) were significantly (p < 0.05) improved, but Ts-6circ (93 
± 44 to 77 ± 58 msec) did not significantly change. Baseline TT-12 was the only measure 
related to % change in LVESV (r = -0.50, p =0.02). Conclusions: Upgrading previously RV 
paced patients to CRT results in improvements in longitudinal and radial dyssynchrony and 
systolic function in all three planes of cardiac motion.
2:00 p.m.
1022-99 Variability in the Three-Dimensional Geometry of 
the Coronary Sinus: A Rotational Coronary Venous 
Angiography Study
Dan Blendea, Veena Nandigam, Theofanie Mela, E. Kevin Heist, Craig A. McPherson, 
Jeremy N. Ruskin, Jagmeet P. Singh, Cardiac Arrhythmia Service, Massachusetts General 
Hospital, Boston, MA, Cardiology Department, Bridgeport Hospital, Bridgeport, CT
Background: The coronary sinus (CS) is often distorted in patients with advanced 
cardiomyopathy, making CS cannulation difficult. The objective of this study was to 
examine the impact of the underlying cardiac pathology on the variability of the CS 
anatomy, using rotational coronary venous angiography (RCVA).
Methods: 79 patients undergoing RCVA for cardiac resynchronization therapy (CRT) were 
evaluated: age 63±15 years, 21 women, LVEF 22±8%, 43% with prior coronary artery 
bypass grafting (CABG). RCVA involves recording a rapid 4-sec isocentric cine-loop from 
RAO 55o to LAO 55o, acquiring 120 frames, thereby enabling a multi-angle review of 
the CS. Aspects of the CS anatomy which could impact cannulation were examined: 1) 
the CS ostial angle, i.e. the angle between the ostium and the main body of the CS 
at the takeoff of the middle cardiac vein; 2) the posterior displacement of the CS away 
from the atrioventricular groove, a measure of CS curvature; 3) the decrease in luminal 
diameter at the CS-great cardiac vein (GCV) junction; and 4) the presence of stenoses 
and aneurysmal dilatations (≥ 30% abrupt change in diameter).
Results: The CS ostial angle was variable (65-151o, mean 119±19o, <90o in 8 patients, 
best seen in LAO 51±4o) and decreased significantly (P=0.0022) with increasing severity 
of tricuspid regurgitation (TR), reaching 94±18o in patients with severe TR. The posterior 
displacement of the CS was significantly more accentuated in patients with prior CABG 
when compared to the patients without CABG (7.1±3.7 vs 4.5±2.8 mm; P=0.0246). 
The decrease in luminal diameter at the CS-GCV junction was 2.0±1.0 mm (23± 10%), 
being more pronounced in patients with prior CABG when compared to patients without 
CABG (26 vs. 20%; P=0.042). Stenoses and aneurysmal dilatations of the CS/GCV were 
encountered in 4 (5%) and 6 (8%) of patients respectively, all of them with prior CABG, 
representing 12% and 18% of the CABG group.
Conclusion: The CS anatomy in patients undergoing CRT is variable, and is impacted 
by the severity of the underlying TR and history of a prior CABG. Knowledge of these 
distortions of the CS can facilitate its cannulation.
2:00 p.m.
1022-100 Left Ventricle Diastolic Function Deteriorated More in 
Patients with Pre-existing Diastolic Dysfunction by 
Right Ventricle Apical Pacing
Fang Fang, Qing Zhang, Joseph YS Chan, Jeffrey WH Fung, Gabriel WK Yip, Anna 
KY Chan, Yat-yin Lam, Eugene B. Wu, Gary CP Chan, Cheuk-man Yu, The Chinese 
University of Hong Kong, Hong Kong, Hong Kong
Background: Little is known if right ventricle apical (RVA) pacing will exert harmful effect 
on left ventricle (LV) diastolic function or diastolic dyssynchrony and the potential effect in 
those with pre-existing diastolic dysfunction (DD).
Methods: 93 sick sinus syndrome patients (68±12yrs, 26male) receiving dual-chamber 
RVA pacing were assessed by 2D echocardiography and tissue Doppler imaging (by 
iE33, Philips, USA) when programmed randomly to ventricular sensing and pacing 
modes. Patients were divided into those with and without pre-existing DD group based on 
the transmitral flow pattern.
Results: 60 patients with pre-existing DD showed that E’ at septal and lateral mitral 
annulus reduced during RVA with elevation of filling pressure as illustrated by E/E’ (Table) 
in those with pre-existing DD. Diastolic dyssynchrony was also increased as assessed by 
the standard deviation of time to peak early diastolic velocity of 12 LV segments (Te-SD). 
Septal E’ reduction moderately correlated with Te-SD deterioration (r=0.362, p=0.006). 
This is in contrast to those 33 patients without pre-existing DD in whom only mitral 
annulus septal E’ reduction is evident at RVA even LVEF was reduced in both groups.
Conclusion: RVA pacing could worsen LV diastolic function with induction of diastolic 
dyssynchrony. However, such changes mainly occurred in those with pre-existing DD 
suggesting the caution of RVA in this vulnerable group. 
Parameters
Without pre-existing DD 
(n=33) With pre-existing DD (n=60)
V sense V pace P value V sense V pace P value
Septal E’ (cm/s) 7.5±2.8 6.6±2.5 0.005 5.3±1.8* 4.9±1.6* 0.003
LV septal E/E’ ratio 10.3±3.7 11.7±4.3 NS 14.4±5.9* 15.6±6.3* 0.01
Lateral E’ (cm/s) 8.5±2.8 8.7±2.6 NS 7.2±2.5* 6.4±2.1 <0.001
LV Lateral E/E’ ratio 9.0±2.7 8.4±2.5 NS 10.9±5.0** 12.3±5.3* 0.003
Te-SD (ms) 24.9±12.9 25.5±14.5 NS 26.3±12.0 31.0±15.4 0.018
LV ejection fraction (%) 62.8±7.4 60.0±8.0 <0.001 58.9±7.2 55±7.9* <0.001
*P<0.01, **P<0.05 vs patients without pre-existing DD
2:00 p.m.
1022-101 Left-ventricular pacing is associated with higher right-
ventricular contractility compared to bi-ventricular 
pacing
Russell Bailey, Richard Shepard, Kevin Hsu, Matt Zmijewski, John Roberts, Aleksandre 
Sambelashvili, Medtronic Inc, Mounds View, MN
Background: While CRT has been shown to increase left-ventricular (LV) contractility in the 
majority of LBBB patients its effect on right-ventricular (RV) function is poorly investigated. 
Previous studies in LBBB canines have shown that higher RV contractility is observed 
when LV resynchronization is suboptimal. We examined the effects of LV pacing (LV Only) 
and simultaneous bi-ventricular pacing (BiV) on LV and RV contractility. Methods: After 
implantation of CRT-D devices eleven patients underwent LV and RV catheterization with 
pressure sensor catheters. The CRT-D device was programmed to atrial pacing (AP) at 
a rate 10% above the patient’s heart rate. BiV and LV Only pacing was then applied at 
different AV delays (AV) programmed as offsets from the intrinsic PR interval (0 to -150 ms, 
steps of 30 ms) in random sequence. Maximum rates of rise in LV and RV pressures (LV 
and RV dP/dt_max) were determined for each AV delay and expressed as percent change 
relative to AP. Results: LV dP/dt_max increased by 10±1% (p=0.001) for BiV at AV offsets 
of -120, -90 and -60 ms and by 10±2% (p=0.007) LV Only at AV offsets of -90, -60 and -30 
ms. RV dP/dt_max decreased by 12±4% (p=0.03) at AV offsets of -150, -120 and -90 ms 
for BiV. No significant change in RV dP/dt_max was observed for LV Only. Compared to 
BiV, LV Only resulted in significantly higher RV dP/dt_max at AV offsets of -150 and -90 
ms. Conclusions: Similar to BiV pacing, LV Only pacing improves LV contractility, but in 
contrast with BiV pacing, it does not suppress RV contractility. 
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2:00 p.m.
1022-102 Far-field electrogram can be used to predict the optimal 
interventricular mechanical delay in CRT patients
Russell Bailey, Richard Shepard, Kevin Hsu, Matt Zmijewski, John Roberts, Aleksandre 
Sambelashvili, Medtronic, Inc, Mounds View, MN
Background: Optimization of CRT timing can result in improvement in cardiac function. 
Previous studies have shown that the maximal increase in left-ventricular (LV) contractility 
(LV dP/dtmax) is associated with fusion between left and right electrical activation 
wavefronts. We hypothesized that this fusion can be detected from far-field electrogram 
(EGM) and used to predict optimal CRT timing. Methods: After implantation of CRT-
D devices eleven patients underwent LV and right-ventricular (RV) catheterization with 
pressure sensor catheters. Simultaneous bi-ventricular (BiV) and LV Only pacing were 
applied at different AV delays (AV) programmed as offsets from the intrinsic PR interval 
(0 to -150 ms, steps of 30 ms). Morphology of the evoked responses in RV coil-to-can 
EGM for pacing at a particular AV delay was compared to that for intrinsic conduction 
by calculating wavelet-based match score (EGM % match). Inter-ventricular mechanical 
delay (IVMD) was determined as the time between upslopes of LV and RV pressure 
curves. Results: For LV Only and BiV pacing normalized EGM % match correlated with 
normalized IVMD (R=0.66±0.23) across AVs. At the longest AV with EGM % match below 
70% LV dP/dtmax increased by 10±10% (p=0.02) for both LV Only and for BiV pacing. This 
increase correlated well with the maximal possible improvement for LV Only (16±11%, 
R=0.76) and BiV (13±10%, R=0.90) pacing. Conclusions: Far-field electrogram may be 
used for AV delay optimization in CRT patients. 
2:00 p.m.
1022-103 Improved Echocardiographic Assessment of Cardiac 
Dyssynchrony With Cross-Correlation Analysis of 
Myocardial Systolic Acceleration
Niels Thue Olsen, Rasmus Mogelvang, Thomas Fritz-Hansen, Peter Sogaard, Gentofte 
Hospital, Copenhagen, Denmark
Background: The value of echocardiography in cardiac resynchronization therapy 
(CRT) has not been conclusively determined. Importantly, current methods for detecting 
dyssynchrony are influenced by regional differences in myocardial performance. We 
introduce a new and potentially more reliable method based on analyzing myocardial 
acceleration during the entire systole.
Methods: We studied a group of 107 unselected cardiac patients (divided into 2 groups, 
LVEF >35%, n = 80 and LVEF ≤35%, n = 27), and 25 patients referred for CRT. All patients 
were examined with tissue Doppler echocardiography.
Results: Cross-correlation analysis of myocardial acceleration showed marked differences 
between the 3 groups; the maximal activation delay was very low in the mixed group with 
LVEF >35% (median 6.5 ms), higher in the group with LVEF ≤35% (18.7 ms, p < 0.001), 
and markedly increased in the CRT group (56.3 ms, p = 0.02 vs. group with LVEF ≤35%). 
Conventional time-to-peak analysis showed no differences between the groups (p = 0.43). 
See Figure.
Conclusions: Cross-correlation analysis revealed an increased prevalence of mechanical 
dyssynchrony in cardiac patients with systolic dysfunction and an even higher prevalence 
in patients with indication for CRT, which is in line with theoretical predictions. Conventional 
time-to-peak measures failed to differentiate between the groups. The data suggest 
improved specificity of the new method, a finding that has potential implications for the 
selection of patients for CRT.
2:00 p.m.
1022-104 Longitudinal Strain Delay Index by Speckle Tracking 
Imaging; A New Marker of Response to Cardiac 
Resynchronization Therapy
Pascal LIM, Adisai Buakhamsri, Zoran B. Popovic, Neil L. Greenberg, James D. Thomas, 
Richard A. Grimm, Cleveland Clinic, Cleveland, OH, APH-HP Henri Mondor Hospital, 
Creteil-Paris, France
Background: In the desynchronized heart, contractility in delayed segments does not 
fully contribute to end-systolic (ES) function. We quantified this component of inefficient 
contraction related to mechanical dyssynchrony (strain delay index, SDI) to predict 
response to Cardiac Resynchronization Therapy (CRT).
Methods: We performed echocardiography in 65 patients (EF=25±9%, 25 ischemic) 
before CRT and 3-months later. Tissue Doppler velocity (TDI) and longitudinal strain (ε) by 
speckle-tracking were obtained from apical views. LV dyssynchrony was measured as: 1) 
Standard deviation of time to peak velocity (SD-TDI) and to peak-ε (SDI-ε) in 12 segments 
and 2) Sum of the difference between peak and ES-ε across 16 segments (SDI).
Results: At 3 months, LVES volume reduction >15% (responder) occurred in 42 patients 
(65%). SD-TDI >33ms was found in 91% of patients, without difference between 
responders and non-responders. In contrast, SD-ε and SDI were higher in responders 
than non responders (111±32ms vs. 88±21ms, p=0.003 and 35±8% vs. 19±7%, 
p<0.0001, respectively). SDI also correlated with reverse remodeling in both ischemic 
and non ischemic patients (r=-0.69, p<0.0001) while SD-ε correlated only in non-ischemic 
patients. The optimal cutoff value to identify responders by SDI was >25% with a 90% 
positive and negative predictive value.
Conclusions: The strain delay index has a strong predictive value for predicting response 
to CRT in both ischemic and non-ischemic patients.
2:00 p.m.
1022-105 Chronic Coupled Pacing Reverses Remodeling in Heart 
Failure Dogs with Rapid Atrial Fibrillation
Pascal Lim, Georges E. Yanulis, Ali Ahmad, Van D. Wagoner, Richard A. Grimm, Don 
Wallick, Cleveland Clinic, Cleveland, APH-HP Henri Mondor Hospital, Creteil-Paris, France
Introduction. Ablation therapy for chronic atrial fibrillation (AF) may be beneficial in heart 
failure (HF) patients with improved left ventricular (LV) function and reverse remodeling. 
When sinus rhythm fails to be reestablished, a proposed rate control therapy, coupled 
pacing (CP), could be an alternative treatment which consists of a stimulation after the 
ventricular refractory period to block rapid AV conduction.
Methods. In 5 dogs with implanted pacemakers, the right ventricle (RV) was rapidly 
paced for 2-4 weeks until reduced LV ejection fraction (EF<40%), then RV pacing was 
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terminated and chronic AF was induced by rapid atrial pacing. After 2-4 weeks of AF, 
sustained ventricular CP was delivered for 2-4 weeks with a time interval between the CP 
beat and the intrinsic ventricular activation set as to minimize a subsequent mechanical 
contraction. Changes in LV end diastolic volume (EDV), atrial size and LVEF were 
quantified by echocardiography.
Results. Compared to sinus rhythm, RV pacing followed by chronic AF was associated 
with a reduced EF (42±16% vs. 28±15%, p=0.04), increased EDV (75±12ml vs. 96±19ml, 
p=0.05) and LA size (21±10 vs. 37±7ml, p=0.01). When CP was applied, a sustained 
decrease of heart rate was observed (159±39bpm vs. 104±21bpm, p=0.05). Under CP, no 
sudden death and ventricular arrhythmia were observed and importantly EDV (-19±11%, 
p=0.04) and LA size (-25±9%, p=0.02) were reduced and EF tended to increase (28±15% 
vs. 47±2%, p=0.08).
Conclusion. Chronic CP was safely delivered in HF animals with chronic AF to slow 
the ventricular contractile rate and improve contractility which resulted in reverse 
remodeling.
2:00 p.m.
1022-106 The Impact of Improvement of Mitral Regurgitation 
on 1-Year Clinical Outcomes in Patients Undergoing 
Cardiac Resynchronization Therapy
Ando Kenji, Yoshimitsu Soga, Shinichi Shirai, Takeshi Arita, Masahiko Goya, Masashi 
Iwabuchi, Hiroyoshi Yokoi, Hitoshi Yasumoto, Hideyuki Nosaka, Masakiyo Nobuyoshi, 
Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan
Background: It is not well known whether improvement of mitral regurgitation (MR) after 
cardiac resynchronization therapy (CRT) affects long-term clinical outcomes.
Methods: We investigated 110 pts received CRT (age 71+/-10years, NYHA class 3.1+/-
0.5, LVEF 26+/-7%, LVEDD 61+/-7mm, pre QRS duration 178+/-29ms) and divided into 
two groups, 48 pts with improvement of MR after CRT (MR improve group) and 62 pts 
without improvement of MR (MR no-improve group). Improvement of MR was defined as 
echocardiographic MR decreased at least 1 grade after 3-6 months CRT. 1-year clinical 
data were obtained.
Results: Baseline MR grade was significantly greater in MR improve group than MR no-
improve group (2.0+/-0.6 in MR improve group vs. 1.5+/-0.8 in MR no-improve group, 
p<0.005), but after 3-6 month, MR grade was significantly smaller in MR improve group 
(0.7+/-0.6 in MR improve group vs. 1.6+/-0.9 in MR no-improve group, p<0.0001).
At 1-year follow up, NYHA functional class was similar between two groups (2.3+/-0.7 
in MR improve group vs.2.2+/-0.6 in MR no-improve group, p=ns). However, event free 
survival rate from combined death and heart failure hospitalization was significantly 
higher in MR improve group (85% vs.67% at 1 year, Log-rank p=0.025).
Conclusion: Pts with improvement of MR after 3-6month CRT had better 1-year clinical 
outcomes than pts without improvement of MR. 
2:00 p.m.
1022-107 Impact of Anterior Versus Posterior Left Ventricular 
Lead Position on Clinical Outcome in Cardiac 
Resynchronization Therapy
Thomas Kleemann, Torsten Becker, Margit Strauss, Steffen Schneider, Ralf Zahn, 
Jochen Senges, Karlheinz Seidl, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Background: A posterolateral position of the left ventricular pacing lead is recommended 
for cardiac resynchronisation therapy (CRT). However, the clinical outcome of patients 
with anterior position of the left ventricular lead compared to those with posterolateral 
lead position is not known. Aim of the study was to evaluate the clinical outcome of 
patients receiving CRT depending on the left ventricular (LV) lead position.
Methods: 169 consecutive patients with advanced heart failure who received a CRT-
defibrillator (CRT-D) were analyzed. The position of the left ventricular lead was 
determined by biplane chest x-ray after implantation. After 3 months of follow-up patients 
were classified as responders or nonresponders, based on the presence or absence of 
improvement in NYHA class.
Results: 124 of the LV leads (73%) were positioned in the posterior region and 45 LV 
leads (23%) in the anterior region. The total median follow-up time was 704 (479/1063) 
days.
Baseline characteristics and follow-up depending on the LV lead position
Anterior/ 
anterolateralN=40
Posterior/ 
posterolateralN=64 p-value
Age (years) 64 + 9 66 + 9 Ns
EF (%) 24 + 7 25 + 6 Ns
QRS (msec) 160 (140-160) 156 (120-180) Ns
NYHA at baseline 3,1 + 0,7 2,8 + 0,7 Ns
ACE inhibitor 100% 100% Ns
Beta blocker 82% 89% Ns
NYHA after 3 months 2,3 + 0,5 2,1 + 0,5 Ns
Responder after 3 months 63% 62% Ns
Total mortality after 704 
days 24% 9% 0.03
Conclusions: 1. 2/3 of the patients receiving CRT had a clinical improvement in NYHA 
class after 3 months. 2. This improvement was observed independently of the LV lead 
position. 3. The total mortality rate after nearly 2 years was more than two-fold increased 
in patients with anterior LV leads compared to those with posterior LV leads.
2:00 p.m.
1022-108 Classification of the Post-implant Final Left Ventricular 
Lead Position: A Comparative Study between 
Radiographic and Angiographic Modalities
K Veena Nandigam, E Kevin Heist, Dan Blendea, Andre D’Avila, Vivek Y. Reddy, Theofanie 
Mela, Jeremy Ruskin, Jagmeet P. Singh, Massachusetts General Hospital, Boston, MA
Background: Post-implant lateral and posteroanterior chest X-rays (CXR) are often 
utilized to determine the final LV lead tip position after cardiac resynchronization therapy 
(CRT). Although it is apparent that cardiac dilatation and rotation in patients with heart 
failure is unpredictable, there is limited data examining the accuracy of CXR to interpret 
LV lead localization.
Objective: This study compared the ability of post-implant CXRs with intra-procedural 
rotational coronary venous angiography (RCVA) to localize the final LV lead position.
Methods: We analyzed RCVA and CXRs from 51 patients undergoing CRT. RCVA 
involves recording a rapid 4-sec isocentric cine-loop from RAO 550 to LAO 550 (120 
frames), thereby enabling a three-dimensional, multi-angle view of the CS and its 
branches. This served as the gold standard for LV lead location. CXR criteria for LV lead 
localization involved using the lateral view to ascribe the ventricular wall (e.g. anterior, 
anterolateral, lateral, posterolateral, or posterior) while the posteroanterior view was used 
to characterize the location as basal, mid, or apical. The LV lead position on CXR and 
RCVA were analyzed separately by two different blinded physicians.
Results: 51 patients (69.3 ± 10.6 years; males 70.6%; ischemic 64.6%; NYHA class 3±0.4 
and LV ejection fraction 23.3±8.5) were analyzed for their LV lead pacing site position. 
Among the study group lateral wall was the most common pacing site 66.7% followed 
by postero-lateral 19.6% and antero-laterlal wall 11.8%. In 82.4% cases, the LV lead 
position was misclassified based on CXR as compared to RCVA. Among the 42 cases 
misclassified with the CXR approach, 32 were lateral LV lead positions misclassified 
as postero-lateral (59%) and posterior (41%); 7 cases of postero-lateral position were 
misinterpreted as either lateral (3) or posterior (4) and; 3 antero-lateral positions were 
erroneously classified as lateral (3) and postero-lateral (1).
Conclusion: CXR is not an accurate method for determining the LV lead tip position and 
intra-procedural angiography should remain the gold standard for classifying the LV lead 
location.
2:00 p.m.
1022-109 Forward Flow Fraction: A Novel Parameter of Cardiac 
Remodeling that Accurately Predicts Functional 
Response in Patients with Cardiac Resynchronization 
Therapy
Sanjay Kumar, Richard A. Grimm, Cleveland Clinic Foundation, Cleveland, OH
Background: Cardiac Resynchronization Therapy (CRT) is performed in patients with 
heart failure however an accurate parameter to evaluate the physiologic response is 
lacking. The discrepancy between clinical response and echocardiographic parameters 
like Ejection Fraction (EF), Left Ventricular End Systolic Volume (LVESV) and Tei Index 
(TI) is common. Forward Flow Fraction (FFF) measures the efficiency in contractility of 
myocardium in ejecting blood towards the aorta at the instant of end systole. Forward Flow 
Fraction was calculated with a formula consisting of Stroke Volume (SV), Ejection Time 
(ET), Systolic Time Interval (STI) and Left Ventricular End Systolic Diameter (LVESD).
FFF = (SVml x ETms) x 100 / (STIms x LVESDcm^2)
Methods: Sixty-one patients (Age 68 ± 10, M: F 46:15) who underwent CRT and 
comprehensive follow up were studied. Echocardiographic and NYHA functional 
assessment was performed before and 6 months after CRT. 34 patients (56%) had 
improvement in NYHA class after implant. A significant improvement (>15% change) in 
EF, LVESV and TI was noted in 34 (56%), 22 (36%) and 22 (36%) patients respectively.
Results: Improvement in FFF was noted in 36 (60%) patients and was significantly 
associated with NYHA class improvement (p < 0.001). Increase in EF and reduction in 
LVESV and TI were only marginally associated with clinical response (p 0.03, p 0.08, 
p=NS respectively). FFF identified NYHA class improvement in 5 out of 9 pts misclassified 
by EF and in 13 out of 17 pts misclassified by LVESV (p <0.05). Increase in FFF correlated 
significantly with a decrease in LVESV and LVESD ((r -0.38, p <0.01 and -0.51, p <0.001 
respectively). Only FFF, but not EF nor LVESV, improved significantly in groups with 
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improvement in wall motion and reduction in grade of mitral regurgitation (p <0.05).
Conclusions: FFF is a physiologic parameter sensitive to changes in global function and 
processes involved in ventricular remodeling. FFF is superior to EF, LVESV and TI in 
predicting and monitoring functional response in CRT patients.
2:00 p.m.
1022-110 Increased Risk of Stroke in Patients with Permanent 
Pacemaker Leads and Patent Foramen Ovale
Orlando Gurdiel, David Paniagua, Jose Antonio Condado, J. De Freitas, Amit H. 
Manhas, B. Amezaga, Baylor College of Medicine, Houston, TX
Background: The prevalence of Patent Foramen Ovale (PFO) in adults is around 25% and 
more than 100,000 pacer leads are implanted annually. An association between PFO, 
stroke and migraines is known. An increased incidence of thromboembolism in patients 
with transvenous pacer leads (TVPL) and intracardiac shunts (ASD, VSD) has been 
published. The association of PFO and TVPL and stroke is unknown.
Objetives: To determine the risk of stroke in patients with TVPL and PFO.
Methods: Sixty consecutive patients from the Pacemaker Clinic at our institution were 
studied for the presence of stroke and PFO. Electrocardiogram, transthoracic Echo-
Doppler with bubble studies, complete neurological assessment and brain imaging were 
performed on each patient to determine the prevalence of PFO, atrial fibrillation (AF) 
and stroke. The population was divided into two groups: PFO and no PFO. Statistical 
comparison were made using Chi square, t test, and odds ratio.
Results: Forty three percent of patients were male, mean age was 77 years ± 9, 15% of 
patients had diabetes, and 40% had hypertension. PFO was present in 10 patients with 
TVPL (16.6%). Four patients with PFOs had a stroke (36%) compared to 7 out of 42 
without PFO (16%). Odds ratio for stroke with PFO was 3.47. Both groups had similar 
demographics including the same prevalence of atrial fibrillation.
Conclusions: PFO is associated with an increased risk of stroke in patients with TVPL. 
Larger controlled clinical studies to test these preliminary findings are required. If these 
findings are verified, a recommendation for screening and closing PFOs in this group 
may be justified.
2:00 p.m.
1022-111 Cardiac Resynchronization and Defibrillator Therapy 
(CRT-D) Improves Survival Compared to CRT Alone 
(CRT-P) in Heart Failure Patients
William T. Abraham, James B. Young, Kevin Wheelan, W. Ben Johnson, Andrew Smith, 
Yanping Chang, Malathi Jakkula, For the InSync Registry and InSync ICD Registry 
Investigators, Medtronic, Inc, Fridley, MN
Background: Multiple large, randomized controlled trials have demonstrated the benefit 
of cardiac resynchronization therapy on functional status and morbidity/mortality in heart 
failure patients. The survival rates of patients receiving CRT-D versus CRT-P in the 
general population have not been adequately evaluated.
Methods: Analyses were based on 1,471 patients enrolled in the InSync ICD Registry of 
CRT-D (N=373) and InSync Registry of CRT-P (N=1,098). Six-month cumulative survival 
curves were constructed using the Kaplan-Meier method and the difference between the 
curves was tested for significance by the adjusted p-value from the stratified Proportional 
Hazards Model to adjust for differences in baseline demographics.
Results: Compared to CRT-P, CRT-D patients were younger (67.7 vs. 70.7; p<0.0001), had 
a lower mean NYHA class ranking (3.0 vs. 3.1; p=0.0012), and a lower mean LVEF (22.8 
vs. 25.4; p<0.0001). CRT-D patients were more likely to have ischemic heart condition 
(p<0.0001), myocardial infarction (p<0.0001), coronary artery disease (p<0.0001), and 
receive beta-blockers (p<0.0001).
Six month survival rates were 94.9% for CRT-D and 89.9% for CRT-P (adjusted p=0.014; 
Figure 1). When sudden cardiac death (SCD) mortality was excluded from the analysis, 
there was no difference in outcomes between groups (p=0.186).
Conclusions: These observations suggest that more lives may be saved by CRT-D compared 
to CRT-P, primarily through the added reduction in SCD with defibrillator therapy. 
2:00 p.m.
1022-112 ICD Patients With Electrical Storm: Clinical 
Characteristics, Concomitants and Outcome in a Single 
Center
Torsten Becker, Thomas Kleemann, Margit Strauss, Klaus Doenges, Karlheinz Seidl, 
Heartcenter Ludwigshafen, Ludwigshafen, Germany
Background: In 10 to 30% of all ICD patients (Pts) the phenomenon of electrical storm 
(ES) occurs. This term denotes a temporal clustering of ventricular tachyarrhythmia with 
consecutive therapy by the ICD. Patients suffering ES are only poorly described.
Methods: Out of our prospective single center ICD registry, pts suffering ES were identified 
and anaylzed for clinical characteristics, concomitants, treatment and outcome as well as 
for differences in mortality in different patient subsets. Definition of ES : > 2 episodes 
of ventricular tachycardia/ fibrillation (VT/VF) within 24 hours, end of ES: freedom from 
arrhythmia for 14 consecutive days.
Results: Out of 1362 pts, 171 pts (13%) suffered 253 episodes of ES. Clinical 
characteristics, concomitants and treatment are outlined in Table 1
Table 1
Age at ICD implantation [y] 62 ± 11 ES episodes with secondary 
causes
43/253 
(17%)
Male gender 133 (78%) Pts with VT ES only 115 (67%)
Coronary artery disease 114 (67%) Pts with VT and/or VF ES 56 (33%)
Dilated cardiomyopathy 39 (23%) ES episodes with ATP only 70/253 (28%)
Pure electrical disease 8 (5%) ES episodes with shock 183/253 (72%)
EF < 40 % 134 (78%) Pts treated with betablocker 135 (79%)
ICD for secondary prevention 157 (92%) Pts treated with amiodarone 65 (38%)
Time ICD implantation to first 
ES [d]
940 ± 
1067 Pts treated with Class-I drug 43 (25%)
Time first ES to end of follow-
up [d] 933 ± 859
Pts treated with catheter 
ablation 24 (14%)
Of pts with ES, 66 (39%) died during follow-up. According to the presence or absence of a 
secondary cause for ES, or to the arrhythmia causative for ES (VT versus VF), cumulative 
survival did not differ significantly (p = 0.22 and 0.3 respectively).
Conclusions: 1. Mortality rate over a period of 2.6 years was 40% in ICD pts suffering ES 
2. Secondary causes were present in every sixth episode of ES 3. VT was the causative 
arrhythmia in most of the pts. However, the majority of ES therapies included ICD shocks 
4. According to the presence of a secondary cause, or the arrhythmia causative for ES 
there was no significant difference in survival
2:00 p.m.
1022-113 Contemporary Implantable Cardioverter Defibrillator 
Complications at a University Center
Andrea M. Russo, Ralph J. Verdino, Edward Gerstenfeld, Fermin Garcia, Rupa Bala, 
David Lin, Sanjay Dixit, Joshua Cooper, Matthew Hutchinson, David J. Callans, Michael 
Riley, Francis E. Marchlinski, University of Pennsylvania, Philadelphia, PA
Background: Previously published reports regarding implantable cardioverter defibrillator 
(ICD) complications demonstrate a variety of complications and limited mortality. Patients 
(pts) enrolled in clinical trials may represent select cohorts, and not necessarily a “real 
life” population.
Methods: Our center has a formalized EP Quality Assurance program where all pts are 
followed prospectively from implant to hospital discharge, and at least one outpatient 
follow-up visit. We summarize data from January 2000 to July 2006, which includes 1397 
consecutive pts undergoing ICD implantation. Procedures were performed by 11 full-time 
electrophysiologists at our teaching hospital where fellows are trained.
Results: A total of 67 acute or subacute complications were noted in 1397 consecutive ICD 
implants (4.8%), which include initial implants, generator replacements, and upgrades. 
Specific complications include infection, requiring device and lead explant (5 pts) or 
antibiotics alone (4 pts); pneumothorax (5 pts); hematoma >10 cm, requiring drainage (2 
pts) or observation (21 pts), 65% on anticoagulation; pericardial effusion with tamponade (3 
pts); lead perforation (1 pt) without tamponade; lead (RA, RV, CS) dislodgement requiring 
revision (15 pts); early insulation breaks requiring revision (2 pts); poor lead connection 
requiring revision (2 pts); pulmonary contusion (1 pt); SVC Syndrome (1 pt); and embolic 
CVA (2 pts), leading to death in 1 pt. There were additional 3 deaths (0.21%) related to 
the implantation procedure with pulseless electrical activity or incessant VT/VF, and 2 of 
these deaths occurred in pts who did not undergo defibrillation testing. Conclusions: (1) 
Overall acute and subacute ICD implantation complications occur in <5% of implants 
at a teaching hospital. (2) Complications are due to hematomas in 34% of cases, most 
of which did not require drainage, typically occurring in pts on anticoagulation. (3) The 
majority (51%) of complications are lead-related. Investigation is warranted to determine 
if complications can be reduced by modifying lead implantation techniques or technology 
and also optimizing strategies to minimize hematoma formation.
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2:00 p.m.
1022-114 Limited Relevance of Invasive Electrophysiologic 
Testing in Patients Meeting Current Primary Prevention 
Indications for an Implantable Cardioverter-Defibrillator
Alawi A. Alsheikh-Ali, Benjamin Kalsmith, N. A. Mark Estes, III, Mark S. Link, Tufts-New 
England Medical Center, Boston, MA
Background: The clinical relevance of invasive electrophysiologic study (EPS) in 
patients meeting current primary prevention indications for an ICD is uncertain. Using 
a prospectively maintained single center ICD registry, we examined the utility of EPS in 
predicting future ventricular tachyarrhythmias (VA) in a primary prevention population with 
CAD and low ejection fraction (EF).
Methods: ICD recepients with CAD and EF ≤ 35 % at our institution (1995-2005, excluding 
those with cardiac arrest, sustained VA, or syncope) were categorized as: EPS not done, 
EPS inducible, EPS non-inducible. Inducibility was defined as sustained monomorphic 
ventricular tachycardia (MVT) with ≤ 3 extrastimuli, or sustained polymorphic ventricular 
tachycardia or ventricular fibrillation with ≤ 2 extrastimuli. Future risk of VA for each group 
was estimated by the Kaplan-Meier method, and compared by the log-rank test.
Results: We identified 525 ICD recepients (age 67±11, male 81%, EF 23±7, EPS not 
done 55%, EPS inducible 22%, EPS non-inducible 23%). Risk of VA requiring ICD therapy 
did not differ by EPS category (Figure). Likewise, EPS category did not predict risk of ICD 
therapy for potentially life-threatening VA (cycle length ≤ 260 ms). Similar findings were 
obtained when inducibility was defined as only MVT with ≤ 3 extrastimuli.
Conclusion: EPS is of limited relevance to predicting VA in ICD recepients with CAD and 
EF ≤ 35 % meeting current primary prevention indications. Non-inducible patients remain 
at high risk of VA. 
2:00 p.m.
1022-115 No Difference in ICD Treated Ventricular Arrhythmias in 
Patients With Left Ventricular Ejection Fraction of 31-35 
% Compared to ≤ 30 %
Alawi A. Alsheikh-Ali, Kevin J. Makati, Benjamin Kalsmith, N. A. Mark Estes, III, Mark S. 
Link, Tufts-New England Medical Center, Boston, MA
BACKGROUND: Whether the rate of appropriate ICD therapy in routine practice differs in 
patients with left ventricular ejection fraction (LVEF) of 31-35% versus ≤ 30% is unknown, 
and remains a specified question of the Coverage with Evidence Development policy 
adopted by the Centers for Medicare and Medicaid Services. We addressed this question 
using a prospectively maintained single center ICD registry.
METHODS: We identified patients with LVEF ≤ 35 % who received an ICD for primary 
prevention (1995-2005), excluding patients who presented with cardiac arrest, sustained 
ventricular tachyarrhythmia (VA), or syncope. Patients were stratified by LVEF (≤ 30 % 
and 31-35 %) and rates of appropriate ICD therapy for VA were assessed by the Kaplan-
Meier method and compared by the log-rank test.
RESULTS: We identified 656 consecutive primary prevention ICD recepients with LVEF ≤ 
35 (79 % male, median age 66 years, median LVEF 23 %, 80 % with ischemic etiology), 
of which 153 (23 %) had appropriate ICD therapy over a mean follow-up of 2.1 years. 
Rates of appropriate ICD therapy were similar in the 2 LVEF groups (Figure, p = 0.91). 
Similar findings were obtained when only ICD therapy for rapid potentially life-threatening 
VA (cycle length ≤ 260 ms) was considered.
CONCLUSION: In a routine practice primary prevention population, rates of ICD therapy 
for VA, including potentially life-threatening VA, are similar in patients with LVEF 31-35 
% compared to ≤ 30 %. Patients with LVEF 31-35 % remain at risk for VA and should be 
offered an ICD. 
2:00 p.m.
1022-116 Microbiology as a Clinical Predictor of Mortality in 
Patients With Infected Cardiac Devices
Timir S. Baman, Sanjaya K. Gupta, Javier A. Valle, Elina Yamada, University of Michigan, 
Ann Arbor, MI
Background: Few studies have examined the impact of bacteremia and specific organisms 
on survival in patients with infected cardiac devices.
Methods: We conducted a retrospective chart review of all patients at the University of 
Michigan admitted with infected pacemakers and defibrillators between January 1997 and 
April 2007. Key clinical parameters at baseline were collected along with demographic, 
clinical, treatment and outcome data. Kaplan-Meier and Cox proportional hazards ratios 
were used to compare survival between the groups.
Results: A total of 210 patients met inclusion criteria for the study. During a six-month 
follow up period, death due to all-cause mortality occurred in 17% (n=36). Adjusting for 
age, sex, and treatment strategy, MRSA (HR 8.75, CI 3.3-23.0; p≤0.01), MRSE (HR 
8.73, CI 2.4-31.4; p≤0.01), and MSSA (HR 6.00, CI 1.9-19.1; p≤0.01) bacteremia were 
associated with increased mortality when compared to those with negative cultures. All 
other individual organisms, including MSSE and enterococcus, were not found to be 
statistically significant for increased mortality. With regards to wound cultures obtained 
from infected device pockets, only MRSA was associated with decreased survival (HR 
3.00, CI 1.2-7.6; p≤0.01).
Conclusion: In patients with infected cardiac devices certain organisms such as MRSA, 
MRSE, and MSSA bacteremia were found to correlate with increased mortality.
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8:00 a.m.
811-3 Real Time Monitoring of Tip Electrode-Tissue 
Orientation and Contact Force: Optimizing Accuracy 
and Safety of Mapping and Ablation Procedures
Luigi Di Biase, Mauricio Arruda, Luciana Armaganijan, Moataz El Hallage, Dimpi Patel, 
Mohamed Kanj, Oussama M. Wazni, Thomas Dresing, Jennifer E. Cummings, Mandeep 
Bhargava, J. David Burkhardt, David O. Martin, Walid I. Saliba, Robert A. Schweikert, 
Andrea Natale, Cleveland Clinic, Cleveland, OH
Background: The accuracy and safety of mapping and ablation procedures depend on tip 
electrode contact which can be improved by applying force against the tissue. Force sensors 
have been incorporated to ablation catheters showing a linear correlation between tissue 
contact force and RF lesion size. We assessed real time monitoring of these parameters.
Methods and Results: An “in vivo” closed chest canine model was used to assess 
electrode tip-tissue contact and to correlate real time applied force with EGMs amplitude 
and RF lesion size. The system (Endosense) consists of 1) a customized 7Fr, 3.5mm 
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open irrigation tip electrode incorporating optical sensors, 2) a workstation for continuous 
display of electrode tip-tissue interface force (axial and lateral) and tip orientation 
(variable degrees between perpendicular and parallel). A 3-D mapping system (NavX, 
St. Jude Medical) was used for atrial and ventricular geometry reconstruction. Continuous 
force feedback allows the operator to optimize force maintain adequate catheter tip-tissue 
interface contact. When blinded to the force display, the operator consistently applies higher 
forces in the ventricles (>30gr) compared to the atria (>20 gr). There were no significant 
atrial electrograms amplitude changes while applying 5-20 gr and no perforation occurred 
up to 50 gr in the atrium and 80 gr in the ventricle. Whereas a strong correlation between 
contact force and RF lesion size at smooth myocardium has been shown, this relationship 
was not confirmed at trabeculated ventricular sites where large lesions, associated with 
“pops” (80% ) were created despite low force (5gr) at 45W (15 ml/min irrigation). A non-
audible pop was detected by the force sensor and confirmed on gross and microscopic 
examination. Esophageal thermal injury occurred with 20gr pressure delivered at 35W for 
30 secs to the LA directly opposite to an esophageal probe.
Conclusions: This novel technology allows real time force and tip orientation monitoring. 
The sensor feedback optimizes electrode tip contact and may favorably impact the 
accuracy and safety of mapping and ablation procedures using conventional catheter 
manipulation and more importantly for remote navigation systems.
8:15 a.m.
811-4 Impedance Phase Angle Optimizes Electrode-Tissue 
Contact and Is Superior to Contact Force to Predict RF 
Lesion Formation and Tissue Popping: Improving Safety 
and Efficacy of Ablation Using Open Irrigation Catheters
Mauricio Arruda, Joe Marak, Hong Cao, Jeffrey M. Fish, Steve Miller, Saurav Paul, 
Luciana Armaganijan, Harry Puryear, Andrea Natale, Newark Beth Israel Medical Ctr, 
Newark, NJ, Cleveland Clinic, Cleveland, OH
Background: Irrigated RF catheter ablation (RFCA) is widely used clinically, but lack 
of temperature and contact force (CF) may compromise safety. We evaluated a novel 
impedance phase angle (IPA) method to assess contact and energy coupling (EC) to 
tissue during RFCA. We compared IPA to CF to predict lesion size and tissue popping 
during open irrigated RFCA.
Methods: 62 RFCA lesions were created on a swine thigh muscle preparation with 7 Fr 
4 mm catheters (irrigated @ 13 ml/min). Ablation settings were 20 or 30W; 30s; 0, 10 
or 20g CF; and parallel or perpendicular orientation. Pseudo trabeculations (PT) were 
created on the thigh muscle to fit the electrode. In addition, 63 lesions, on either smooth 
or trabeculated myocardium (TM), were created in canine arterially perfused ventricular 
wedge preparations to study tissue popping.
Results: In the thigh model, IPA correlated well with the lesion depth in smooth tissue (r = 
0.85) compared to CF (r = 0.61). IPA demonstrated significantly better prediction for lesion 
depth than CF in PT (r = 0.82 vs. 0.22). In the ventricular wedge preparation, lesions 
associated with an audible pop had a significantly greater IPA value compared those with 
no pop (14.2 ± 4.0 º vs. 9.6 ± 4.0 º, n = 33 pops, p < 0.001) Conversely, the mean CF 
values for lesions with pops vs. those without were 10.2 ± 9.4 g vs. 7.6 ± 9.0 g (p = NS).
Conclusions: IPA is superior to CF to predict RF lesion size and tissue popping, particularly 
in TM where EC is high and CF may be low. IPA may improve safety and efficacy of RFCA 
procedures.
8:30 a.m.
811-5 Prospective Comparison of the Septal Imaging 
Capabilities of Intracardiac Echocardiography with Trans-
Esophageal Echocardiography: The ICE-CHIP study
Sanjeev Saksena, Jasbir Sra, Luc Jordaens, Bradley Knight, Fred Kusumoto, Andrea 
Natale, Abraham Kocheril, Navin Nanda, Mary A. Viggiano, Mary Chandler, ICE-CHIP 
Investigator Study Group, Electrophysiology Research Foundation, Warren, NJ
Background: Patients with atrial fibrillation (AF) have a propensity for thromboembolic 
events & anatomic defects in the inter-atrial septum (IAS) can lead to paradoxical 
embolism. Transesophageal echocardiography (TEE) is used to diagnose abnormal 
IAS anatomy and physiology. Intracardiac echocardiography (ICE) imaging has been 
recently used to image the IAS during interventional procedures. However, a prospective 
comparison of these two techniques for IAS imaging in a multicenter clinical trial has not 
been performed.
Methods: The Intracardiac Echocardiography guided Cardioversion Helps Interventional 
Procedures (ICE-CHIP) study is a prospective open label multi-center investigation that 
evaluated the efficacy of ICE as compared to TEE for cardioovascular imaging in patients 
with atrial fibrillation. Patients were imaged by TEE and ICE and a blinded comparison of 
the two imaging modalities was performed at a core laboratory. 100 pts were enrolled in 
6 European and US centers. IAS image quality by each method was classified as good 
or satisfactory, unsatisfactory, or not profiled. Analysis of the IAS anatomy/physiology 
included detection of patent foramen ovale (PFO), IAS defects or aneurysms.
Results: 95 AF patients, mean age was 58 ± 12 yrs completed the study. ICE images 
were classified as good/satisfactory for 91% of patients as compared to 97% for TEE. 
(p=ns) The concordance for the image quality between ICE and TEE was 90%. In paired 
comparisons, ICE & TEE were concordant in PFO detection but a PFO was detected in 5 
additional pts by TEE in whom a completed ICE evaluation was unavailable. ICE detected 
IAS aneurysms more frequently (15 pts) as compared to TEE (9 pts). The concordance 
for the detection of IAS aneurysms between ICE and TEE was 96%. No IAS defects were 
detected by either method in this population.
Conclusions: There is a high degree of equivalence between TEE and ICE when employed 
for IAS imaging. This study supports the use of ICE in interventional procedures involving 
the IAS and could obviate the need for esophageal cannulation & TEE.
8:45 a.m.
811-6 Reversibility of connexin43 downregulation only after 
24 hours of hypoxia and reoxygenation in atrial cardiac 
cells: reversibility of an arrhytmogenic substrate for 
atrial fibrillation
Anna Severino, Maria L. Narducci, Stefano Toldo, Michela Casella, Antonio Dello 
Russo, Gemma Pelargonio, Giovanna Liuzzo, Eliano P. Navarese, Alfonso Baldi, Luigi 
M. Biasucci, Claudio Tondo, Filippo Crea, Institute of Cardiology,Catholic University of 
Sacred Heart, Rome, Italy
Background: In chronic atrial fibrillation (AF) and severe heart failure, downregulation of 
connexins Cx43 and up-regulation of Cx40 have been observed in left atrium. We tested 
different possible triggers (hypoxia, inflammation, vagal and adrenergic stimulation) of this 
gap junctional remodeling in atrial cardiomyocyte cell line (HL-1) and reversibility of this 
process after reoxygenation.
Methods: HL-1 cells, differentiated atrial cardiomyocytes, were exposed to hypoxia (3% 
O2) for 24 and 48 hours and to early hypoxia (2-4-6-16-20 hours). Western blot analysis 
using anti-Cx43 and anti-Cx40 polyclonal antibodies (Santa Cruz,CA) was performed. We 
used total RNA of hypoxia treated HL-1cells to analyze, by qRT-PCR, Cx43 expression. 
Cx43 levels were also evaluated during 24 and 48 hours of hypoxia followed by 
reoxigenation (8-24-30-48 hours) and after exposition to C-reactive Protein (CRP: 1-5-10-
20-50 µg/ml), to Angiotensin II (Ang II: 1, 2.5, 5 µM), IL-6 (1, 10, 100 ng/ml), TNF-alpha (1, 
5, 10 ng/ml), Acetylcholine and Epinephrine (1, 10, 100 µM), for 24 and 48 hours.
Results: After 24 and 48 hours of hypoxia, total Cx43 was decreased respectively by 75% and 
90% (p <0.001).The changes in Cx43 protein levels were associated with 40% decreased 
mRNA levels after 24 and 48 hours of hypoxia (p= 0.007). Cx43 expression during CRP, 
IL-6, Ang II, TNF-alpha treatment for 24 and 48 hours was unaltered as during vagal and 
adrenergic stimulation. Hypoxia, inflammation, vagal and adrenergic stimulation did not 
significantly change the expression of Cx40. After 24 hours of hypoxia, total Cx 43 protein 
levels increased gradually during reoxygenation to reach the basal level within 48 hours. 
Instead, after 48 hours of hypoxia, Cx43 protein remained at low level during reoxygenation.
Conclusions: Cx43 protein was markedly decreased by hypoxia stress in atrial 
cardiomyocytes. This protein downregulation is reversible by reoxygenation after 24 hours 
but not after 48 hours of hypoxia. These alterations might contribute to the generation of 
an arrhytmogenic substrate observed in left atrium of patients with severe heart failure 
and atrial fibrillation.
9:00 a.m.
811-7 Who Suffers Sudden Cardiac Arrest as the First 
Manifestation of Heart Disease? A Population-based 
Comparison of Cardiac Arrest With and Without Prior 
Coronary Events
Tejwant Singh, Kydaron Reinier, Audrey Uy-Evanado, Ronald Mariani, Karen Gunson, 
Jonathan Jui, Sumeet S. Chugh, Oregon Health and Science University, Portland, OR
Background: The vast majority of sudden cardiac arrests (SCA) are related to coronary 
disease. Identification of risk predictors is likely to be most challenging in those who 
present without prior warning. We sought to identify distinguishing characteristics of SCA 
patients with no history of prior coronary events.
Methods: In the ongoing Oregon Sudden Unexpected Death Study, all cases of SCA 
in Multnomah County, Oregon (population 677,813; 2002 to 2006) were prospectively 
ascertained. All preceding coronary events were retrospectively assessed. Of a total of 
1615 SCD cases aged ≥18 years, detailed medical records were available on 1119 cases. 
Comparisons were made between 3 groups: cases with no prior history of coronary 
events, cases with remote (>2 years) and recent (≤2 years) prior coronary events.
Results: The majority of SCA patients had no prior coronary event (795/1119; 71%), with 
SCA as the first clinical manifestation of heart disease. Subjects with a prior coronary 
event (324/1119; 29%) had their event a mean 5.6 years prior to SCA. Cases with no 
prior coronary event were less likely than patients with a remote or recent event to have 
diabetes (30% vs. 41% vs. 46%; p=0.0001), and were younger (65 vs. 71 vs. 73 yrs, 
p<0.0001). Cases with no prior event also had a higher percentage of normal ejection 
fraction (54% vs. 32% vs. 23%; p<0.0001). There were no significant differences in the 
remote vs. recent coronary event groups.
Conclusions: SCA without prior coronary event may be more common than previously 
recognized and were distinguishable by younger age, less diabetes and significantly 
higher likelihood of normal left ventricular systolic function. Risk stratification for this 
subgroup may involve the identification of novel risk predictors.
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9:15 a.m.
811-8 Variability in Risk with Different Hot-spot Mutations 
Involving the LQT1-KCNQ1 Gene
Christian Jons, Arthur J. Moss, Scott McNitt, Wojciech Zareba, Jennifer L. Robinson, 
Ming Qi, International Long QT Syndrome Investigative Group, The Heart Research 
Follow-up Program, University of Rochester Medical Center, Rochester, NY
Background: This study focuses on the risk associated with the individual missense 
mutations located in hotspot areas of the LQT-1 KCNQ1 gene.
Methods: Using the International LQTS registry we identified 528 subjects with known 
missense mutations in the KCNQ1 gene. We defined a KCNQ1 hotspot location when 
a specific missense mutation involved ten or more individuals in the database. Cox 
proportional regression analysis was used to evaluate time dependent hazard ratios.
Results: We identified 15 hotspot mutations: 2 mutations (V254M, A341V) were associated 
with a similar high risk for cardiac events (hazard ratio = 3.47, p < 0.001) and cardiac 
death (hazard ratio = 4.44, p = 0.026); 2 mutations (G345R, S349W) were associated 
with a more moderate increased risk of cardiac events (hazard ratio = 2.01, p < 0.027) but 
not an increased risk of cardiac death (hazard ratio = 1.20, p = 0.15) when compared to 
the 11 low risk hotspots (figure). 
This risk was independent of QTc, gender and beta-blocker therapy. The risk of the 
genotype was independent of the location in the channel, with several low-risk missense 
mutations located only few base-pairs away from the high-risk mutations. Beta-blockers 
significantly reduced the risk in all three groups.
Conclusions: This genotype study indicates that in LQT1, the risks associated with 
individual mutations are quite variable and are independent of traditional risk factors such 
as gender, QTc and use of beta-blockers.
ACC.POSTER CONTRIBUTIONS
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10:00 a.m.
1029-89 Implantable Cardioverter-Defibrillator Outcomes in 
Cocaine Abusers
Farhat Mehmood, Lisa Schmidt, Shahid Qamar, Atul Bhatia, Ryan Cooley, Vikram 
Nangia, M. Eyman Mortada, Aurora Sinai/Aurora St. Luke’s Med Ctrs, Univ Wisconsin 
School of Med and Public Health-MCC, Milwaukee, WI
Background: The ACC/AHA guidelines for sudden cardiac death (SCD) prevention in 
cocaine abusers using implantable cardioverter-defibrillator (ICD) are not clear. We tested 
the hypothesis that the increased complications in cocaine abusers associated with ICD 
placement outweigh the benefit.
Method: A retrospective analysis was performed on 36 patients who received ICD for 
prevention of SCD. They were divided into 2 matched groups: Group A with a history of cocaine 
abuse (n=18; mean age 48.8±7.1 years) and Group B with no known history of cocaine abuse 
(n=18; same mean age). We compared defibrillator threshold (DFT), ICD pocket-related 
complications (infection or bleed), ICD shocks, use of antiarrhythmic medication, compliance, 
hospital readmissions and associated costs, cardiac and all-cause mortality.
Results: Per ACC/AHA guidelines, in Group B, ICDs were implanted after maximizing 
medical therapy for 3 to 9 months (0.9±1.2 years). In Group A, ICD implant was delayed in 
order to substantiate freedom from cocaine abuse over a period of 2±1.6 years (p=0.03). 
There were no statistical differences in baseline characteristics between the two groups 
with the exception of a higher number of alcoholics (88.9% vs. 22%, p=0.001) and the 
presence of more non-ischemic cardiomyopathy (88.9% vs. 50%, p=<0.03) in Group A. In 
line with earlier findings, the DFT at the time of implantation was higher in Group A than 
Group B (24.3±5.9 joules vs. 19.3±4 joules, p=0.01). At a mean follow-up of 1.6±1.2 years 
in Group A and 2.3±1.6 years in Group B, the following were found to be worse in Group 
A: ICD shocks (50% vs. 5.6%, p=0.01), poor compliance (66.7% vs. 5.6%, p=<0.001) 
and total healthcare readmission costs (Group A, $768,247 for 19 readmissions; Group 
B, $35,259 for 2 readmissions). There was one cardiac-related mortality (SCD) in Group 
A and none in Group B.
Conclusions: 1) ICD implantation in cocaine abusers is associated with a higher 
number of dysrhythmic episodes and ICD shocks. 2) Cocaine abusers have a higher 
rate of complications and related hospital readmissions resulting in substantially higher 
healthcare costs.
10:00 a.m.
1029-90 Implantable Cardiac Defibrillator for Sudden Cardiac 
Death Prophylaxis Therapy Rates After Primary 
Percutaneous Coronary Intervention
Brian Lindsay, Timothy D. Henry, William T. Katsiyiannis, Chuen Y. Tang, Charles C. 
Gornick, Adrian K. Almquist, Daniel P. Melby, Minneapolis Heart Institute Foundation at 
Abbott Northwestern Hospital, Minneapolis, MN
Background: Currently there is no data on the percentage of patients who have an 
indication for Implantable Cardiac Defibrillator (ICD) therapy following ST-segment 
myocardial infarction (STEMI). Primary percutaneous coronary intervention (PCI) is 
the preferred method of treatment for STEMI with reduced rates of death and recurrent 
ischemia compared to other treatment modalities. The purpose of this study is to 
determine the prevalence of class I indications for prophylactic ICD therapy in a large 
cohort of STEMI patients treated with primary PCI at a tertiary cardiac catheterization 
center.
Methods: The Minneapolis Heart Institute Level 1 MI Program represents a dedicated 
STEMI recognition and transfer system for primary PCI treatment at a tertiary hospital. 
Primary PCI was available to patients presenting up to 210 miles away. All patients 
underwent LVEF assessment during the index hospitalization, and again within 6 months 
if the initial LVEF was <50%. Patient data from this program were analyzed including 
baseline characteristics, infarct location, revascularization, post infarct LVEF and 
indication for ICD therapy.
Results: A total of 1132 patients underwent primary PCI for acute STEMI. During the 
index hospitalization, 235 (20.8%) patients were identified as having an LVEF less than 
or equal to 35%. At mean 2.5 year follow-up, only 53 (4.7%) patients had persistent LV 
dysfunction as an indication for primary ICD therapy. Of those with a primary prevention 
indication, 23 (2.0%) underwent implantation, 30 (2.7%) did not due to patient therapy 
refusal, contraindications, loss of follow-up, and other reasons. A total of 21 patients 
(1.9%) underwent ICD implantation for secondary prevention indications.
Conclusions: This data represents the only modern study on the rate of ICD indication in 
patients post-STEMI. In this large cohort we found a low rate of persistent LV dysfunction 
and need for prophylactic ICD therapy following primary PCI for STEMI. The majority of 
patients with a low initial EF during index hospitalization for primary PCI treatment recover 
significant LV function with only 6.5% of patients ultimately demonstrating a primary or 
secondary indication for ICD post-primary PCI.
10:00 a.m.
1029-91 Prediction of Recurrent Implantable-Cardioverter 
Discharges
John N. Catanzaro, Amgad N. Makaryus, Christina Sison, Ram L. Jadonath, North 
Shore University Hospital, Manhasset, NY
Background: Predictors of appropriate implantable cardioverter-defibrillator (ICD) 
discharge have been described in the literature. Changes in cardiac structure and 
electrophysiology after ICD implantation can lead to recurrent discharge. In the era of 
more aggressive follow up and pharmacotherapy, we sought to examine predictors of 
recurrent ICD discharge.
Methods: Recurrent discharge was defined as any occurrence of a discharge (appropriate 
or inappropriate) after the first discharge. There were 53 patients experiencing a recurrent 
discharge identified from a group of 591 patients (474 males; mean age 67.9±13 years 
; mean follow-up 10.9±13.8 months [0-120 mo]) who were receiving medical therapy 
including beta blockers, ace-inhibitors, and antiarrhythmics. Clinical predictors (age, 
gender, hypertension, diabetes, syncope, atrial fibrillation (AF)), and medications were 
analyzed to determine association with recurrent ICD discharge.
Results: Risk factors individually associated with any recurrent discharge included: atrial 
fibrillation (p<0.001), age <65 (p=0.049), and any valve repair (p=0.015) Subjects who 
had a history of AF were 1.8 times more likely to have a recurrent discharge. A logistic 
regression utilizing a backward elimination algorithm yielded age<65 (p=0.015) and any 
valve repair (p=0.003) as being associated with recurrent discharge. Subjects who had 
any valve repair were 3.5 times more likely to have a recurrent discharge. Subjects who 
are less than 65 years of age were 2.5 times more likely to have a recurrent discharges.
Conclusion: The main factors associated with recurrent ICD discharge are: age <65 years 
and any valve repair. These patient subgroups may require more aggressive therapy 
with anti-arrhythmic drugs and ICD programming to prevent recurrent discharge and to 
maximize necessary therapy for the avoidance of sudden cardiac death.
10:00 a.m.
1029-92 Intraventricular Conduction Delays on a 12-Lead ECG 
Is Associated With Significantly Higher Arrhythmic 
Events Than Bundle Branch Block in Patients With an 
Implanted Cardioverter-Defibrillator
Waddah Maskoun, Hussam Suradi, Jo Mahenthiran, Mithilesh K. Das, Indiana 
University, Indianpolis, IN
Background: Wide QRS (wQRS, QRS > 120ms) on a 12-lead ECG with or without typical 
bundle branch block (BBB) is associated with increased arrhythmic events (AE) in patients 
(pts) with an ICD. wQRS occurs due to BBB or intraventricular conduction delays (IVCD). 
We postulate that IVCD, which most likely represents myocardial disease, is associated 
with a significantly higher risk for AE than BBB, which is primarily due to conduction 
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system disease and may or may not be associated with significant myocardial scar.
Methods: ECGs and AE (appropriate ICD shock & antitachycardia therapy) in 352 ICD pts 
were studied. BBB group included right and left BBB. IVCD group included pts with QRS 
> 120 ms who did not meet the standard criteria for a BBB.
Results: 158 pts had wQRS (age: 66 + 11 years, male: 91%, ischemic cardiomyopathy: 
72%, primary prevention indications: 57%, mean follow-up: 12 + 9 months) and 36% of 
the pts (n = 57) had BBB (LBBB: 72%). Age and EF did not differ between the IVCD and 
BBB groups. 41 (23%) pts had AE. The IVCD group had significantly higher AE than 
the BBB group (35% vs. 9.7%, p<0.001). Cox Regression analysis revealed that IVCD 
was the only univariate predictor of AE (p = 0.003, RR: 1.9, 95% CI [1.3-2.7]); age, EF, 
CHF class, or secondary prophylaxis indication did not predict AE. Kaplan Meier survival 
analysis revealed a significantly decreased AE-free survival in the IVCD group vs. BBB 
group (p = 0.012).
Conclusion: IVCD on a 12-lead ECG is a significant independent predictor of AE as 
compared to BBB in ICD pts with a wQRS.
10:00 a.m.
1029-93 Clinical Predictors of Increased Mortality in Patients 
With Infected Cardiac Devices
Timir S. Baman, Sanjaya K. Gupta, Javier A. Valle, Elina Yamada, University of Michigan, 
Ann Arbor, MI
Background: The utility of clinical parameters as a predictive tool for mortality in patients 
with infected cardiac devices is unknown.
Methods: We conducted a retrospective chart review of patients at the University of 
Michigan admitted with infected pacemakers and defibrillators between January 1997 and 
April 2007. Key clinical parameters at baseline were collected along with demographic, 
clinical, and outcomes data.
Results: 210 patients met inclusion criteria for the study. During a six-month follow up 
period, death due to all-cause mortality occurred in 17% (n=36). Adjusting for age, 
gender, and treatment we identified the following clinical parameters to be associated with 
increased mortality: acute renal failure (HR 20.2, p≤0.01), pulmonary abscess (HR 7.7, 
p≤0.01), systemic embolization (HR 7.2, p≤0.01), bacteremia (HR 7.1, p≤0.01), end stage 
renal disease (HR 6.5, p≤0.01), evidence of lead infection (HR 5.5, p≤0.01), ischemic 
heart disease (HR 2.4, p=0.03), recent or present line (HR 5.3, p≤0.01), and peak serum 
creatinine (HR 1.5, p≤0.01). A final Cox proportional hazards model that simultaneously 
included all clinical parameters found bacteremia (HR 6.7, p≤0.01), age (HR 1.8, p≤0.01), 
and peak serum creatinine (HR 1.4, p≤0.01) to be independent predictors of mortality.
Conclusion: Bacteremia, age, and creatinine were found to be more strongly correlated 
with mortality when compared to all other clinical parameters in patients with infected 
cardiac devices. 
Confidence Interval
Final Model Variables Number of Cases p-value
Adjusted 
Hazard 
Ratio
Lower Higher
Bacteremia 210 ≤0.01 6.67 2.52 17.65
Age in deciles 210 ≤0.01 1.77 1.36 2.29
Peak serum creatinine 208 ≤0.01 1.41 1.24 1.62
10:00 a.m.
1029-94 Failure of a Small Diameter High Voltage Implantable 
Cardioverter Defibrillator Lead is Associated with 
Patient Age and Left Ventricular Function
Richard T. Birkett, Robert G. Hauser, Linda M. Kallinen, Adrian K. Almquist, Charles C. 
Gornick, William T. Katsiyiannis, Minneapolis Heart Institute Foundation, Minneapolis, MN
Background: We and others have reported unexpected failure of Sprint Fidelis model 
6949 (Medtronic, Inc.) high voltage implantable cardioverter defibrillator leads (HVL). The 
aim of this study was to identify clinical variables that are associated with Sprint Fidelis 
HVL failure.
Methods: The records of all patients implanted with the Sprint Fidelis model 6949 
HVL at our center were reviewed. All HVL were implanted by 5 board certified/eligible 
electrophysiologists who had performed at least 70 HVL implants during the prior year. 
Venous access was achieved by cephalic cutdown or micropunture of the extrathoracic 
subclavian or axillary vein. HVL were positioned in the right ventricular apex (RVA), or 
high (HS), mid (MS), or low (LS) septum. Left venticular ejection fraction (LVEF) was 
measured by echocardiography or left ventriculography.
Results: Between September 2004 and February 2007 583 Sprint Fidelis HVL were 
implanted for approved indications. Of these, 501 Sprint Fidelis HVL have been followed 
at our center and constitute the study population. Fifteen of these HVL (3%;15/501) have 
failed from 4 to 33 months after implant (avg 19.1+/-8.1). HVL failure was heralded by 
inappropriate shocks (n= 7), failure to capture (n= 2), or were detected by noninvasive 
impedance or short interval counter measurements (n= 6). Causes of failure were low 
(n=13 ) or high (n=1 ) voltage conductor fracture, and fixation mechanism failure (n=1 ). 
The average age of patients whose lead failed was 55.3+/-22.8 vs 66.1+/-14.0 for patients 
whose leads were functioning normally; by logistic regression age was inversely associated 
with failure (p=0.006). After age adjustment patients with normal LVEF (>55%) were 5 times 
more likely to experience HVL failure than those with LVEF<30% (p=0.02). Neither gender 
or lead location (RVA, HS, MS, LS) were significantly associated with HVL failure (p>0.3).
Conclusions: Our results suggest that Sprint Fidelis model 6949 HVL failures are more 
common in younger patients and those who have normal left ventricular function. These 
observations may have important implications for selecting high voltage leads for 
implantation and for managing patients who have Sprint Fidelis HVL.
10:00 a.m.
1029-94A A Prospective Randomized Comparison of Defibrillation 
Thresholds From the Right Ventricular Apex and 
Outflow Tract
Michael R. Gold, Robert B. Leman, J. Marcus Wharton, John F. Quigley, J. Lacy 
Sturdivant, Medical University of South Carolina, Charleston, SC, Medtronic, Inc., 
Minneapolis, MN
Background: Transvenous implantable defibrillator (ICD) leads are traditionally placed 
in the right ventricular apex (RVA) for stability and because this is felt to minimize 
defibrillation thresholds (DFTs). However, the right ventricular outflow tract (RVOT) is 
preferred for pacing or hemodynamic monitoring. The effect of RV lead location on DFTs 
is not well studied.
Methods: This was a prospective, randomized, crossover study of RVA versus RVOT DFTs in 
33 patients (pts) undergoing left pectoral ICD implantation for standard indications. An active 
fixation, dual coil lead was used with an RVΑSVC+Can shocking pathway. A binary search 
algorithm was used to measure DFT, with initial lead position tested in randomized order.
Results: The pt population had a mean age of 59±12 years and 76% were male. The 
mean ejection fraction was 33±14% and 61% had coronary artery disease. There was 
no significant difference in DFT between apical (9.8±7.3 J) or RVOT (10.8±7.2 J) lead 
positions (p=0.51; Wilcoxon’s Matched-Pairs Signed-Ranks Test). The DFT was ≤ 24 
J in 97% of pts in both the RVA and RVOT configurations. Shock impedances were 
significantly higher in the RVA than RVOT (43.4±5.0 Ω vs 40.8±5.3 Ω, p < .0005).
Conclusions: ICD lead implantation in the RVOT does not increase DFTs compared with 
RVA lead placement. An adequate safety margin for defibrillation was observed in 97% 
of pts. RVOT placement should be considered when frequent pacing or hemodynamic 
monitoring is anticipated. 
10:00 a.m.
1029-97 Type 2 Diabetes mellitus is strongly associated with 
third degree AV-block
Mohammad-Reza Movahed, Mehrtash Hashemzadeh, Mazen Jamal, University of Arizona 
Sarver Heart Center and Southern Arizona VA Health Care System, Tucson, AZ, and Long 
Beach Veteran Administration Medical Center, Long Beach, CA, Long Beach, CA
Background: Diabetes (DM) is a risk factor of cardiovascular disease. Recent data 
suggests association between DM and third degree AV- Block. The goal of this study was 
to evaluate independent association between diabetes and third degree AV-bBlock using 
a very large data base.
Method: We used ICD-9 Codes for DM (codes for 250s), and third degree AV-block 
(426.0) and co-morbid conditions from the Nationwide Inpatient Sample (NIS) database. 
We randomly selected 1992 and 2002 databases which are 10 years apart as two 
independent samples. NIS involves approximate a 20-percent sample of U.S. community 
hospitals and other specialty hospitals. We used uni- and multi- variate analysis to 
evaluate any association between DM and Third degree AV- block adjusting for co-morbid 
conditions.
Results: 1992 database contained a total of 6,195,744 patients. Diabetes occurred in 
(0.5%) of patients with third degree AV-block vs. (0.2%) of the control (OR: 2.15, CI 
2.06-2.25, p<0.0001). 2002 database contained a total of 7,853,982 patients. Diabetes 
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occurred in (0.4%) of patients with third degree AV-block vs. (0.2%) of the control (OR: 
1.86, CI: 1.80-1.93, p<0.0001). Using Multivariate analysis adjusting for age, congestive 
heart failure and coronary artery disease, DM remained independently associated with 
third degree AV block in both database. (for 1999: OR: 2.54, CI 2.51-2.57, p<0.0001 and 
for 2002 OR: 1.56, CI 1.55-1.57, p<0.0001)
Conclusion: DM is independently associated with third degree AV-block with persistent 
association over a period of 10 years. The cause of this association is not known 
warranting further investigation.
10:00 a.m.
1029-98 The Prognostic Significance of QT Interval Prolongation 
in a Clinical Population of Male Veterans
Amir Kaykha, Kenneth B. Desser, Nathan Laufer, Robert Halligan, Ashish Pershad, Sina 
Nafisi, Jonathan Myers, Victor F. Froelicher, Banner Good Samaritan Medical Center, 
Phoenix, AZ, VA Palo Alto Health Care System, Stanford University, Palo Alto, CA
Background: Although QT prolongation has been associated with sudden death and 
increased mortality in selected populations of patients, its prognostic power in a large 
clinical population is unclear.
Methods: Computerized ECGs obtained on 42,301 male veterans were evaluated. Subjects 
with pacing, WPW, QRS>120 milliseconds (ms) and atrial fibrillation were excluded, 
leaving 37,279 patients for analysis. Using computerized algorithms, QT duration was 
analyzed and corrected QT interval (QTc) was measured according to Bazett’s formula. 
ECGs were over-read by cardiologists. All-cause (AC) and cardiovascular (CV) deaths 
were used as outcomes.
Results: During a mean follow-up of 6 years, there were 2,957 CV and 8,511 AC deaths. 
After adjusting for age (with and without adjustment for heart rate) in a Cox model, QTc 
was a strong predictor of both endpoints [CV death: HR 1.5, p<0.001; AC death: HR 1.4, 
p<0.001; for a QTc >450 ms], outperforming many established ECG predictors of death. 
For every 10 ms increase in QTc (above 400 ms), there was a 10% increase in CV death 
and 7% increase in AC death. Survival curves showed significant separation according 
to a QTc score (defined as QTc≤400=1, 401-450=2, 451-500=3, >500 ms=4). Subgroup 
analyses among inpatients and outpatients as well as patients with normal and abnormal 
ECG groups showed similar results.
Conclusions: QTc prolongation is a strong predictor of CV and AC mortality in a male 
clinical population and should be considered as part of clinical risk stratification. 
10:00 a.m.
1029-99 Acute Sleep Deprivation Is Associated With Prolonged 
Electrocardiographic P-wave and QT Dispersion in 
Healthy Young Adults
Ibrahim SARI, Vedat DAVUTOGLU, Burcu OZBALA, Orhan OZER, Murat SUCU, Serdar 
SOYDINC, Yasemin BALTACI, Sema YAVUZ, Mehmet AKSOY, Gaziantep University 
School of Medicine Cardiology Department, Gaziantep, Turkey, Gaziantep University 
School of Medicine Physiology Department, Gaziantep, Turkey
Background: Sleep deprivation (SD) is associated with increased incidence of adverse 
cardiovascular and metabolic disorders in humans, including mortality. We hypothesized 
that there might be an association between acute SD and electrocardiographic maximum 
P-wave duration (Pmax), P-wave dispersion (Pd), maximum QT interval (QTmax), QT 
and corrected QT dispersion (QTd/cQTd) in otherwise healthy young adults which are 
known as predictors of atrial fibrillation, ventricular arrhythmias and sudden death.
Methods: 37 mentally and physically healthy volunteers were included into the study (age: 
28,45±7,97; 11 women). First, we obtained electrocardiographies of the participants after 
a night in which they reported having regular sleep and repeated electrocardiographies 
after a night with sleep debt. We measured, minimum P-wave duration (Pmin), Pmax, Pd, 
minimum QT interval (QTmin), QTmax, QTd and cQTd in milliseconds.
Results: Average sleep time of the subjects were 7.7 ± 0.8 hours after a regular sleep 
and 1.7 ± 1.6 hours after a night of sleep debt (p<0.001). Subjects had significantly lower 
values of Pmin in milliseconds after a night of sleep debt when compared after regular 
sleep (65.13 ± 8.03 vs 74.86 ± 10.95; p<0.001), whereas had significantly higher values 
of Pmax and Pd (102.16 ± 9.46 vs 95.13 ± 11.21; p<0.001 and 37.02 ± 8.11 vs 20.27 ± 
11.42; p<0.001 respectively). Subjects had similar values of QTmin in milliseconds after a 
night of sleep debt when compared after regular sleep (347.56 ± 29.75 vs 344.59 ± 20.89; 
p=0.51), whereas had significantly higher values of QTmax, QTd and cQTd (396.48 ± 
30.11 vs 378.10 ± 23.90; p=0.001, 49.45 ± 9.11 vs 33.51 ± 10.05; p<0.001 and 54.92 ± 
10.42 vs 37.23 ± 10.81; p<0.001 respectively). In Pearson’s correlation analysis which 
was performed between sleep time and Pmin, Pmax, Pd, QTmin, QTmax, QTd and cQTd; 
only Pd was inversely correlated with sleep time (p=0.04, r=-0.332).
Conclusions: In conclusion, prolongation of Pmax, Pd, QTmax, QTd and cQTd in acute 
SD in this crossover study suggest that these electrocardiographic parameters may play 
role in negative effects of SD on cardiovascular system.
10:00 a.m.
1029-100 Sudden Death, the Anniversary Effect
Ivan Mendoza, Juan A. Marques, Federico Moleiro, Ivan Mendoza-Britto, Central 
Universisty of Venezuela, Caracas, Venezuela, Albert Einstein Hospital, Philadelphia, PA
Background: Sudden death (SD) is one of the major problems of public health and 
responsible for nearly half of all cardiac deaths. A better understanding of the trigger 
mechanism will have an important preventive impact. Recently psychologic and chrono-
biologic factors have been described as potential triggers of lethal arrhythmias. Anniversary 
of death has been mentioned as sudden death triggers, but has been poorly evaluated. 
The objective was to evaluate the impact of some family member death anniversary as a 
trigger of SD in an adult population.
Methods: A consecutive series of 102 documented sudden death cases with ages 
between 37 and 79 were evaluated. Life circumstances that preceded the final event 
were investigated.
Results: In 69 (68%) the underlying disease was coronary artery disease. In 13 cases 
(12,7%) SD occurs on the anniversary date of the traumatic event of death of their 
parents, 7 (53,8%) the anniversary of father´s death and 5 (38.5%) the anniversary of 
mother´s death and 1 (7,7%) the anniversary of death of mother and father who died on 
the same date . In our series no death is related with, any other close family member. 10 
of 13 (77 %) were male. 4 of 13 (30,8%) have a similar age of the family member who 
died previously
Conclusions: Anniversary of death of a close family member, especially mother and/or 
father is an important trigger of SD, predominantly in males. Age of SD cases is similar to 
the family member who died previously in one third of the cases.
10:00 a.m.
1029-101 High Throughput Screening of Drug-Induced 
QT Prolongation in Small Animals by Micro-
Magnetocardiography System With Superconducting 
Quantum Interference Device: Comparison With 
Electrocardiography
Kazuo Komamura, Yoshiaki Adachi, Jun Kawai, Masakazu Miyamoto, Masashi Inagaki, 
Masaru Sugimachi, Gen Uehara, National Cardiovascular Center, Suita, Japan, 
Kanazawa Institute of Technology, Kanazawa, Japan
Background: Drug-induced QT prolongation is a critical problem for drug development 
process. The guideline of International Conference on Harmonization requires evaluating 
pre-clinical potential hazards of drug-induced QT prolongation. We have developed a 
micro- magnetocardiography (MCG) system for small animals comprised of ultrafine 
magnetometer array of superconducting quantum interference device (SQUID) on a 
single silicon chip of 10mm square. MCG does not need electrodes for measurement of 
electric currents in the heart. We compared QT intervals in MCG with those in ECG.
Methods: Ten male Hartley guinea pigs (250g) were anesthetized with pentobarbital. 
Platinum needle electrodes were attached to animals. Excessive quinidine (60mg/kg) was 
administered intraperitoneally. MCG and ECG were recorded simultaneously at baseline, 
3, 5, 7, 10, 15 min after injection. QT interval was automatically analyzed by PowerLab 
and QTc was calculated by Bazett formula.
Results: QTc was prolonged from 284±10 to 299±11msec in ECG (QTc-ECG)(p<0.01). 
QTc was prolonged from 280±16msec to 295±10msec in MCG (QTc-MCG)(p<0.01). 
QTc-MCG correlated well with QTc-ECG at baseline (r2=0.944, p<0.0001) and at 15min 
after injection (r2=0.780, p=0.0007).
Conclusions: Micro-MCG successfully measured drug-induced QT prolongation with a 
close correlation with ECG in guinea pig. Non-contact characteristics of MCG may enable 
high throughput screening test of drug-induced QT prolongation. 
10:00 a.m.
1029-102 The Prognostic Significance of Left Axis Deviation in 
Patients with Left Bundle Branch Block
Amir Kaykha, Kenneth B. Desser, Mansour Assar, Timothy J. Byrne, Akil I. Loli, Richard 
Gerkin, Robert Halligan, Sina Nafisi, Jonathan Myers, Victor F. Froelicher, Banner Good 
Samaritan Medical Center, Phoenix, AZ, VA Palo Alto Health Care System, Stanford 
University, Palo Alto, CA
Background: Although QRS prolongation has been reported to be a significant predictor 
of mortality in patients with left bundle branch block (LBBB), the prognostic value of QRS 
axis deviation in patients with LBBB in a large general medical population has not been 
reported.
Methods: Analyses were performed on the first ECG digitally recorded among 42,301 
male veterans since 1987. Subgroup analysis was performed on those with LBBB, 
and patients were stratified according to QRS axis [normal axis and left axis deviation 
(LAD)] and QRS duration [above and below 150 milliseconds (ms)]. Cardiovascular (CV) 
mortality was the main outcome with a mean follow-up of 6 years.
Results: LBBB was present in 556 (1.3%) patients with a mean age of 57 years. After 
adjusting for age and heart rate in a Cox model, QRS duration (HR 1.8, p<0.0001, for a 
QRS duration>150 ms) and LAD (HR 1.5, p<0.0001) were strong independent predictors 
of CV death in patients with LBBB. When further subdivided using a QRS duration of 
150 ms as the cut-off, LAD with a QRS duration>150 ms (HR 2.0, p<0.0001) was the 
strongest predictor of CV death, outperforming all other established ECG predictors of 
death. Survival curves demonstrated significant separation according to the presence or 
absence of LAD and QRS durations above or below 150 ms.
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Conclusions: LAD in patients with LBBB is associated with increased CV mortality despite 
QRS prolongation. This axis shift can be easily determined on the ECG and should be 
considered as part of clinical risk stratification. 
10:00 a.m.
1029-103 The “PhysioGlove”®, a New Diagnostic 12-Lead ECG 
Acquisition Device: Assessment of Reproducibility 
and Diagnostic Accuracy Compared to ECGs Acquired 
Using the Conventional ECG Cable
Michael Luc, Roberto M. Lang, Dan Tzivoni, Roderick Childers, Morton Arnsdorf, Irving 
Levi, Daniel David, University of Chicago, Chicago, IL, Tel Aviv University, Tel Aviv, Israel
Background: Presently12 lead ECG still lacks in reproducibility (R) and diagnostic 
accuracy (DA). The PhysioGlove® (PG), a new ECG acquisition device incorporates all 
10 electrodes in a glove placed on the left hand (Fig), for rapid (no lead wires, no skin 
preping), accurate & reproducible ECG recording with minimal proficiency. Methods: To 
compare R and DA of PG-ECGs with regular ECG cable (RC) ECGs, 207 consecutive, 
consenting adult cardiology outpatients (pts) were studied. Height, weight, chest 
circumference (CC) and diagnoses were noted. The PG was carefully designed (using 
modeling and extensive anthropomorphic population studies) to fit >80% of a random 
adult US population. All pts had three ECG’s. ECG-I= using the PG, ECG-II= using a RC 
with chest electrodes (CE’s) positioned in the exact location of the PG CE’s, ECG-III= 
placing the RC-CE’s in the conventional anatomic locations. ECG-I & II were compared to 
asses R, ECG-I & III were compared to assess DA. Automatic ECG analysis was used for 
comparisons. Results: M/F ratio: 123/84, ages: 21-88y, >50% of African American origin, 
height range 57-76”, weight 102-320lb. CC range 31”-52”. Overall R was 95% (regardless 
of anthropomorphism). In pts with CC range 34”-46” (n=184/207 = 89%) DA was 96.8%. 
In pts with CC>46” DA was 91.8%. Conclusions: The PG showed excellent R regardless 
of anthropomorphism. The PG DA was 96.8% in almost 90% of a representative US 
cardiology outpatient clinic population, significantly exceeding the published conventional 
ECG R and DA. 
10:00 a.m.
1029-104 Holter-Based T-wave Alternans Predicts Sudden 
Cardiac Death in High-Risk Post-MI Patients
Phyllis K. Stein, Peter P. Domitrovich, Devang Sanghavi, Prakash Deedwania, 
Washington University School of Medicine, St. Louis, MO
Background: Microvolt T-wave alternans (TWA) measured from treadmill testing and using 
spectral analysis techniques identifies patients at increased risk of sudden death (SCD). 
TWA can be measured from 24-hour Holter recordings using a time domain method called 
modified moving average (MMA). The relationship of Holter TWA to SCD is unknown.
Methods: The design and results of the EPHESUS study have been published previously. 
EPHESUS enrolled hospitalized post-MI patients with heart failure and/or diabetes with 
left ventricular dysfunction. Prior to randomization to drug treatment, Holter recordings 
were obtained from 493 patients. Of these patients, 48 died, 18 suddenly and the rest 
of cardiovascular causes (nonSCD). A case control study was performed using 92 
controls, alive at the end of follow up and matched with non-survivors based on age, 
gender and having diabetes. MMA TWA analysis was performed using a MARS system 
(GE Healthcare, Milwaukee, WI) running software version 7.1.1. The software provides 
a histogram of TWA values and the ECG strips associated with them. The three highest 
values for TWA from artifact-free periods were identified and averaged (AVMAXTWA) for 
each channel. The cutpoint that maximized the separation between those who had SCD 
and those who did not was determined using Cox regression analyses.
Results: AVMAXTWA on either channel was higher for those who had SCD but not different 
between nonSCD and survivors. For channel 1, AVMATWA was 38±12 µV for SCD vs. 
29±11 µV for survivors and 26±8 µV for nonSCD (p=0.002). For channel 2, AVMATWA was 
45±19 µV for SCD vs. 33±19 µV for survivors and 33±13 µV for nonSCD (p=0.05). The best 
cutpoint for prediction of SCD from AVMAXTWA on channel 1 was 43 µV. AVMAXTWA 
above this cutpoint identified 14 patients with a nearly six fold risk of sudden death of 
[RR=5.9 (95% CI= 2.2-15.8, p<0.001)]. Seven of these 14 died, all but one suddenly. The 
channel 2 cutpoint was 47 µV with a relative risk of sudden death among the 19 patients 
above this cutpoint of 5.5 (95% CI=2.2-13.8, p<0.001). Eight died suddenly.
Conclusions: Holter-based TWA measured using MMA appears to be a powerful predictor 
of SCD in high-risk post-MI patients
10:00 a.m.
1029-105 Fragmented QRS: A novel marker to identify disease 
in patients suspected of having Arrhythmogenic Right 
Ventricular Cardiomyopathy
Gopi Dandamudi, Nicola Monteforte, Raffaella Bloise, Mithilesh K. Das, Carlo 
Napolitano, Silvia G. Priori, Krannert Institute of Cardiology, Indianapolis, IN, IRCCS 
Fondazione Maugeri, Pavia, Italy
Background: To assess if fragmented QRS (fQRS) on a standard 12-lead ECG can 
serve as an additional marker in identifying patients with arrhythmogenic right ventricular 
cardiomyopathy (ARVC) & compare its utility to existing ECG markers.
Methods: Retrospective review of ECGs of 2 groups were analyzed: ARVC + [positive 
genotype and/or positive imaging] (n=38; mean age 37.5 yrs; 23 males) and ARVC - 
(n=26; mean age 33.1 yrs; 14 males). fQRS was defined by the presence of an additional 
R wave (R’) or notching in the nadir of S wave or presence of >1 R’ (fragmentation) in 2 
contiguous leads. RBBB ECGs were included in the analysis if they showed additional 
fragmentation or notching other than the typical RSR’ pattern (n=6).
Results: In the ARVC + group, 63% had fQRS (p<0.0001), 33% had precordial T wave 
inversions in ≥ 2 precordial leads (p =NS), and 16% had Epsilon waves (p = NS). In the 
ARVC - group, 12% had fQRS, 15% had precordial T wave inversions, and 8.0% had 
Epsilon waves. Positive predictive value of fQRS in ARVC + patients was 92% if fQRS 
was present in ≥4 leads and 100% if fQRS was present in ≥ 5 leads. The average number 
of fQRS leads/patient in the ARVC + group was 3.9.
Conclusion:
Our data demonstrate that fQRS is a novel diagnostic indicator for ARVC. As compared 
to precordial T wave inversions and Epsilon waves that are the currently recommended 
diagnostic ECG markers for ARVC, fQRS has comparable specificity but remarkably, it 
shows a much higher sensitivity and positive predictive value. 
Diagnostic utility of various ECG markers in patients with ARVC
Sensitivity 
(%) Specificity(%)
Positive Predictive 
Value (%)
Negative Predictive 
Value (%)
fQRS 63 88 89 62
Precordial T wave 
inversions 33 85 73 50
Epsilon waves 16 92 75 44
10:00 a.m.
1029-106 Comparison of Microvolt T-Wave Alternans with Invasive 
and Noninvasive Risk Stratifiers for Sudden Cardiac 
Death in Hypertrophic Cardiomyopathy
Frank Cuoco, Valerian Fernandes, Christopher D. Nielsen, J. Lacy Sturdivant, Robert B. 
Leman, J. Marcus Wharton, William H. Spencer, Michael R. Gold, Medical University of 
South Carolina, Charleston, SC
Introduction: Microvolt T-wave alternans (TWA) and electrophysiology studies (EPS) 
are commonly used to assess arrhythmia vulnerability in diverse patient populations. 
However, nonarrhythmic clinical parameters are typically used to risk stratify for sudden 
death (SCD) among patients with hypertrophic cardiomyopathy (HCM). The relationship 
between arrhythmia measures and these risk factors (RFs) is not well studied.
Methods: We evaluated 30 patients with HCM who underwent alcohol septal ablation 
and were referred for EPS. The traditional RFs for SCD were assessed, including a 
family history of SCD, syncope, marked septal thickness, and abnormal blood pressure 
response during exercise. TWA was performed in all pts prior to EPS.
Results: The mean age of the cohort was 50±13 years, 60% were male, and they had 
1.3±1 RFs for SCD. Positive (pos), negative (neg), and indeterminate (ind) TWA results 
were 27%, 57%, and 17%, respectively. Six patients (20%) had neg EPS, while 24 patients 
(80%) had pos EPS. In the TWA neg group, 88% had pos EPS, whereas in the TWA non-
neg (pos + ind) group, 69% had a pos EPS (p=0.36, Fisher’s exact test). The table shows 
the relationship between TWA and EPS with the traditional RFs for SCD in HCM.
Conclusions: TWA does not predict the results of EPS, and neither TWA nor EPS are 
associated with traditional RFs for SCD in patients with HCM. EPS was frequently positive 
and likely a nonspecific finding. Long term follow-up is needed to assess if TWA predicts 
arrhythmic events.
Traditional RFs for SCD in HCM - EPS vs. TWA (all p-val NS using Fisher’’s exact/
student-t tests)
Septal 
Thickness 
(cm)
Abnormal BP 
Response
Syncope/Near-
syncope
Family 
History of 
SCD
Total Risk 
Factors
EPS Pos 
(n=24) 2.4 ± 0.6 48% 46% 25% 1.4 ± 1.1
EPS Neg 
(n=6) 2.3 ± 0.4 17% 50% 17% 0.8 ± 1.0
TWA Neg 
(n=17) 2.3 ± 0.5 40% 35% 18% 1.1 ± 1.1
TWA Non-
Neg (n=13) 2.3 ± 0.7 42% 62% 31% 1.5 ± 1.0
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10:00 a.m.
1029-107 Fragmented QRS Complexes on a 12-lead ECG is 
a Marker of Greater Myocardial Scaring Related to 
Coronary Artery Disease by Magnetic Resonance 
Imaging
Mohamed Homsi, Lamaan Alsayed, Mithilesh K. Das, Jo Mahenthiran, Krannert Institute 
of Cardiology, Indiana University School of Medicine, Indianpolis, IN
Background: Fragmented QRS complexes (fQRS) on a 12-lead ECG are a marker 
of greater myocardial scarring. The possibility of coronary artery disease (CAD) as 
the etiology of this is not known. Hence, we evaluated this by Gadolinium-delayed 
enhancement (GDE) Cardiac magnetic resonance (CMR) imaging.
Method: CMR was performed on 1.5-T Siemens system. GDE was obtained 10 minutes 
post contrast injection (0.1 mmol/kg dose). Sub-endocardial GDE corresponding to 
coronary territory was considered a marker of CAD scar. The fQRS was defined by 
the presence of fragmented QRS, notched R or S wave, or RSR` pattern in at least 2 
contiguous leads in one of the major coronary artery territories (LAD: lead V1 to V6, LCx: 
lead I, aVL and V6, and RCA: lead II, III and aVF).
Results: We studied 33 pts (mean age 48 ± 15 years, 42% male, 33% known CAD). 12 
(36%) pts had fQRS and 4 (12%) pts had Q waves on their 12-lead ECG. 8(24%) pts 
had GDE. Sensitivity, specificity, positive predictive value and negative predictive value of 
detecting myocardial scar by fQRS were 100%, 86%, 67% and 100%; respectively with 
an accuracy of 97% CI [0.91-1.00]; p<0.001. Results with analysis of anterior, lateral and 
inferior fQRS and Q wave are summarized in the table.
Sensitivity Specificity Accuracy P value
FQRS 100% 84% 97% <0.001
Q wave 50% 100% 75% 0.03
fQRS and/or Q wave 100% 84% 92% <0.001
Anterior fQRS 100% 93% 97% 0.009
Anterior Q wave 67% 100% 83% 0.06
Anterior fQRS and/or Q wave 100% 93% 99% 0.006
Lateral fQRS 83% 96% 90% 0.003
Lateral Q wave no cases
Lateral fQRS and/or Q wave 83% 96% 90% 0.003
Inferior fQRS 100% 82% 91% 0.004
Inferior Q wave 60% 96% 78% 0.04
Inferior fQRS and/or Q wave 100% 82% 95% 0.002
Conclusion: Presence of fragmented QRS complexes (fQRS ) on a 12-lead ECG is a 
highly sensitive marker of the presence of a sub-endocardial myocardial scar related to 
underlying CAD, and provides greater accuracy compared to Q-waves alone for detecting 
occult CAD scarring of all regions by a 12-lead ECG.
10:00 a.m.
1029-108 Fragmentation of Wide QRS on 12-Lead ECG Predicts 
Myocardial Scar
Hussam Suradi, Waddah Maskoun, Mark Michael, Hicham El Masry, Mithilesh K. Das, 
Krannert Institute of Cardiology, Indiana University, Indianapolis, IN
Background: Fragmented QRS (fQRS) with a QRS <120 ms represents myocardial 
conduction delay due to myocardial infarction scar in patients with coronary artery 
disease (CAD). However, fQRS is not defined in presence of a wide QRS (>120 ms). 
We postulate that a wide fQRS (wfQRS) due to bundle branch block (fBBB), premature 
ventricular complexes (fPVC) or a paced rhythm (fpQRS) on a 12-lead ECG signifies 
myocardial scar.
Methods: ECGs of pts who underwent cardiac evaluation of CAD with nuclear stress 
imaging or cardiac catheterization for presence of myocardial scar were studied. WfQRS 
was defined by the presence of > 2 notches on R or S wave, in at least two or more 
contiguous leads representing a major coronary artery.
Results: 879 patients (age 67.3+11, Male 97%, mean follow-up: 29+19 months) were 
included in the study. 310 had BBB, 301 PVC and 268 paced rhythm. WfQRS was present 
in 415 (47.2%) pts. Myocardial scar was present in 442 (50.3%) pts. 170 had fBBB, 124 
had fPVCs and 121 had fpQRS. The wfQRS was an independent predictor for myocardial 
scar (p<0.001). The sensitivity, specificity, positive and negative predictive values of 
wfQRS for detecting myocardial scar were 86.9%, 92.9%, 92.5% and 87.5%, respectively. 
The wfQRS was also associated with significantly increased mortality (35.1% vs. 18%, P 
<0.001) as compared to its absence.
Conclusions: The wfQRS is a highly specific novel ECG sign for myocardial scar in pts with 
known or suspected CAD. The wfQRS is also associated with significantly higher mortality.
10:00 a.m.
1029-109 Anger, Alternans, and Arrhythmia: Anger-Induced TWA 
Predicts Future Ventricular Arrhythmias in Patients 
With ICDs
Rachel J. Lampert, Vladimir Shusterman, Matthew Burg, William Batsford, Craig 
McPherson, Robert Soufer, Yale University School of Medicine, New Haven, CT, 
University of Pittsburgh, Pittsburgh, PA
Background: Anger can precipitate ventricular arrhythmias, and induce T-wave alternans 
(TWA). However, whether anger-induced TWA predicts future ventricular arrhythmias 
(VT/VF) is unknown.
Methods: Fifty-seven patients with ICDs (50 male, 63 ±12 years, 51 with CAD, 21 with history 
of prior clinical arrhythmia) underwent ambulatory ECG monitoring during a laboratory 
mental stress protocol including sequential resting-baseline and anger conditions, three 
months after implant. Pacing was programmed VVI, 40 bpm, resulting in sinus rhythm with 
native AV conduction in all. TWA was analyzed continuously using time-domain methods. 
Patients were followed for ≥ 1 year (median 36 months) and ICD stored electrograms and 
event details reviewed to determine incidence of VT/VF terminated by the ICD.
Results: Patients with ICD-terminated VT/VF during follow-up (N=9) had higher mean TWA 
induced by anger in the laboratory, 12.8± 1.0uV, compared to those without subsequent 
VT/VF, 9.4±0.8uV (p<0.008). To evaluate the predictive value of anger-induced TWA, the 
15 subjects in the highest quartile of anger-induced TWA were compared with the 41 in the 
bottom quartiles. Patients in the top quartile were more likely to experience VT/VF by one 
year than those in the lower quartile, 25% vs 5%, (p<0.05), and during extended follow-
up, 33% vs 9% (p<0.05.) After adjusting for heart rate during anger and length of follow-
up, the likelihood of VT/VF during follow-up for those in the top quartile was 5.4 times 
that of the lower quartiles (95% CI 1.7-90, p<0.03). In multivariable regression further 
controlling for ejection fraction, history of prior clinical arrhythmia, and wide QRS, anger-
induced TWA was the only significant predictor of VT/VF, with likelihood in the top quartile 
7.8 times that of the lower(CI 1.2-81, p<0.05.) Kaplan-Meier analysis confirmed that those 
in the top quartile were more likely to suffer an ICD-terminated VT/VF (p<0.05)
Conclusion: Anger-induced TWA predicts future VT/VF in patients with ICDs, suggesting 
that emotion-induced repolarization instability may be one mechanism linking stress and 
sudden death. Whether there is a clinical role for anger-induced TWA testing requires 
further study.
10:00 a.m.
1029-110 Electrocardiographic Abnormalities Are Common 
Among Pre-participation ECGs in a Population of Elite 
US College Athletes
J. Jason West, John M. MacKnight, Ethan N. Saliba, Benjamin S. Rose, John D. 
Ferguson, John P. Dimarco, John P. Dimarco, Srijoy Mahapatra, J. Paul Mounsey, 
Dilaawar J. Mistry, University of Virginia, Charlottesville, VA
Background: Screening of elite athletes with a history and physical is recommended 
for the identification of those at risk of sudden cardiac death. The value of routine pre-
participation ECG screening is debated, but it is not recommended by the ACC. Currently, 
350-450,000 athletes compete at the U.S. collegiate level, yet the incidence of abnormal 
ECGs in contemporary athletes is unknown.
Methods: We obtained ECGs in 643 athletes at a Division IA university. Each ECG was 
reviewed according to the screening criteria of the European Society of Cardiology (ESC). 
The ECG was graded as being Normal, Non-LVH Abnormal, or LVH. LVH was defined as 
having R or S wave amplitude in a standard lead >=2mV, S wave in lead V1 or V2 >=3mV, 
or R wave in lead V5 or V6 >=3mv. Non-LVH Abnormal ECGs encompassed all other 
abnormalities delineated in the ESC Criteria. Sports were graded by aerobic intensity 
according to ACC Bethesda guidelines as low, moderate, or high.
Results: There were 75/643 (11.6%) LVH and 57/643 (8.9%) Non-LVH Abnormal ECGs. 
LVH was present in ECGs from 53/337 (16.6%) male and 19/306 (6.2%) female athletes 
(P<0.001). Non-LVH Abnormal ECGs were present in 32/337 (9.5%) male and 25/306 
(8.2%) female athletes (P=NS). There was a trend towards more LVH in ECGs from 
African-American 15/96 (15.6%) vs. Caucasian 51/477 (10.7%) athletes (P=0.08). LVH 
was equally distributed between the low 13/128 (10.1%), moderate 31/237 (13.1%), and 
high 31/278 (11.1%) intensity groups (P=NS). The Non-LVH abnormal group consisted 
of bradycardia (2), PVCs (3), axis deviation (6), long PR (9), short PR (8; 2 subjects had 
clinically relevant WPW which was subsequently ablated), wide QRS (4), LAE (9), RAE 
(6), and isolated ST-T changes (29). No athletes were banned from participation due to 
ECG abnormalities and no deaths occurred.
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Conclusions: In this population of collegiate athletes, ECG abnormalities were common. 
LVH was the most common abnormality. Women athletes rarely demonstrated LVH on 
ECG, but African-American athletes commonly did. Based on ECG, further evaluation 
would be indicated in approximately 20% of athletes. Thus, any proposed collegiate ECG 
screening program should expect significant follow-up testing.
10:00 a.m.
1029-111 Non-Sustained Ventricular Tachycardia as a Predictor of 
Sudden Death in Heart Failure: A Meta-Analysis
Marcos R. Sousa, Carlos A. Morillo, Fábio T. Rabelo, Antonio M. Nogueira Filho, Antonio 
L. Ribeiro, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, McMaster 
University, Hamilton, Canada
Background: There is a clear need for improving the risk stratification of sudden death in heart 
failure (HF); the role of non-sustained ventricular tachycardia (NSVT) remains controversial. 
Our aim was to evaluate the value of NSVT on Holter monitoring as a predictor of major 
arrhythmic events (sustained ventricular tachycardia, resuscitated ventricular fibrillation or 
sudden death) in patients with HF or left ventricular dysfunction (LVD). Methods: The literature 
review and study selection were systematically done by 2 researchers using PubMed/
LILACS databases. Studies included fullfilled the following criteria were: a) > 100 patients 
with HF/LVD; b) multivariate analysis; c) good quality data on the relation between NSVT/ 
type of death. We chose the Moses model to build a summary ROC curve and DerSimonian 
Laird method with random effects model to obtain summary Likelihood Ratios (LR) and the 
diagnostic Odds Ratio (OR). Results: Eleven studies were included in the meta-analysis 
(ischemic and non-ischemic etiology). Summary negative LR was 0.62 (95%CI 0.55-0.69) 
without significant heterogeneity. Summary Positive LR was 1.86 (95%CI 1.56-2.21) with 
significant heterogeneity (p<0.001). Summary Diagnostic OR was 3.03 (95%CI 2.44-3.76) 
without significant heterogeneity. The AUC of the sROC curve was 0.68 (SE=0.02), showing 
significant contribution of NSVT to risk stratification. Conclusion: NSVT significantly improves 
the prediction of sudden death in HF/LVD patients, independently of LVD.
10:00 a.m.
1029-112 Fragmented QRS Complexes on 12-Lead ECG Predict 
Significant Mortality in Patients With Congestive Heart 
Failure
Waddah Maskoun, Bilal Safadi, Mithilesh K. Das, Indiana University, Indianpolis, IN
Background: We have previously shown that fragmented QRS (fQRS) on a 12-lead 
ECG without typical bundle branch block (BBB) is associated with myocardial scar and 
higher mortality in patients undergoing stress testing. We postulate that fQRS in patients 
with congestive heart failure (CHF) is associated with significantly higher mortality than 
patients without fQRS.
Methods: We reviewed the ECGs of 163 CHF patients; these ECGs were performed at the 
time a CHF diagnosis was first made. Mortality was the endpoint of follow-up, which was 
defined as death or cardiac transplant. The fQRS was defined as various RSR patterns 
(rSr, rSR, RSr, notched R or S wave) in any two contiguous leads corresponding to a 
major coronary artery territory (figure).
Results: 39 patients with typical BBB were excluded. Of 124 patients (mean age: 60.8 + 
11.7 years, male: 97.6%, ejection fraction: 32% + 18, mean follow-up: 5.9 + 2.9 years), 
81 patients (65%) had fQRS. Clinical and medical therapy variables, QRS duration, and 
ejection fraction did not differ significantly between the fQRS and non-fQRS patients. 
The fQRS patients had significantly higher mortality than the non-fQRS patients (70.4% 
vs. 41.9%, p = 0.004). Kaplan Meier survival analysis (figure) revealed a significantly 
decreased survival in the fQRS group versus non-fQRS group (p = 0.013).
Conclusions: fQRS on a 12-lead ECG is associated with significantly increased mortality 
in CHF patients.
10:00 a.m.
1029-113 Risk Prediction in Post-Infarction Patients Presenting 
with Atrial Fibrillation
Petra Barthel, Axel Bauer, Raphael Schneider, Alexander Müller, Anke Joeinig, Kurt 
Ulm, Georg Schmidt, 1. Medizinische Klinik, University of Technology, Munich, Germany
Background: In most studies dealing with risk stratification after acute myocardial infarction, 
patients presenting with atrial fibrillation (Afib) and patients with pacemakers (PM) were 
excluded from further analyses because all heart rate variability parameters could not be 
calculated in this patients. Goal of this prospective cohort study in post-infarction patients of 
the reperfusion era was (1) to explore the incidence and outcome of patients presenting not 
with sinus rhythm, and (2) detect risk predictors in this patient population.
Methods: 2952 survivors of an acute myocardial infarction were prospectively enrolled. 
Left ventricular ejection fraction, mean heart rate, QRS duration, incidence of ventricular 
premature complexes and non-sustained ventricular tachycardia were assessed during 
the second week after the index infarction and dichotomized at pre-defined cut-off points 
Primary endpoint was five year all-cause mortality.
Results: 187 patients out of 2952 patients did not show sinus rhythm during the 24h-
Holter recording. 110 patients presented with permanent Afib, 46 patients presented 
with intermittent Afib and 31 patients presented permanent or intermittent PM rhythm. 
On univariate Cox analysis there was no difference in the hazard ratio of patients with 
permanent or intermittent Afib (4.2 and 4.1, p<0.001; 2.7, p<0.01 for PM rhythm). During 
a follow-up of 4.5 years, 64 of the 187 patients died. The probability of death of any cause 
at five years was comparable to patients presenting with sinus rhythm and a LVEF ≤30% 
(41% and 45%, respectively (p<0.001). On multivariate analysis, LVEF, age and QRS 
duration were the only significant variables (hazard ratios of 3.1, 2.8 and 1.9; p<0.001).
Conclusions: In post-infarction patients presenting with atrial fibrillation or pacemaker 
rhythm the survival probability at five years is almost identical with the survival probability 
of patients with a LVEF ≤30%. In these patients an impaired LVEF, advanced age and 
prolonged QRS duration are independent risk predictors of late mortality.
10:00 a.m.
1029-114 A highly purified omega-3 fatty acid derivative does 
not alter QTc interval but does reduce QT dispersion in 
patients with stable coronary artery disease
Sheba K. Meymandi, Mahmoud I. Traina, Mark McDonnell, Atef H. El Gassier, Mohamed R. 
Labedi, Tarik A. Ngab, Robin Y. Wachsner, Olive View-UCLA Medical Center, Sylmar, CA
Background: Fish oil has been shown to reduce sudden death in patients with coronary 
artery disease (CAD) potentially by decreasing fatal arrhythmias. Increased QTc and 
QT dispersion (QTd) have been found to be associated with increased risk of venricular 
arrhythmias. Several epidemiologic trials have suggested increased fish intake may reduce 
the QTc interval, potentially reducing the risk of sudden death. However, no prior randomized 
trial has evaluated the effects of fish oil on QTc interval and QTd in this population.
Methods: In a randomized, double-blinded, placebo-controlled trial, 71 patients with 
established CAD and normal or near-normal ejection fraction received either 1 gram twice 
a day of a highly purified omega-3 fatty acid derivative, Lovaza, (n=37) or placebo (n=34) 
for 2 months. One patient in each group developed atrial fibrillation and were excluded 
from the analysis. At day 0 and day 60, electrocardiograms were obtained. Measurements 
of QTd were performed manually.
Results: Fish oil supplementation did not result in any significant change in QTc (2.1ms in 
fish oil, -2.0ms in placebo, P=0.34). However, a significant reduction in QT dispersion was 
noted (-6.4±13.2ms in fish oil, -0.07±9.8ms in placebo, P=0.047).
Conclusions: Fish oil supplementation in patients with CAD did not result in any significant 
effect on QTc interval. However, there was a significant reduction in QTd. This effect may 
partly explain the mechanism of reduction of sudden death with fish oil supplementation. 
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10:00 a.m.
1029-115 Tonic and reflex vagal activity for prediction of mortality 
in diabetic post-infarction patients
Axel Bauer, Petra Barthel, Raphael Schneider, Anke Joeinig, Georg Schmidt, 1. Med. 
Klinik und Deutsches Herzzentrum, TU München, Munich, Germany
Introduction: Diabetic post-infarction patients are at increased risk for death. As cardiac 
autonomic neuropathy is a common finding in these patients, this study was performed to 
investigate the power of decreased tonic and reflex vagal activity for prediction of death.
Methods: The study included 2,343 survivors of acute MI in sinus rhythm. 412 suffered 
from diabetes mellitus. During follow-up of 5 years 61 diabetic and 120 non-diabetic 
patients died. Holter recordings were performed within the second week after infarction. 
Tonic vagal activity was assessed by means of heart rate deceleration capacity (DC). 
Reflex vagal activity was assessed by means of Heart-Rate Turbulence slope (TS). 
According to previously published cut-off values, DC and TS were considered abnormal if 
<= 4.5ms and <= 2.5 ms/RRI, respectively.
Results: DC and TS were significantly lower in diabetic patients compared to non-
diabetic patients (4.4±3.5 vs. 5.8±3.7 and 6.1±7.3ms/RRI vs. 9.4±9.1ms/RRI;p<0.0001 
respectively). Both, DC and TS were independent predictors of mortality and added to 
risk prediction: If both factors were abnormal, 5-year mortality rate was 43.2%. If only 
one factor was abnormal, this figure was 9.0%; if neither factor was abnormal, this figure 
was 4.1%. 
Conclusions: Tonic and reflex vagal activity assessed by DC and TS are impaired 
in diabetic post-infarction patients. Combination of abnormal DC and TS identifies a 
subgroup of diabetic post-MI patients at very high risk for subsequent death.
10:00 a.m.
1029-116 Enhanced Detection of Coronary Artery Disease and 
Myocardial Ischaemia Using Spectral Analysis of 
Energy-based ECG Indices
David Eccleston, Andrew M. Tonkin, Dipak Kotecha, Igor Zilberman, Aaron Ginzberg, 
Monash University, Melbourne, Australia
Background: The resting electrocardiogram (ECG) is insensitive for detection of coronary 
artery disease. Fluctuations of High-frequency QRS and ST fluctuations associated with 
ischaemia during coronary angioplasty (PCI) may also detect ischaemia in
resting ECGs.
Methods: In 110 patients undergoing elective PCI and 20 normal controls, we compared 
standard 12-lead ECG ST/T changes with the presence and regional localisation of 
novel energy-based indices of QRS and ST segments. Global (CPI-G) and regional 
(CPI-R) indices were derived from 12-lead ECG recordings with blinded analysis by 3 
investigators.
Results: Baseline CPI-G and CPI-R were higher for the PCI group (37.0+16.6 and 
48.8+23.3) than controls (12+7.9, p<0.001 for both). Baseline ECGs revealed definite or 
possible ischaemic changes in only 52% of PCI patients vs. 73% or 98% of CPI-ECG using 
a cut-off of mean+2 or 1 SD from controls. CPI indices were similar irrespective of whether 
the baseline ECG was normal. Only 50% of patients developed diagnostic ECG changes 
during balloon inflation. However, both CPI-G and CPI-R increased significantly (59+110%) 
during inflation, regardless of the presence or absence of ischaemia on ECG (Table).
Conclusions: Resting spectral energy ECGs are superior to standard ECGs in detection 
of coronary artery disease or ischaemia. CPI indices demonstrate consistent increases 
during coronary artery occlusion by balloon angioplasty and may be better able to detect 
acute ischaemia than traditional ECG examination. 
CPI indices (mean+/-SD) by ECG and PCI status
Baseline ECG Normal (n=46) Abnormal N=64) p
CPI-G 35.2+13.0 38.2 +18.3 0.34
CPI-R 46.1+17.9 50.6 +26.0 0.31
PCI Baseline Inflation p
CPI-G 37.0+16.6 56.7+30.2 <0.0001
CPI-R 48.8+23.3 75.4+36.0 <0.0001
